<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><?properties manuscript?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-journal-id">9918435075106676</journal-id><journal-id journal-id-type="pubmed-jr-id">51835</journal-id><journal-id journal-id-type="nlm-ta">Front Syst Biol</journal-id><journal-id journal-id-type="iso-abbrev">Front Syst Biol</journal-id><journal-title-group><journal-title>Frontiers in systems biology</journal-title></journal-title-group><issn pub-type="epub">2674-0702</issn></journal-meta><article-meta><article-id pub-id-type="pmid">40012834</article-id><article-id pub-id-type="pmc">PMC11864782</article-id><article-id pub-id-type="doi">10.3389/fsysb.2024.1368555</article-id><article-id pub-id-type="manuscript">NIHMS2015369</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>A review of mathematical modeling of bone remodeling from a systems biology perspective</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Cook</surname><given-names>Carley V.</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="FN1" ref-type="author-notes">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Lighty</surname><given-names>Ariel M.</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="FN1" ref-type="author-notes">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Smith</surname><given-names>Brenda J.</given-names></name><xref rid="A2" ref-type="aff">2</xref><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Ford Versypt</surname><given-names>Ashlee N.</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="A4" ref-type="aff">4</xref><xref rid="A5" ref-type="aff">5</xref><xref rid="CR1" ref-type="corresp">*</xref></contrib></contrib-group><aff id="A1"><label>1</label>Department of Chemical and Biological Engineering, University at Buffalo, The State University of New York, Buffalo, NY, United States,</aff><aff id="A2"><label>2</label>Indiana Center for Musculoskeletal Health, School of Medicine, Indiana University, Indianapolis, IN, United States,</aff><aff id="A3"><label>3</label>Department of Obstetrics and Gynecology, School of Medicine, Indiana University, Indianapolis, IN, United States,</aff><aff id="A4"><label>4</label>Department of Biomedical Engineering, University at Buffalo, The State University of New York, Buffalo, NY, United States,</aff><aff id="A5"><label>5</label>Institute for Artificial Intelligence and Data Science, University at Buffalo, The State University of New York, Buffalo, NY, United States</aff><author-notes><fn fn-type="equal" id="FN1"><label>&#x02020;</label><p id="P1">These authors have contributed equally to this work and share first authorship</p></fn><fn fn-type="con" id="FN2"><p id="P2">Author contributions</p><p id="P3">CC: Conceptualization, Data curation, Formal Analysis, Investigation, Methodology, Visualization, Writing&#x02013;original draft, Writing&#x02013;review and editing. AL: Conceptualization, Data curation, Formal Analysis, Investigation, Methodology, Visualization, Writing&#x02013;original draft, Writing&#x02013;review and editing. BS: Conceptualization, Funding acquisition, Project administration, Writing&#x02013;review and editing. AF: Conceptualization, Data curation, Formal Analysis, Funding acquisition, Methodology, Project administration, Resources, Supervision, Writing&#x02013;review and editing.</p></fn><corresp id="CR1"><label>*</label><bold>CORRESPONDENCE:</bold> Ashlee N. Ford Versypt, <email>ashleefv@buffalo.edu</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>9</day><month>8</month><year>2024</year></pub-date><pub-date pub-type="ppub"><year>2024</year></pub-date><pub-date pub-type="epub"><day>8</day><month>4</month><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>26</day><month>2</month><year>2025</year></pub-date><volume>4</volume><elocation-id>1368555</elocation-id><permissions><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><self-uri xlink:href="https://www.frontiersin.org/journals/systems-biology/articles/10.3389/fsysb.2024.1368555/full"/><abstract id="ABS1"><p id="P4">Bone remodeling is an essential, delicately balanced physiological process of coordinated activity of bone cells that remove and deposit new bone tissue in the adult skeleton. Due to the complex nature of this process, many mathematical models of bone remodeling have been developed. Each of these models has unique features, but they have underlying patterns. In this review, the authors highlight the important aspects frequently found in mathematical models for bone remodeling and discuss how and why these aspects are included when considering the physiology of the bone basic multicellular unit, which is the term used for the collection of cells responsible for bone remodeling. The review also emphasizes the view of bone remodeling from a systems biology perspective. Understanding the systemic mechanisms involved in remodeling will help provide information on bone pathology associated with aging, endocrine disorders, cancers, and inflammatory conditions and enhance systems pharmacology. Furthermore, some features of the bone remodeling cycle and interactions with other organ systems that have not yet been modeled mathematically are discussed as promising future directions in the field.</p></abstract><kwd-group><kwd>bone remodeling cycle</kwd><kwd>basic multicellular unit</kwd><kwd>bone chemical signaling</kwd><kwd>bone cells</kwd><kwd>osteoimmunology</kwd><kwd>mechanistic modeling</kwd><kwd>differential equations</kwd><kwd>agent-based modeling</kwd></kwd-group></article-meta></front><body><sec id="S1"><label>1</label><title>Introduction</title><p id="P5">Bone is a dynamic living tissue that plays a crucial role in providing mechanical support to the body and maintaining systemic homeostasis. Bone remodeling is the delicately balanced process of coordinated activity of bone cells that remove and deposit new bone tissue to renew the adult skeleton (<xref rid="R5" ref-type="bibr">Allen and Burr, 2014</xref>; <xref rid="R21" ref-type="bibr">Bellido et al., 2014</xref>). Multiple biochemical, physical, and mechanical factors within the bone microenvironment and throughout the body regulate bone cell activity. When these factors operate within a homeostatic range, bone removal and formation activities of bone cells are balanced, and the bone remodeling cycle ends without a net change in bone volume or mass during tissue turnover. Perturbations outside this range can cause an imbalance between bone removal and formation leading to pathological bone loss (<xref rid="R5" ref-type="bibr">Allen and Burr, 2014</xref>). The pathologies of bone loss due to conditions such as renal failure, cancer, diabetes, and age-related bone loss differ (as well as their responses to treatment). The drive to understand bone pathologies and to design effective therapeutics leads researchers to study the local and systemic mechanisms that regulate bone remodeling. Developing mathematical models that could be adapted to the unique aspects of these scenarios would provide a powerful tool.</p><p id="P6">Mechanisms of bone remodeling are complex to capture in traditional <italic toggle="yes">in vivo</italic> and <italic toggle="yes">in vitro</italic> experiments due to the dynamic nature of the cell populations involved and the complexity of their local and systemic interactions. For preclinical <italic toggle="yes">in vivo</italic> studies, the measurements that can be performed at the tissue or mechanistic level are limited by the number of timepoints typically relegated to cross-sectional study designs. With <italic toggle="yes">in vitro</italic> studies, it is challenging to create an environment that allows the cells to respond to systemic changes that influence the <italic toggle="yes">in vivo</italic> bone microenvironment. Mathematical modeling captures the dynamics of cell populations and simulates complex interactions over time, integrating effects from multiple scales locally and systemically. It is widely used for understanding bone remodeling biology and hormone dynamics. By enhancing existing models from a systems biology perspective, we can bridge the gap between molecular signaling and clinically measurable properties that correspond to tissue and patient phenotypes. This perspective considers the human body as an integrated whole with multiple interacting systems, requiring the integration of diverse data sets to understand, design, and control therapeutic responses.</p><p id="P7">Many mathematical models have been developed to enhance the understanding of the bone remodeling process. Here, we review 88 such models, with annotations included in <xref rid="SD1" ref-type="supplementary-material">Supplementary Tables S1</xref>&#x02013;<xref rid="SD1" ref-type="supplementary-material">S3</xref>. These models primarily fall into two categories for types of effects that they consider: biomechanical and biochemical. Biomechanical models aim to describe how the morphology, structural integrity, and mechanical loading of the bone matrix affect the evolution of bone (<xref rid="R247" ref-type="bibr">van Oers et al., 2008</xref>; <xref rid="R148" ref-type="bibr">Lerebours et al., 2016</xref>; <xref rid="R128" ref-type="bibr">Kameo et al., 2020</xref>; <xref rid="R40" ref-type="bibr">Calvo-Gallego et al., 2023</xref>). Some biomechanical models incorporate individual bone cell dynamics in a simplified manner. In contrast, biochemical models focus on a detailed representation of the biochemical processes governing bone cell populations. Biochemical models incorporate interactions between key molecular signals and bone cells but often neglect critical mechanical signals. Mechano-chemo-biological models are a newer third category of bone remodeling models to address the need for sufficient biomechanical and biochemical detail (<xref rid="R148" ref-type="bibr">Lerebours et al., 2016</xref>; <xref rid="R160" ref-type="bibr">Martin et al., 2019</xref>; <xref rid="R15" ref-type="bibr">Ashrafi et al., 2020</xref>; <xref rid="R3" ref-type="bibr">Ait Oumghar et al., 2020</xref>; <xref rid="R182" ref-type="bibr">Pant et al., 2021</xref>).</p><p id="P8">Here, we provide a comprehensive review of biochemical mathematical models of bone remodeling. We include a few mechano-chemo-biological models in this review to highlight how they consider changes to the biochemical bone remodeling network. Unique among other related reviews (<xref rid="R88" ref-type="bibr">Gerhard et al., 2009</xref>; <xref rid="R89" ref-type="bibr">Geris et al., 2009</xref>; <xref rid="R191" ref-type="bibr">Pivonka and Komarova, 2010</xref>; <xref rid="R257" ref-type="bibr">Webster and M&#x000fc;ller, 2011</xref>; <xref rid="R202" ref-type="bibr">Riggs and Cremers, 2019</xref>; <xref rid="R50" ref-type="bibr">Coelho et al., 2020</xref>), our review analyzes the mathematical forms used to represent the physiological processes of bone remodeling, highlights important local and systemic biological features found in mathematical models, and synthesizes these into comprehensive tables that should be useful to others interested in building or adapting such models (<xref rid="T1" ref-type="table">Tables 1</xref>&#x02013;<xref rid="T7" ref-type="table">7</xref>). Spatiotemporal biochemical models (<xref rid="R247" ref-type="bibr">van Oers et al., 2008</xref>; <xref rid="R210" ref-type="bibr">Ryser et al., 2009</xref>; <xref rid="R16" ref-type="bibr">Ayati et al., 2010</xref>; <xref rid="R208" ref-type="bibr">Ryser et al., 2010</xref>; <xref rid="R37" ref-type="bibr">Buenzli et al., 2011</xref>; <xref rid="R35" ref-type="bibr">Buenzli et al., 2012a</xref>; <xref rid="R96" ref-type="bibr">Graham and Ayati, 2012</xref>; <xref rid="R211" ref-type="bibr">Ryser et al., 2012</xref>; <xref rid="R8" ref-type="bibr">Araujo et al., 2014</xref>; <xref rid="R38" ref-type="bibr">Buenzli et al., 2014</xref>; <xref rid="R34" ref-type="bibr">Buenzli, 2015</xref>; <xref rid="R148" ref-type="bibr">Lerebours et al., 2016</xref>; <xref rid="R209" ref-type="bibr">Ryser and Murgas, 2017</xref>; <xref rid="R9" ref-type="bibr">Arias et al., 2018</xref>; <xref rid="R189" ref-type="bibr">Peyroteo et al., 2019</xref>; <xref rid="R128" ref-type="bibr">Kameo et al., 2020</xref>; <xref rid="R238" ref-type="bibr">Taylor-King et al., 2020</xref>; <xref rid="R18" ref-type="bibr">Baldonedo et al., 2021</xref>; <xref rid="R40" ref-type="bibr">Calvo-Gallego et al., 2023</xref>; <xref rid="R111" ref-type="bibr">Idrees and Sohail, 2023</xref>) are categorized in <xref rid="T1" ref-type="table">Table 1</xref>. Temporal biochemical models are organized based on which of two prevailing mathematical formulations are used to describe bone cell population dynamics and their biochemical signaling dynamics in the BMU. The temporal models that adopt the power law approach defined in <xref rid="S17" ref-type="sec">Section 4.1</xref> (<xref rid="R135" ref-type="bibr">Komarova et al., 2003</xref>; <xref rid="R134" ref-type="bibr">Komarova, 2005</xref>; <xref rid="R87" ref-type="bibr">Garz&#x000f3;n-Alvarado, 2012</xref>; <xref rid="R153" ref-type="bibr">Li&#x000f2; et al., 2012</xref>; <xref rid="R95" ref-type="bibr">Graham et al., 2013</xref>; <xref rid="R121" ref-type="bibr">Jerez and Chen, 2015</xref>; <xref rid="R47" ref-type="bibr">Chen-Charpentier and Diakite, 2016</xref>; <xref rid="R49" ref-type="bibr">Coelho et al., 2016</xref>; <xref rid="R122" ref-type="bibr">Jerez et al., 2018</xref>; <xref rid="R41" ref-type="bibr">Camacho and Jerez, 2019</xref>; <xref rid="R112" ref-type="bibr">Idrees et al., 2019</xref>; <xref rid="R119" ref-type="bibr">Javed et al., 2019</xref>; <xref rid="R110" ref-type="bibr">Idrees and Sohail, 2020</xref>; <xref rid="R168" ref-type="bibr">Miranda et al., 2020</xref>; <xref rid="R42" ref-type="bibr">Camacho and Jerez, 2021</xref>; <xref rid="R114" ref-type="bibr">Islam et al., 2021</xref>; <xref rid="R52" ref-type="bibr">Cook et al., 2022</xref>) are categorized in <xref rid="T2" ref-type="table">Table 2</xref>, described in <xref rid="S26" ref-type="sec">Section 5.2</xref>, and detailed in <xref rid="SD1" ref-type="supplementary-material">Supplementary Table S1</xref>. The temporal models that adopt the mass action kinetics approach defined in <xref rid="S18" ref-type="sec">Section 4.2</xref> (<xref rid="R147" ref-type="bibr">Lemaire et al., 2004</xref>; <xref rid="R158" ref-type="bibr">Marathe et al., 2008</xref>; <xref rid="R192" ref-type="bibr">Pivonka et al., 2008</xref>; <xref rid="R187" ref-type="bibr">Peterson and Riggs, 2010</xref>; <xref rid="R193" ref-type="bibr">Pivonka et al., 2010</xref>; <xref rid="R159" ref-type="bibr">Marathe et al., 2011</xref>; <xref rid="R217" ref-type="bibr">Schmidt et al., 2011</xref>; <xref rid="R254" ref-type="bibr">Wang et al., 2011</xref>; <xref rid="R36" ref-type="bibr">Buenzli et al., 2012b</xref>; <xref rid="R188" ref-type="bibr">Peterson and Riggs, 2012</xref>; <xref rid="R205" ref-type="bibr">Ross et al., 2012</xref>; <xref rid="R255" ref-type="bibr">Wang and Qin, 2012</xref>; <xref rid="R190" ref-type="bibr">Pivonka et al., 2013</xref>; <xref rid="R196" ref-type="bibr">Post et al., 2013</xref>; <xref rid="R214" ref-type="bibr">Scheiner et al., 2013</xref>; <xref rid="R124" ref-type="bibr">Ji et al., 2014</xref>; <xref rid="R215" ref-type="bibr">Scheiner et al., 2014</xref>; <xref rid="R25" ref-type="bibr">Berkhout et al., 2015</xref>; <xref rid="R70" ref-type="bibr">Eudy et al., 2015</xref>; <xref rid="R24" ref-type="bibr">Berkhout et al., 2016</xref>; <xref rid="R143" ref-type="bibr">Lee and Okos, 2016</xref>; <xref rid="R72" ref-type="bibr">Farhat et al., 2017</xref>; <xref rid="R206" ref-type="bibr">Ross et al., 2017</xref>; <xref rid="R100" ref-type="bibr">Hasegawa and Duffull, 2018</xref>; <xref rid="R185" ref-type="bibr">Pastrama et al., 2018</xref>; <xref rid="R126" ref-type="bibr">Ji et al., 2019</xref>; <xref rid="R146" ref-type="bibr">Lemaire and Cox, 2019</xref>; <xref rid="R160" ref-type="bibr">Martin et al., 2019</xref>; <xref rid="R164" ref-type="bibr">Mart&#x000ed;nez-Reina and Pivonka, 2019</xref>; <xref rid="R245" ref-type="bibr">Trichilo et al., 2019</xref>; <xref rid="R266" ref-type="bibr">Zhang and Mager, 2019</xref>; <xref rid="R15" ref-type="bibr">Ashrafi et al., 2020</xref>; <xref rid="R17" ref-type="bibr">Bahia et al., 2020</xref>; <xref rid="R123" ref-type="bibr">Ji et al., 2020</xref>; <xref rid="R141" ref-type="bibr">Lavaill et al., 2020</xref>; <xref rid="R161" ref-type="bibr">Martin et al., 2020</xref>; <xref rid="R140" ref-type="bibr">Larcher and Scheiner, 2021</xref>) are categorized in <xref rid="T3" ref-type="table">Table 3</xref>, described in <xref rid="S27" ref-type="sec">Section 5.3</xref>, and detailed in <xref rid="SD1" ref-type="supplementary-material">Supplementary Table S2</xref>. The temporal models that do not explicitly use the power law or mass action kinetics approaches (<xref rid="R139" ref-type="bibr">Kroll, 2000</xref>; <xref rid="R200" ref-type="bibr">Rattanakul et al., 2003</xref>; <xref rid="R162" ref-type="bibr">Martin and Buckland-Wright, 2004</xref>; <xref rid="R169" ref-type="bibr">Moroz et al., 2006</xref>; <xref rid="R170" ref-type="bibr">Moroz and Wimpenny, 2007</xref>; <xref rid="R4" ref-type="bibr">Akchurin et al., 2008</xref>; <xref rid="R125" ref-type="bibr">Ji et al., 2012</xref>; <xref rid="R197" ref-type="bibr">Proctor and Gartland, 2016</xref>; <xref rid="R43" ref-type="bibr">Chaiya and Rattanakul, 2017</xref>; <xref rid="R118" ref-type="bibr">Javed et al., 2018</xref>; <xref rid="R267" ref-type="bibr">Zhao and Zhang, 2019</xref>; <xref rid="R117" ref-type="bibr">Javed et al., 2020</xref>; <xref rid="R174" ref-type="bibr">Nutini et al., 2021</xref>; <xref rid="R127" ref-type="bibr">Jorg et al., 2022</xref>) are categorized in <xref rid="T4" ref-type="table">Table 4</xref> and detailed in <xref rid="SD1" ref-type="supplementary-material">Supplementary Table S3</xref>. A recent review of existing mechanical models of bone remodeling is provided by <xref rid="R59" ref-type="bibr">Della Corte et al. (2020)</xref>, and <xref rid="R182" ref-type="bibr">Pant et al. (2021)</xref> reviews mechanical and mechano-chemo-biological and points to opportunities for integrating mechanics, biology, and biochemistry at the cellular and molecular scales. The review of <xref rid="R3" ref-type="bibr">Ait Oumghar et al. (2020)</xref> complements our review of biochemical models but distinctly emphasizes the experimental evidence for biochemical models of bone diseases, such as osteoporosis, Paget&#x02019;s disease, and bone metastases. <xref rid="R142" ref-type="bibr">Ledoux et al. (2022)</xref> organizes their discussion of existing models by the biological features, but their focus is on summarizing a wealth of relevant clinical data for parameterizing such models. We intend for the present review to motivate systems biology researchers to look at bone beyond the local microenvironment to better understand the complexities of bone within the body as an integrated whole while still using past accomplishments in localized mathematical modeling and experimental data.</p><p id="P9">In <xref rid="S2" ref-type="sec">Section 2</xref> we introduce the background of the biology for the bone local environment. <xref rid="S6" ref-type="sec">Section 3</xref> expands the background to include systemic biological and pharmacological influences on bone remodeling. Key techniques for mathematical modeling are categorized and introduced in <xref rid="S16" ref-type="sec">Section 4</xref> and are applied to cells of the bone remodeling cycle. <xref rid="S24" ref-type="sec">Section 5</xref> reviews existing biochemical models for bone remodeling. In <xref rid="S28" ref-type="sec">Section 5.4</xref> we emphasize how current models consider bone remodeling aspects from a systems biology perspective and point to several gaps in biological concepts that have yet to be considered thoroughly, thus highlighting opportunities for future systems biology models. Summaries of the mathematical models discussed in our review can be found in <xref rid="SD1" ref-type="supplementary-material">Supplementary Tables S1</xref>&#x02013;<xref rid="SD1" ref-type="supplementary-material">S3</xref>, where the models are organized by modeling technique and include information about the cellular and biochemical molecules used, motivations and insights, and connections to other models.</p></sec><sec id="S2"><label>2</label><title>Background on bone remodeling from a local perspective</title><p id="P10">Modern understanding of bone remodeling focuses locally on a basic multicellular unit (BMU) (<xref rid="R81" ref-type="bibr">Frost, 1966b</xref>; <xref rid="R82" ref-type="bibr">Frost, 1973</xref>; <xref rid="R120" ref-type="bibr">Jee, 2001</xref>; <xref rid="R5" ref-type="bibr">Allen and Burr, 2014</xref>). A BMU is considered a functional spatial packet where bone turnover occurs during remodeling (<xref rid="R78" ref-type="bibr">Frost, 1964a</xref>; <xref rid="R80" ref-type="bibr">Frost, 1966a</xref>). The prevalent view of the BMU typically consists of three cell types: osteoclasts, osteoblasts, and osteocytes. Osteoclast cells in the BMU are responsible for bone resorption, which involves the dissolution of the hydroxyapatite mineral layer and enzymatic degradation of the bone protein matrix (<xref rid="R21" ref-type="bibr">Bellido et al., 2014</xref>; <xref rid="R130" ref-type="bibr">Kenkre and Bassett, 2018</xref>). In opposition, osteoblast cells in the BMU form the bone protein matrix by depositing unmineralized tissue called osteoid, which undergoes a highly regulated mineralization process (<xref rid="R69" ref-type="bibr">Eriksen, 2010</xref>; <xref rid="R223" ref-type="bibr">Sims and Martin, 2020</xref>; <xref rid="R71" ref-type="bibr">Everts et al., 2022</xref>). Osteoblasts embedded in the osteoid tissue during this process differentiate into osteocyte cells. These osteocytes trigger and possibly terminate remodeling by releasing signaling molecules at various cycle phases (<xref rid="R21" ref-type="bibr">Bellido et al., 2014</xref>; <xref rid="R97" ref-type="bibr">Guder et al., 2020</xref>; <xref rid="R54" ref-type="bibr">Creecy et al., 2021</xref>).</p><sec id="S3"><label>2.1</label><title>Bone remodeling cycle</title><p id="P11">In its simplest form, a remodeling cycle consists of four phases: activation, resorption, formation, and resting. Bone remodeling is activated by localized mechanical damage and osteocyte apoptosis, which may be initiated by systemic biochemical changes, aging, or mechanical loading (<xref rid="R5" ref-type="bibr">Allen and Burr, 2014</xref>; <xref rid="R130" ref-type="bibr">Kenkre and Bassett, 2018</xref>; <xref rid="R182" ref-type="bibr">Pant et al., 2021</xref>). These factors trigger osteocytes to secrete signals that stimulate the proliferation of mononuclear cells, which fuse into preosteoclasts and then become active osteoclasts (<xref rid="R69" ref-type="bibr">Eriksen, 2010</xref>; <xref rid="R223" ref-type="bibr">Sims and Martin, 2020</xref>; <xref rid="R71" ref-type="bibr">Everts et al., 2022</xref>). As osteoclasts resorb bone, signaling factors (e.g., transforming growth factor beta (TGF-<inline-formula><mml:math id="M14" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula>), insulin-like growth factor (IGF)-1, IGF-2, bone morphogenic protein (BMP)2, and Wnt-10b (<xref rid="R223" ref-type="bibr">Sims and Martin, 2020</xref>)) are released from the bone matrix or secreted by osteoclasts themselves. These signals, in turn, initiate osteoblast proliferation, migration, and activation. Osteoblasts produce the extracellular protein matrix that becomes bone tissue. Embedded osteocytes secrete signals to slow bone formation and indicate when the resorption cavity is filled, leading to a resting phase.</p><p id="P12">A more complex and recent representation of the bone remodeling cycle adds a reversal phase between the resorption and formation phases (<xref rid="R120" ref-type="bibr">Jee, 2001</xref>; <xref rid="R5" ref-type="bibr">Allen and Burr, 2014</xref>; <xref rid="R21" ref-type="bibr">Bellido et al., 2014</xref>) (<xref rid="F1" ref-type="fig">Figure 1</xref>). Before osteoblasts rebuild bone, it is suggested that the resorbed bone cavity is cleared of debris by reversal cells, which are currently not considered part of the BMU (<xref rid="R57" ref-type="bibr">Delaisse et al., 2020</xref>). The origin of these cells is unclear, but they express markers of osteoblastic lineage (<xref rid="R57" ref-type="bibr">Delaisse et al., 2020</xref>; <xref rid="R68" ref-type="bibr">Epsley et al., 2021</xref>). Bone lining cells are another cell not canonically considered part of the BMU. However, osteoblasts can also become bone lining cells at the end of the bone formation phase, forming a protective layer on the bone surface that prevents osteoclasts from interacting with bone where remodeling should not occur (<xref rid="R21" ref-type="bibr">Bellido et al., 2014</xref>; <xref rid="R76" ref-type="bibr">Florencio-Silva et al., 2015</xref>; <xref rid="R59" ref-type="bibr">Della Corte et al., 2020</xref>).</p></sec><sec id="S4"><label>2.2</label><title>Cells of the BMU</title><p id="P13">Osteoclasts are the only cells known to break down bone. They originate from hematopoietic stem cells that differentiate into monocyte progenitors (<xref rid="R21" ref-type="bibr">Bellido et al., 2014</xref>) (<xref rid="F2" ref-type="fig">Figure 2</xref>). In bone remodeling, the monocyte progenitor cells are often called uncommitted osteoclasts because they can also differentiate into other cell types. Upon stimulation by various signaling factors, monocyte progenitor cells become mononuclear preosteoclasts (also known as precursor osteoclasts) that later proliferate and fuse into osteoclasts (<xref rid="R163" ref-type="bibr">Martin and Rodan, 2009</xref>; <xref rid="R69" ref-type="bibr">Eriksen, 2010</xref>; <xref rid="R21" ref-type="bibr">Bellido et al., 2014</xref>; <xref rid="R132" ref-type="bibr">Kim et al., 2020</xref>; <xref rid="R223" ref-type="bibr">Sims and Martin, 2020</xref>; <xref rid="R68" ref-type="bibr">Epsley et al., 2021</xref>; <xref rid="R71" ref-type="bibr">Everts et al., 2022</xref>). Thus, osteoclasts are multinucleated cells that remove bone (<xref rid="R120" ref-type="bibr">Jee, 2001</xref>).</p><p id="P14">Osteoblasts produce osteoid, the collagenous organic matrix that makes up bone (<xref rid="R5" ref-type="bibr">Allen and Burr, 2014</xref>; <xref rid="R21" ref-type="bibr">Bellido et al., 2014</xref>; <xref rid="R219" ref-type="bibr">Sharma et al., 2020</xref>). Osteoblasts are derived from mesenchymal stem cells from bone marrow that differentiate into osteochondro progenitor cells (<xref rid="F2" ref-type="fig">Figure 2</xref>). These are often classified as uncommitted osteoblasts. Osteochondro progenitor cells later differentiate into committed preosteoblast cells (also known as precursor osteoblasts). During bone remodeling, signaling factors activate the proliferation and migration of preosteoblasts to the resorption site, where they differentiate into osteoblast cells. When osteoblasts become trapped in the osteoid collagen matrix, they differentiate into osteocytes. The osteoblasts that remain after bone formation become inactive bone lining cells or undergo apoptosis (<xref rid="R120" ref-type="bibr">Jee, 2001</xref>; <xref rid="R21" ref-type="bibr">Bellido et al., 2014</xref>).</p><p id="P15">Although questions remain about what regulates osteoblast differentiation into osteocytes, the change is marked by the formation of dendrites (<xref rid="R54" ref-type="bibr">Creecy et al., 2021</xref>) that form a network to communicate with other osteocytes and bone cells (<xref rid="R21" ref-type="bibr">Bellido et al., 2014</xref>). Osteocytes have a 25-year lifespan and are the longest-living and most abundant bone cells (<xref rid="R120" ref-type="bibr">Jee, 2001</xref>; <xref rid="R26" ref-type="bibr">Bonewald, 2011</xref>; <xref rid="R21" ref-type="bibr">Bellido et al., 2014</xref>; <xref rid="R76" ref-type="bibr">Florencio-Silva et al., 2015</xref>).</p><p id="P16">The roles of osteocytes in the bone remodeling process are relatively recent discoveries, as these cells were initially considered inert (<xref rid="R27" ref-type="bibr">Bonewald and Johnson, 2008</xref>; <xref rid="R26" ref-type="bibr">Bonewald, 2011</xref>; <xref rid="R76" ref-type="bibr">Florencio-Silva et al., 2015</xref>). Osteocytes stimulate remodeling in response to mechanical and hormonal stimuli and other stressors (<xref rid="R26" ref-type="bibr">Bonewald, 2011</xref>; <xref rid="R21" ref-type="bibr">Bellido et al., 2014</xref>) by secreting key regulatory molecules for cellular differentiation and activity in the BMU (<xref rid="R3" ref-type="bibr">Ait Oumghar et al., 2020</xref>; <xref rid="R54" ref-type="bibr">Creecy et al., 2021</xref>) and regulate calcium homeostasis by triggering mineral release from the bone matrix (<xref rid="R26" ref-type="bibr">Bonewald, 2011</xref>; <xref rid="R115" ref-type="bibr">J&#x000e4;hn et al., 2017</xref>). Osteocyte apoptosis following estrogen deficiency increases remodeling (<xref rid="R241" ref-type="bibr">Tomkinson et al., 1997</xref>; <xref rid="R240" ref-type="bibr">Tomkinson et al., 1998</xref>; <xref rid="R67" ref-type="bibr">Emerton et al., 2010</xref>; <xref rid="R131" ref-type="bibr">Khosla et al., 2012</xref>; <xref rid="R21" ref-type="bibr">Bellido et al., 2014</xref>). Osteocyte lifespan and apoptosis are also linked to <italic toggle="yes">in vivo</italic> mechanical forces and accumulated microdamage in aging (<xref rid="R21" ref-type="bibr">Bellido et al., 2014</xref>).</p><p id="P17">As with most biological concepts, the bone remodeling process is more complex than a four-step process consisting of only three cell types. The reversal phase is an example of such complexity. Precursor bone cells are another example. Although not included in the simplified BMU, precursor bone cells are important cells in the bone remodeling cycle (<xref rid="R30" ref-type="bibr">Boyle et al., 2003</xref>; <xref rid="R207" ref-type="bibr">Rutkovskiy et al., 2016</xref>). The numerous signaling factors that regulate bone remodeling add another layer of complexity (<xref rid="F2" ref-type="fig">Figure 2</xref>), discussed further in <xref rid="S5" ref-type="sec">Sections 2.3</xref>, <xref rid="S6" ref-type="sec">3</xref>.</p></sec><sec id="S5"><label>2.3</label><title>Signaling pathways of the BMU</title><p id="P18">A key signaling mechanism driving the coordination of osteocytes, osteoclasts, and osteoblasts is the RANK-RANKL-OPG pathway (<xref rid="F2" ref-type="fig">Figure 2</xref>). Preosteoclasts and active osteoclasts express receptor activator of nuclear factor kappa-B (RANK) (<xref rid="R69" ref-type="bibr">Eriksen, 2010</xref>). RANK binds to its ligand RANKL, a soluble and membrane-bound protein expressed by osteoblastic-lineage cells, such as mesenchymal stem cells, preosteoblasts, osteoblasts, and osteocytes (<xref rid="R69" ref-type="bibr">Eriksen, 2010</xref>). RANK-RANKL binding triggers intracellular cascades, such as the nuclear factor kappa B (NF-<italic toggle="yes">&#x003ba;</italic>B) pathway, which produces nuclear factor of activated T cell cytoplasmic 1 (NFATc1), a transcription factor that induces osteoclastic genes (<xref rid="R252" ref-type="bibr">Walsh and Choi, 2014</xref>). These genes regulate cell proliferation, differentiation, and survival through the osteoclastic lineage, a process called osteoclastogenesis. RANK-RANKL binding is inhibited by osteoprotegerin (OPG), a soluble decoy receptor expressed by osteoblastic cells that binds to RANKL (<xref rid="R69" ref-type="bibr">Eriksen, 2010</xref>).</p><p id="P19">As shown in <xref rid="F2" ref-type="fig">Figure 2</xref>, the wingless-related integration site (Wnt) pathways play a complementary role in bone remodeling by regulating osteoblastogenesis (<xref rid="R22" ref-type="bibr">Bennett et al., 2005</xref>; <xref rid="R23" ref-type="bibr">Bennett et al., 2007</xref>). Wnt is a family of 19 glycoproteins that can activate the canonical Wnt/<inline-formula><mml:math id="M15" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula>-catenin pathway, the non-canonical Wnt/Ca<sup>2+</sup> pathway, and the Wnt/planar cell polarity pathway (<xref rid="R27" ref-type="bibr">Bonewald and Johnson, 2008</xref>; <xref rid="R108" ref-type="bibr">Houschyar et al., 2019</xref>; <xref rid="R156" ref-type="bibr">Maeda et al., 2019</xref>). Wnt ligands, such as osteoclast-derived Wnt-3a and Wnt-10b, activate the canonical pathway by binding to low-density lipoprotein receptor-related protein 5 or 6 (LRP5/6) and the Frizzled coreceptor (<xref rid="R150" ref-type="bibr">Lerner and Ohlsson, 2015</xref>; <xref rid="R156" ref-type="bibr">Maeda et al., 2019</xref>; <xref rid="R186" ref-type="bibr">Perkins et al., 2023</xref>). This increases <inline-formula><mml:math id="M17" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula>-catenin levels, upregulating osteoblastic genes (<xref rid="R186" ref-type="bibr">Perkins et al., 2023</xref>). The canonical pathway promotes mesenchymal stem cell differentiation into preosteoblasts by inhibiting their differentiation into adipocytes and chondrocytes (<xref rid="R221" ref-type="bibr">Siddiqui and Partridge, 2016</xref>; <xref rid="R156" ref-type="bibr">Maeda et al., 2019</xref>; <xref rid="R132" ref-type="bibr">Kim et al., 2020</xref>). Additionally, canonical signaling upregulates OPG expression by osteoblastic-lineage cells (<xref rid="R138" ref-type="bibr">Kramer et al., 2010</xref>; <xref rid="R21" ref-type="bibr">Bellido et al., 2014</xref>; <xref rid="R194" ref-type="bibr">Plotkin and Bivi, 2014</xref>), suppressing osteoclastogenesis (<xref rid="R221" ref-type="bibr">Siddiqui and Partridge, 2016</xref>). The canonical cascade is inhibited by osteoblast-derived dickkopf-related protein 1 (DKK1) and osteocyte-derived sclerostin, which bind to LRP5/6 instead of Wnt ligands (<xref rid="R156" ref-type="bibr">Maeda et al., 2019</xref>). Osteocytes secrete sclerostin to terminate and prevent activation of a remodeling cycle (<xref rid="R70" ref-type="bibr">Eudy et al., 2015</xref>; <xref rid="R3" ref-type="bibr">Ait Oumghar et al., 2020</xref>; <xref rid="R54" ref-type="bibr">Creecy et al., 2021</xref>).</p><p id="P20">As in the Wnt/<inline-formula><mml:math id="M18" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula>-catenin pathway, non-canonical signaling stimulates osteoblastogenesis when osteoclast-derived Wnt binds to osteoblastic receptors (<xref rid="R150" ref-type="bibr">Lerner and Ohlsson, 2015</xref>). Contrarily, non-canonical signaling can inhibit or stimulate osteoclastogenesis (<xref rid="R150" ref-type="bibr">Lerner and Ohlsson, 2015</xref>). Osteoblast-derived Wnt-16 inhibits osteoclast differentiation directly by activating osteoclastic receptors. However, it indirectly stimulates osteoclastogenesis by activating osteoblastic receptors that upregulate OPG production (<xref rid="R132" ref-type="bibr">Kim et al., 2020</xref>). Together, these findings highlight the complexity of Wnt signaling and its regulation of bone remodeling. In the remainder of this paper, we use Wnt and Wnt signaling to refer to the canonical Wnt/<inline-formula><mml:math id="M19" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula>-catenin pathway, unless otherwise specified. For further details on chemical agents that regulate cells of the BMU organized by cell type, readers are referred to <xref rid="R120" ref-type="bibr">Jee (2001)</xref>.</p></sec></sec><sec id="S6"><label>3</label><title>Background on bone remodeling from a systemic perspective</title><p id="P21">The numerous signals that regulate bone remodeling originate not only from bone cells (<xref rid="F2" ref-type="fig">Figure 2</xref>) but also from beyond the bone microenvironment (<xref rid="F3" ref-type="fig">Figure 3</xref>). Systemic influences on bone remodeling are seen in multiple bone diseases. Rheumatoid arthritis, for example, is an autoimmune condition that causes joint inflammation and destruction but also increases the risk of osteoporosis twofold (<xref rid="R101" ref-type="bibr">Haugeberg et al., 2000</xref>; <xref rid="R102" ref-type="bibr">Hauser et al., 2014</xref>; <xref rid="R154" ref-type="bibr">Llorente et al., 2020</xref>). This hints at immune-bone crosstalk. Furthermore, sex hormones have long been thought to control the bone remodeling process due to the link between estrogen decline and postmenopausal osteoporosis (<xref rid="R200" ref-type="bibr">Rattanakul et al., 2003</xref>; <xref rid="R152" ref-type="bibr">Li et al., 2016</xref>; <xref rid="R3" ref-type="bibr">Ait Oumghar et al., 2020</xref>; <xref rid="R145" ref-type="bibr">Lehmann et al., 2021</xref>). Sex hormones also regulate the immune system (<xref rid="R137" ref-type="bibr">Kovats, 2015</xref>). Bone cancers (e.g., osteosarcoma) and metastatic bone disease also interfere with bone homeostasis (<xref rid="R36" ref-type="bibr">Buenzli et al., 2012b</xref>; <xref rid="R8" ref-type="bibr">Araujo et al., 2014</xref>; <xref rid="R124" ref-type="bibr">Ji et al., 2014</xref>; <xref rid="R72" ref-type="bibr">Farhat et al., 2017</xref>). Intestinal dysbiosis also influences the bone remodeling cycle (<xref rid="R152" ref-type="bibr">Li et al., 2016</xref>; <xref rid="R264" ref-type="bibr">Zaiss et al., 2019</xref>; <xref rid="R98" ref-type="bibr">Hao et al., 2021</xref>). The complexity of bone remodeling extends beyond the local bone environment to the systemic whole body level (<xref rid="F3" ref-type="fig">Figure 3</xref>). The rest of this section provides an overview of several local and systemic cellular and chemical signaling mechanisms that modulate bone remodeling.</p><sec id="S7"><label>3.1</label><title>Osteoimmunology</title><p id="P22">Evidence that immune activity modulates bone remodeling first appeared in <xref rid="R106" ref-type="bibr">Horton et al. (1972)</xref> (<xref rid="R235" ref-type="bibr">Takayanagi, 2007</xref>; <xref rid="R59" ref-type="bibr">Della Corte et al., 2020</xref>). This study showed that bone cultures from rats had increased resorption activity after treatment with supernatant from cultures with human peripheral blood mononuclear cells. This was an early sign of crosstalk between bone and immune cells. However, the importance of bone-immune interplay was not fully realized until multiple publications in the 1990s showed that signals from the immune system signal bone remodeling (<xref rid="R113" ref-type="bibr">Iotsova et al., 1997</xref>; <xref rid="R262" ref-type="bibr">Wong et al., 1997</xref>; <xref rid="R84" ref-type="bibr">Fuller et al., 1998</xref>; <xref rid="R62" ref-type="bibr">Dougall et al., 1999</xref>; <xref rid="R136" ref-type="bibr">Kotake et al., 1999</xref>; <xref rid="R171" ref-type="bibr">Naito et al., 1999</xref>; <xref rid="R234" ref-type="bibr">Suda et al., 1999</xref>). One such study found that RANK, a protein of the tumor necrosis factor (TNF) superfamily secreted by immune cells, is a crucial receptor in bone remodeling (<xref rid="R62" ref-type="bibr">Dougall et al., 1999</xref>). Mice lacking this receptor protein had fewer B cells in the spleen, almost no peripheral lymph nodes, and fewer mature osteoclasts. The importance of these discoveries is highlighted by <xref rid="R13" ref-type="bibr">Arron and Choi (2000)</xref>. This seminal article coined the term osteoimmunology to describe the intersection of bone and immune research, leading to a new subfield of research. Several more recent reviews provide in-depth surveys of osteoimmunology beyond the scope of the present review (<xref rid="R149" ref-type="bibr">Lerner, 2006</xref>; <xref rid="R65" ref-type="bibr">Eastell et al., 2016</xref>; <xref rid="R261" ref-type="bibr">Weitzmann and Ofotokun, 2016</xref>; <xref rid="R260" ref-type="bibr">Weitzmann, 2017</xref>; <xref rid="R56" ref-type="bibr">Dar et al., 2018</xref>; <xref rid="R195" ref-type="bibr">Ponzetti and Rucci, 2019</xref>). Several cytokines and immune cells influence bone remodeling and are summarized in the following.</p><sec id="S8"><label>3.1.1</label><title>MCSF, TGF-<inline-formula><mml:math id="M20" display="inline"><mml:mi mathvariant="bold">&#x003b2;</mml:mi></mml:math></inline-formula>, and other cytokines</title><p id="P23">In addition to Wnt and RANK-RANKL-OPG signaling, two cytokines play essential signaling roles in bone remodeling: macrophage colony-stimulating factor (MCSF) and TGF-<inline-formula><mml:math id="M21" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula>. MCSF stimulates osteoclastogenesis by binding to monocyte progenitor cells and preosteoclasts. This triggers intracellular cascades that induce NFATc1, the main transcription factor for osteoclastogenesis (<xref rid="R97" ref-type="bibr">Guder et al., 2020</xref>). The importance of MCSF stems from its role in stimulating the first stage of osteoclastogenesis (<xref rid="F2" ref-type="fig">Figure 2</xref>), which RANKL does not stimulate, and the proliferation of osteoclast precursor cells. The role of TGF-<inline-formula><mml:math id="M22" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula> is less straightforward. Its regulatory effects are concentration dependent (<xref rid="R116" ref-type="bibr">Janssens et al., 2005</xref>; <xref rid="R263" ref-type="bibr">Wu et al., 2016</xref>). Moreover, it regulates both bone formation and bone resorption. Low concentrations of TGF-<inline-formula><mml:math id="M23" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula> stimulate osteoclast production while promoting preosteoblast migration and proliferation. High concentrations inhibit osteoclastogenesis. Also, high concentrations inhibit preosteoblast migration and late-stage osteoblast differentiation. Although these contradictory findings still puzzle researchers, the mechanism of changes in TGF-<inline-formula><mml:math id="M24" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula> concentration during remodeling is well understood. Inactive TGF-<inline-formula><mml:math id="M25" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula> is stored in the extracellular matrix of bone (<xref rid="R68" ref-type="bibr">Epsley et al., 2021</xref>). As osteoclasts remove bone, TGF-<inline-formula><mml:math id="M26" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula> is released and activated, increasing the concentration of TGF-<inline-formula><mml:math id="M27" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula> (<xref rid="R116" ref-type="bibr">Janssens et al., 2005</xref>; <xref rid="R166" ref-type="bibr">Matsumoto and Abe, 2011</xref>).</p><p id="P24">Numerous other cytokines also regulate bone remodeling. TGF-<inline-formula><mml:math id="M28" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula> is not the only cytokine released from the bone matrix during resorption; others include IGF-1, IGF-2, and BMP2 (<xref rid="R223" ref-type="bibr">Sims and Martin, 2020</xref>). Typically, cytokines are classified as osteoclastogenic or osteoblastogenic, though their roles may be concentration-dependent as described with TGF-<inline-formula><mml:math id="M29" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula>. Bone resorption is inhibited by anti-inflammatory cytokines such as interleukin (IL)-4, IL-10, IL-13, IL-18, and interferon (IFN)-<inline-formula><mml:math id="M30" display="inline"><mml:mi>&#x003b3;</mml:mi></mml:math></inline-formula> (<xref rid="R253" ref-type="bibr">Walsh et al., 2006</xref>). Conversely, it is stimulated by pro-inflammatory cytokines such as IL-1, IL-1<inline-formula><mml:math id="M31" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula>, TNF-<inline-formula><mml:math id="M32" display="inline"><mml:mi>&#x003b1;</mml:mi></mml:math></inline-formula>, IL-6, IL-11, IL-15, and IL-17. These cytokines modulate RANKL and Wnt signaling to increase osteoclast activity (<xref rid="R253" ref-type="bibr">Walsh et al., 2006</xref>; <xref rid="R239" ref-type="bibr">Tilg et al., 2008</xref>). For example, TNF-<inline-formula><mml:math id="M33" display="inline"><mml:mi>&#x003b1;</mml:mi></mml:math></inline-formula> upregulates the expression of RANKL, DKK1, and sclerostin in osteocytes (<xref rid="R133" ref-type="bibr">Kitaura et al., 2020</xref>; <xref rid="R68" ref-type="bibr">Epsley et al., 2021</xref>). The influx of RANKL promotes osteoclastogenesis, while the influx of DKK1 and sclerostin inhibits osteoblastogenesis. Cytokines interact in a complex network with RANK-RANKL-OPG, Wnt, MCSF, and TGF-<inline-formula><mml:math id="M34" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula> to regulate bone remodeling.</p><p id="P25">For further detailed coverage of cytokines and growth factors that locally regulate bone cell function and thorough diagrams of signaling ligands and their associated receptors, intracellular kinases and transcription factors, and biological outcomes, readers are referred to <xref rid="R194" ref-type="bibr">Plotkin and Bivi (2014)</xref>.</p></sec><sec id="S9"><label>3.1.2</label><title>Immune cells</title><p id="P26">Immune cells contribute to bone homeostasis through cytokine expression and direct immune cell activity. Osteoclasts are derived from innate immune cells called monocytes (<xref rid="R213" ref-type="bibr">Saxena et al., 2021</xref>). Monocytes are more commonly differentiated into macrophages and dendritic cells. Studies have shown that these cells can transdifferentiate into preosteoclasts (<xref rid="R28" ref-type="bibr">Bonomo et al., 2016</xref>; <xref rid="R213" ref-type="bibr">Saxena et al., 2021</xref>; <xref rid="R232" ref-type="bibr">Srivastava and Sapra, 2022</xref>). Macrophages further modulate bone remodeling through the expression of inflammatory cytokines IL-1, IL-6, and TNF-<inline-formula><mml:math id="M35" display="inline"><mml:mi>&#x003b1;</mml:mi></mml:math></inline-formula> or bone formation factors IL-10, BMP-2, and TGF-<inline-formula><mml:math id="M36" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula> (<xref rid="R74" ref-type="bibr">Fischer and Haffner-Luntzer, 2022</xref>). In contrast, dendritic cells primarily stimulate osteoclastogenesis through RANK-RANKL activation of T cells, which upregulates T cell production of RANKL, IL-1, IL-6, IL-17, and TNF-<inline-formula><mml:math id="M37" display="inline"><mml:mi>&#x003b1;</mml:mi></mml:math></inline-formula> (<xref rid="R28" ref-type="bibr">Bonomo et al., 2016</xref>). However, not all T cells are osteoclastogenic.</p><p id="P27">Different populations of T cells affect osteoclasts and osteoblasts in different ways. Na&#x000ef;ve CD4<sup>+</sup> T cells can differentiate into osteoclastogenic subtypes, e.g., T helper (Th)17 and Th9 cells, or anti-osteoclastic subtypes, e.g., Th1, Th2, and T regulatory (Treg) cells, characterized by their cytokine expression profiles (<xref rid="R97" ref-type="bibr">Guder et al., 2020</xref>). For example, Th17 cells express high levels of IL-17, which upregulates RANK in preosteoclasts and RANKL in osteoblasts, increasing bone resorption (<xref rid="R74" ref-type="bibr">Fischer and Haffner-Luntzer, 2022</xref>; <xref rid="R232" ref-type="bibr">Srivastava and Sapra, 2022</xref>). Th17 cells also secrete IL-6, RANKL, and TNF-<inline-formula><mml:math id="M38" display="inline"><mml:mi>&#x003b1;</mml:mi></mml:math></inline-formula> to promote osteoclastogenesis and suppress osteoblast activity (<xref rid="R231" ref-type="bibr">Srivastava et al., 2018</xref>; <xref rid="R68" ref-type="bibr">Epsley et al., 2021</xref>). Cytokine profiles of Th1, Th2, and Treg cells contrast the profiles from Th17 cells. These cells secrete anti-osteoclastic cytokines such as IFN-<inline-formula><mml:math id="M39" display="inline"><mml:mi>&#x003b3;</mml:mi></mml:math></inline-formula>, IL-4, TGF-<inline-formula><mml:math id="M40" display="inline"><mml:mi>&#x003b2;</mml:mi><mml:mn>1</mml:mn></mml:math></inline-formula>, and IL-10 (<xref rid="R179" ref-type="bibr">Okamoto et al., 2017</xref>; <xref rid="R231" ref-type="bibr">Srivastava et al., 2018</xref>; <xref rid="R97" ref-type="bibr">Guder et al., 2020</xref>). However, following the pattern of Wnt, TGF-<inline-formula><mml:math id="M41" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula>, and other cytokines, T cell roles are not always clear. Activated Tregs secrete DKK1, which inhibits Wnt-mediated bone formation (<xref rid="R145" ref-type="bibr">Lehmann et al., 2021</xref>). This inhibitory effect contrasts studies showing Tregs increase Wnt-10b production by CD8<sup>+</sup> T cells (<xref rid="R246" ref-type="bibr">Tyagi et al., 2018</xref>). Despite this, studies indicate a balance between Th17 and Treg cells is important for healthy bone remodeling, such that higher Th17 to Treg ratios contribute to rheumatoid arthritis and osteoporosis (<xref rid="R179" ref-type="bibr">Okamoto et al., 2017</xref>; <xref rid="R231" ref-type="bibr">Srivastava et al., 2018</xref>). Declining bone health is associated with many classic inflammatory diseases, such as periodontitis, rheumatoid arthritis, and aseptic prosthesis (<xref rid="R68" ref-type="bibr">Epsley et al., 2021</xref>). To obtain a more complete picture of bone remodeling, it is vital to consider these complex bone-immune interactions.</p></sec></sec><sec id="S10"><label>3.2</label><title>Endocrine system and pharmaceuticals</title><p id="P28"><xref rid="F4" ref-type="fig">Figure 4</xref> highlights the influence of the endocrine system and other common bone-related medications on bone health. The crosstalk between the endocrine and the skeletal systems is expansive. Here, we discuss only parathyroid hormone (PTH) and estrogen, which are most prevalent in bone mathematical research. Intermittent PTH and hormone replacements for estrogen are commonly used as pharmacological interventions for bone diseases. As such, we consider pharmaceuticals together with the endocrine system.</p><sec id="S11"><label>3.2.1</label><title>Parathyroid hormone</title><p id="P29">PTH is a systemic hormone that regulates calcium levels in the blood in part by triggering calcium release from the bone. Chief cells within the parathyroid gland produce PTH when serum calcium levels are low (<xref rid="R43" ref-type="bibr">Chaiya and Rattanakul, 2017</xref>). The increase in circulating PTH triggers bone remodeling, and subsequently, osteoclasts release calcium from the bone into the blood to maintain homeostasis (<xref rid="R187" ref-type="bibr">Peterson and Riggs, 2010</xref>; <xref rid="R49" ref-type="bibr">Coelho et al., 2016</xref>). This ability to stimulate remodeling has led to the development of synthetic PTH for osteoporosis treatment. However, PTH is another signaling factor with a dual role in osteoclastogenesis. Circulating PTH stimulates osteoclast activity by increasing the RANKL to OPG ratio but inhibits osteoclast formation by decreasing sclerostin and DKK1 (<xref rid="R222" ref-type="bibr">Silva and Bilezikian, 2015</xref>; <xref rid="R130" ref-type="bibr">Kenkre and Bassett, 2018</xref>; <xref rid="R259" ref-type="bibr">Wein and Kronenberg, 2018</xref>; <xref rid="R97" ref-type="bibr">Guder et al., 2020</xref>). Exogenous PTH alters bone remodeling differently depending on the administration schedule. Continuous administration decreases overall levels of bone density, whereas intermittent administration increases bone density levels (<xref rid="R49" ref-type="bibr">Coelho et al., 2016</xref>; <xref rid="R146" ref-type="bibr">Lemaire and Cox, 2019</xref>). This has led many researchers to develop mathematical models to understand the mechanisms of PTH regulation.</p><p id="P30">The dual role of PTH is currently understood to involve both stimulation of preosteoblast production and inhibition of preosteoblast differentiation (<xref rid="R43" ref-type="bibr">Chaiya and Rattanakul, 2017</xref>). As a result, preosteoblast cell populations increase while osteoblast populations remain unchanged. This causes an increase in the RANKL to OPG ratio since osteoblastic cells produce more OPG and less RANKL (<xref rid="R92" ref-type="bibr">Gori et al., 2000</xref>) as they mature. A short burst of PTH stimulates remodeling by increasing RANKL and suppressing OPG. High concentrations of PTH over a long period, as in the case of hyperparathyroidism, dysregulate bone remodeling due to the overproduction of osteoclasts. This leads to a larger resorption cavity that the limited number of osteoblasts cannot fill. This interrelationship between bone cells and PTH exemplifies the complexity of the bone remodeling process.</p></sec><sec id="S12"><label>3.2.2</label><title>Estrogen</title><p id="P31">Estrogen and bone health have been closely linked for decades due to the correlation between postmenopausal estrogen decline and bone loss (<xref rid="R131" ref-type="bibr">Khosla et al., 2012</xref>). Although early research on the mechanism of estrogen regulation of bone remodeling was unclear, recent studies in osteoimmunology have improved our understanding. Estrogen deficiency increases bone turnover and unbalanced remodeling (<xref rid="R131" ref-type="bibr">Khosla et al., 2012</xref>). This occurs through estrogen-mediated inhibition of RANKL production and stimulation of OPG expression, which limits osteoclastogenesis (<xref rid="R69" ref-type="bibr">Eriksen, 2010</xref>; <xref rid="R76" ref-type="bibr">Florencio-Silva et al., 2015</xref>; <xref rid="R172" ref-type="bibr">Noirrit-Esclassan et al., 2021</xref>). Estrogen has also been shown to prevent apoptosis of osteoblasts and osteocytes (<xref rid="R76" ref-type="bibr">Florencio-Silva et al., 2015</xref>). This is consistent with studies showing that estrogen deficiency induces osteocyte apoptosis (<xref rid="R241" ref-type="bibr">Tomkinson et al., 1997</xref>; <xref rid="R240" ref-type="bibr">Tomkinson et al., 1998</xref>; <xref rid="R67" ref-type="bibr">Emerton et al., 2010</xref>; <xref rid="R131" ref-type="bibr">Khosla et al., 2012</xref>; <xref rid="R58" ref-type="bibr">Delgado-Calle and Bellido, 2022</xref>). Ovariectomized (OVX) murine experiments demonstrate that estrogen directly supports bone formation by upregulating Wnt-10b in bone marrow stromal cells (<xref rid="R186" ref-type="bibr">Perkins et al., 2023</xref>).</p><p id="P32">Further evidence of the estrogen-bone link is based on the presence of estrogen receptors (ER) on bone cells and targeted deletion studies. ER<inline-formula><mml:math id="M42" display="inline"><mml:mi>&#x003b1;</mml:mi></mml:math></inline-formula> is found on osteoclastic and osteoblastic cells, while ER<inline-formula><mml:math id="M43" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula> is found on osteoblasts (<xref rid="R219" ref-type="bibr">Sharma et al., 2020</xref>). Targeted deletion of osteoblastic ER<inline-formula><mml:math id="M44" display="inline"><mml:mi>&#x003b1;</mml:mi></mml:math></inline-formula> in murine models led to low bone mass in both males and females (<xref rid="R6" ref-type="bibr">Almeida et al., 2017</xref>; <xref rid="R86" ref-type="bibr">Gao et al., 2021</xref>). The targeted deletion of ER<inline-formula><mml:math id="M45" display="inline"><mml:mi>&#x003b1;</mml:mi></mml:math></inline-formula> in osteoclasts and osteoclast progenitor cells increased osteoclast numbers in females but not in males (<xref rid="R6" ref-type="bibr">Almeida et al., 2017</xref>). Another study of ER<inline-formula><mml:math id="M46" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula> deletion in mesenchymal stem cells found that bone mass increased only in female rodents (<xref rid="R6" ref-type="bibr">Almeida et al., 2017</xref>). These knockout studies indicate that estrogen signaling is vital to bone homeostasis in males and females, with sex-based differences in these signaling mechanisms.</p><p id="P33">Estrogen regulates bone remodeling through direct and immune-mediated mechanisms (<xref rid="R131" ref-type="bibr">Khosla et al., 2012</xref>). For instance, estrogen protects against T-cell-mediated bone loss by upregulating Wnt signaling. While mice with DKK1-expressing T cells experienced OVX-induced bone loss, knockout mice without DKK1-expressing T cells did not, and prior to OVX, these mice exhibited higher bone mass (<xref rid="R145" ref-type="bibr">Lehmann et al., 2021</xref>). The loss of bone in response to estrogen deficiency is recognized as a cytokine-driven process involving T cell populations such as Tregs and Th17 cells that results in the bone resorption activity of osteoclasts exceeding that of bone-forming osteoblasts (<xref rid="R181" ref-type="bibr">Pacifici, 2012</xref>). The anti-inflammatory effect of estrogen extends to macrophages and dendritic cells. Estrogen deficiency has been shown to induce the transdifferentiation of pro-inflammatory M1 macrophages into osteoclasts and increase the ratio of M1 to anti-inflammatory M2 macrophages (<xref rid="R213" ref-type="bibr">Saxena et al., 2021</xref>). Without estrogen, more dendritic cells were shown to express IL-7 and IL-15, which upregulates IL-17 and TNF-<inline-formula><mml:math id="M47" display="inline"><mml:mi>&#x003b1;</mml:mi></mml:math></inline-formula> production by T cells (<xref rid="R213" ref-type="bibr">Saxena et al., 2021</xref>). Furthermore, a cross-sectional clinical study of postmenopausal women showed that elevated inflammatory markers such as IL-6, IL-<inline-formula><mml:math id="M48" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula>, and TNF-<inline-formula><mml:math id="M49" display="inline"><mml:mi>&#x003b1;</mml:mi></mml:math></inline-formula> were negatively correlated with bone mass (<xref rid="R55" ref-type="bibr">Damani et al., 2023</xref>). These findings indicate estrogen regulates bone remodeling through immune-mediated effects and direct signaling within the bone microenvironment.</p></sec><sec id="S13"><label>3.2.3</label><title>Pharmaceuticals</title><p id="P34">Pharmaceuticals can indirectly regulate remodeling while treating various diseases, or they can be designed to target mechanisms in the bone remodeling cycle intentionally. Glucocorticoids are anti-inflammatory agents that are used broadly but have negative effects on bone health by decreasing osteoblast and osteocyte populations and increasing osteoclast survival (<xref rid="R99" ref-type="bibr">Hardy et al., 2018</xref>). Despite this, they are often used to reduce chronic inflammation in rheumatoid arthritis that can otherwise lead to osteoporosis. Teriparatide, a PTH analog that has anabolic effects on the bone, has several proposed mechanisms for its action (<xref rid="R259" ref-type="bibr">Wein and Kronenberg, 2018</xref>). Since teriparatide requires expensive daily injections, it is used mainly for severe osteoporosis or those who need to use glucocorticoids long-term for other conditions (<xref rid="R105" ref-type="bibr">Hodsman et al., 2005</xref>).</p><p id="P35">Estrogen replacement therapy (ERT) is a pharmaceutical intervention directly designed to impact bone remodeling based on the association between estrogen decline and osteoporosis after menopause. Hormone replacement therapy (HRT) augments estrogen with progestogens. Selective estrogen receptor modulators (SERMS) act as estrogen receptor agonists in some tissues like bone and antagonists in other tissues, sometimes detrimentally (<xref rid="R66" ref-type="bibr">Ellis et al., 2015</xref>). These treatments have different and controversial risks associated with breast cancer, coronary heart disease, and stroke that impact their adoption based on individualized management of benefits and risks (<xref rid="R157" ref-type="bibr">Manson et al., 2013</xref>; <xref rid="R66" ref-type="bibr">Ellis et al., 2015</xref>; <xref rid="R104" ref-type="bibr">Hodis and Sarrel, 2018</xref>; <xref rid="R73" ref-type="bibr">Faubion et al., 2022</xref>; <xref rid="R180" ref-type="bibr">Onwude, 2022</xref>; <xref rid="R173" ref-type="bibr">Nudy et al., 2023</xref>).</p><p id="P36">Another group of medications to reduce bone loss are antiresorptives, which target signaling mechanisms of bone remodeling that contribute to osteoclast activity. Bisphosphonates are antiresorptives that are currently the most common treatments for bone loss. These drugs inhibit bone resorption by inducing osteoclast apoptosis and reducing osteoclast activity (<xref rid="R25" ref-type="bibr">Berkhout et al., 2015</xref>; <xref rid="R49" ref-type="bibr">Coelho et al., 2016</xref>; <xref rid="R2" ref-type="bibr">Aibar-Almaz&#x000e1;n et al., 2022</xref>). Bisphosphonates even alter bone remodeling after treatment is terminated because they bind to hydroxyapatite crystals on the surface of the bone matrix (<xref rid="R64" ref-type="bibr">Drake et al., 2008</xref>; <xref rid="R2" ref-type="bibr">Aibar-Almaz&#x000e1;n et al., 2022</xref>). They can be released from the surface in subsequent remodeling cycles (<xref rid="R49" ref-type="bibr">Coelho et al., 2016</xref>). Bisphosphonates are generally well tolerated but are most often discontinued due to gastrointestinal distress or concerns about side effects such as osteonecrosis of the jaw or spiral fractures of the femur midshaft (<xref rid="R2" ref-type="bibr">Aibar-Almaz&#x000e1;n et al., 2022</xref>). The monoclonal antibody denosumab is a newer antiresorptive. Denosumab inhibits resorption by blocking RANK-RANKL binding. It acts as an OPG mimic, binding to RANKL to prevent osteoclast activation. Although denosumab is more effective at preventing bone loss than bisphosphonates and used for metastatic cancers that target bone, there is a higher risk of osteonecrosis of the jaw (<xref rid="R2" ref-type="bibr">Aibar-Almaz&#x000e1;n et al., 2022</xref>; <xref rid="R83" ref-type="bibr">Fu et al., 2023</xref>) and higher frequency of second tumors in cancer patients on denosumab (<xref rid="R233" ref-type="bibr">Stopeck et al., 2010</xref>; <xref rid="R75" ref-type="bibr">Fizazi et al., 2011</xref>; <xref rid="R103" ref-type="bibr">Henry et al., 2011</xref>; <xref rid="R198" ref-type="bibr">Raje et al., 2018</xref>; <xref rid="R243" ref-type="bibr">Tovazzi et al., 2019</xref>).</p><p id="P37">Romosozumab is the newest pharmaceutical intervention for the bone remodeling cycle. Romosozumab is a monoclonal antibody that binds to sclerostin, allowing Wnt ligands to activate the canonical pathway, stimulate bone formation, and inhibit bone resorption (<xref rid="F2" ref-type="fig">Figure 2</xref>). The disadvantage is that romosozumab is associated with more undesirable side effects than bisphosphonates including increased risk of adverse cardiovascular events (<xref rid="R14" ref-type="bibr">Asadipooya and Weinstock, 2019</xref>; <xref rid="R2" ref-type="bibr">Aibar-Almaz&#x000e1;n et al., 2022</xref>). Overall, targeted treatments of the bone remodeling cycle have poor compliance and high discontinuation rates due to a combination of high costs, unwanted side effects, and psychological factors (<xref rid="R2" ref-type="bibr">Aibar-Almaz&#x000e1;n et al., 2022</xref>). Viable new treatments need to eliminate or reduce these concerns.</p></sec></sec><sec id="S14"><label>3.3</label><title>Gut metabolites and immune connections</title><p id="P38">Gut and bone health are connected via shared crosstalk with the immune system. The gut regulates immune response and bone remodeling through the intestinal barrier. The intestinal barrier consists of a mucus layer and tight junction proteins, which protect the immune system from pathogens and toxins (<xref rid="R183" ref-type="bibr">Paone and Cani, 2020</xref>). Intestinal microbes help maintain this barrier (<xref rid="R7" ref-type="bibr">Anderson et al., 2010</xref>; <xref rid="R225" ref-type="bibr">Sj&#x000f6;gren et al., 2012</xref>). <xref rid="R225" ref-type="bibr">Sj&#x000f6;gren et al. (2012)</xref> found that conventional mice had increased gut permeability and inflammatory cytokines, resulting in lower bone mass than germ-free mice. Since systemic immune inflammation can increase bone resorption, it follows that gut-induced immune inflammation can cause bone loss. Additionally, estrogen deficiency compromises the gut barrier, affecting inflammation onset and trafficking of immune cells from the gut to the periphery (<xref rid="R31" ref-type="bibr">Braniste et al., 2009</xref>; <xref rid="R152" ref-type="bibr">Li et al., 2016</xref>; <xref rid="R203" ref-type="bibr">Rios-Arce et al., 2017</xref>).</p><p id="P39">Gut microbial populations contribute to gut-mediated immunomodulation of bone health through metabolites such as short-chain fatty acids (SCFAs). SCFAs stimulate mucus production and tight junction protein expression (<xref rid="R91" ref-type="bibr">Gizard et al., 2020</xref>; <xref rid="R183" ref-type="bibr">Paone and Cani, 2020</xref>; <xref rid="R11" ref-type="bibr">Arnold et al., 2021</xref>). Additionally, SCFAs can enter the bloodstream, where they not only inhibit NF-&#x003ba;B pathways and downregulate TNF-<inline-formula><mml:math id="M50" display="inline"><mml:mi>&#x003b1;</mml:mi></mml:math></inline-formula> but also upregulate macrophage and dendritic cell expression of IL-10 (<xref rid="R107" ref-type="bibr">Hosseinkhani et al., 2021</xref>). In a study of healthy male mice, dietary supplementation with the SCFA butyrate showed increases in <italic toggle="yes">Clostridia</italic> populations, circulating Tregs, Wnt-10b, osteoblastogenesis, and bone mass (<xref rid="R246" ref-type="bibr">Tyagi et al., 2018</xref>). <xref rid="R46" ref-type="bibr">Chen et al. (2020)</xref> also showed increased SCFAs and Tregs due to prebiotic lactulose administration in OVX mice, preventing subsequent bone loss. Furthermore, SCFAs have been shown to improve calcium absorption, balance Tregs and Th17 cells, and produce bone-forming IGF-1 (<xref rid="R20" ref-type="bibr">Behera et al., 2020</xref>; <xref rid="R155" ref-type="bibr">Lu et al., 2021</xref>; <xref rid="R186" ref-type="bibr">Perkins et al., 2023</xref>). Another study demonstrated that a change in microbial composition reduced SCFAs, increased gut permeability, increased serum lipopolysaccharide (an inflammatory marker), and, ultimately, increased osteoclast activity, leading to bone loss (<xref rid="R20" ref-type="bibr">Behera et al., 2020</xref>). Further studies provided evidence in support of probiotic and prebiotic restoration of intestinal barrier function and prevention of bone loss (<xref rid="R216" ref-type="bibr">Schepper et al., 2019</xref>; <xref rid="R46" ref-type="bibr">Chen et al., 2020</xref>). The numerous osteogenic functions of SCFAs thus indicate their potential for treating inflammatory bone loss.</p><p id="P40">Evidence linking gut health and inflammation has led researchers to explore opportunities for dietary prebiotic and probiotic treatment of estrogen-deficient bone loss (<xref rid="R225" ref-type="bibr">Sj&#x000f6;gren et al., 2012</xref>; <xref rid="R32" ref-type="bibr">Britton et al., 2014</xref>; <xref rid="R152" ref-type="bibr">Li et al., 2016</xref>). Dietary manipulation of the gut microbiota using probiotics (e.g., <italic toggle="yes">Lactobacillus</italic> and <italic toggle="yes">Bifidobacteria</italic>) protected against bone loss in a small clinical trial (<xref rid="R236" ref-type="bibr">Takimoto et al., 2018</xref>) and in animal models of periodontal disease (<xref rid="R167" ref-type="bibr">Messora et al., 2013</xref>), diabetes (<xref rid="R265" ref-type="bibr">Zhang et al., 2015</xref>), and estrogen deficiency (<xref rid="R32" ref-type="bibr">Britton et al., 2014</xref>; <xref rid="R175" ref-type="bibr">Ohlsson et al., 2014</xref>; <xref rid="R152" ref-type="bibr">Li et al., 2016</xref>). <xref rid="R152" ref-type="bibr">Li et al. (2016)</xref> induced sex hormone deficiency in germ-free and conventional mice. They found that conventional mice had degraded intestinal walls, increased immune inflammation, and increased bone loss compared to germ-free mice. Their treatment of conventional mice with probiotics prevented inflammation and bone loss. Mechanistically, another study demonstrated that probiotic treatment of mice with drug-induced osteoporosis increased Wnt-10b levels (<xref rid="R186" ref-type="bibr">Perkins et al., 2023</xref>). Consumption of SCFAs and prebiotics, which can be fermented to form SCFAs, also increased intestinal calcium absorption in adolescents and post-menopausal osteoporosis patients (<xref rid="R20" ref-type="bibr">Behera et al., 2020</xref>; <xref rid="R155" ref-type="bibr">Lu et al., 2021</xref>). Other murine studies indicated that prebiotic and probiotic treatments prevented OVX-induced increases in Th17 cells and the inflammatory cytokines IL-17, TNF-<inline-formula><mml:math id="M51" display="inline"><mml:mi>&#x003b1;</mml:mi></mml:math></inline-formula>, IL-6, and RANKL (<xref rid="R155" ref-type="bibr">Lu et al., 2021</xref>). These changes were accompanied by reduced intestinal permeability and increases in IL-10, IGF-1, and BMPs that promote osteoblastogenesis and improve bone strength (<xref rid="R20" ref-type="bibr">Behera et al., 2020</xref>). Additional studies linked prebiotics, such as oligosaccharides, to altered SCFAs, enhanced intestinal barrier function, and programmed tolerogenic immune cell responses (<xref rid="R48" ref-type="bibr">Chonan et al., 1995</xref>; <xref rid="R1" ref-type="bibr">Abrams et al., 2005</xref>; <xref rid="R256" ref-type="bibr">Weaver et al., 2011</xref>; <xref rid="R144" ref-type="bibr">Legette et al., 2012</xref>; <xref rid="R12" ref-type="bibr">Arpaia et al., 2013</xref>; <xref rid="R85" ref-type="bibr">Furusawa et al., 2013</xref>; <xref rid="R229" ref-type="bibr">Smith et al., 2013</xref>; <xref rid="R44" ref-type="bibr">Chang et al., 2014</xref>; <xref rid="R224" ref-type="bibr">Singh et al., 2014</xref>; <xref rid="R237" ref-type="bibr">Tan et al., 2016</xref>; <xref rid="R45" ref-type="bibr">Chen et al., 2017</xref>; <xref rid="R109" ref-type="bibr">Hu et al., 2018</xref>; <xref rid="R90" ref-type="bibr">Ghosh et al., 2021</xref>). Numerous studies including several of our own showed how foods with prebiotic activity affect SCFAs, the immune system, and the bone even without alterations in gut barrier function or where there is no compromise in gut barrier function (<xref rid="R48" ref-type="bibr">Chonan et al., 1995</xref>; <xref rid="R204" ref-type="bibr">Roberfroid et al., 2002</xref>; <xref rid="R10" ref-type="bibr">Arjmandi et al., 2004</xref>; <xref rid="R1" ref-type="bibr">Abrams et al., 2005</xref>; <xref rid="R218" ref-type="bibr">Scholz-Ahrens et al., 2007</xref>; <xref rid="R33" ref-type="bibr">Bu et al., 2009</xref>; <xref rid="R256" ref-type="bibr">Weaver et al., 2011</xref>; <xref rid="R144" ref-type="bibr">Legette et al., 2012</xref>; <xref rid="R250" ref-type="bibr">Vulevic et al., 2008</xref>, <xref rid="R251" ref-type="bibr">2015</xref>; <xref rid="R201" ref-type="bibr">Rendina et al., 2012</xref>; <xref rid="R226" ref-type="bibr">Smith et al., 2014</xref>; <xref rid="R176" ref-type="bibr">Ojo et al., 2016</xref>, <xref rid="R178" ref-type="bibr">2019</xref>, <xref rid="R177" ref-type="bibr">2021</xref>; <xref rid="R93" ref-type="bibr">Graef et al., 2018a</xref>,<xref rid="R94" ref-type="bibr">b</xref>; <xref rid="R220" ref-type="bibr">Shen et al., 2019</xref>; <xref rid="R227" ref-type="bibr">Smith et al., 2019</xref>; <xref rid="R61" ref-type="bibr">Dodier et al., 2021</xref>; <xref rid="R129" ref-type="bibr">Keirns et al., 2020</xref>; <xref rid="R228" ref-type="bibr">Smith et al., 2022</xref>).</p></sec><sec id="S15"><label>3.4</label><title>Metastatic cancer cells</title><p id="P41">Many cancers metastasize to bone, including prostate, breast, and myeloma cancers (<xref rid="R3" ref-type="bibr">Ait Oumghar et al., 2020</xref>; <xref rid="R51" ref-type="bibr">Coleman et al., 2020</xref>). Cancer cells dysregulate the bone remodeling cycle by secreting osteoclastogenic cytokines that initiate bone resorption to make room for tumor growth (<xref rid="R158" ref-type="bibr">Marathe et al., 2008</xref>). This increased remodeling leads to increased bone formation during the early stages of tumor growth (<xref rid="R16" ref-type="bibr">Ayati et al., 2010</xref>). However, continued remodeling results in a tumor-initiated resorption rate that exceeds that of bone formation. It also increases the rate of tumor growth, which is stimulated by the TGF-<inline-formula><mml:math id="M52" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula> released from the bone matrix during resorption. Eventually, the growing tumor fills the resorption cavity before osteoblast signaling occurs (<xref rid="R124" ref-type="bibr">Ji et al., 2014</xref>). Cancer cells also secrete molecules besides cytokines to promote bone resorption or inhibit bone formation. For example, myeloma cells produce DKK1 to prevent osteoblast development (<xref rid="R266" ref-type="bibr">Zhang and Mager, 2019</xref>). These are just a few examples of how cancer and bone interact; readers are referred to <xref rid="R51" ref-type="bibr">Coleman et al. (2020)</xref> and <xref rid="R199" ref-type="bibr">Rao et al. (2020)</xref> and references therein for further details. The complex interplay between multiple organ systems in metastatic cancer means that almost all cancers have adverse effects on bone health (<xref rid="R63" ref-type="bibr">Drake, 2013</xref>).</p></sec></sec><sec id="S16"><label>4</label><title>Techniques for mathematical modeling of bone remodeling</title><p id="P42">Biochemical models of bone remodeling consider the population dynamics of bone cells, which are regulated by numerous chemical signaling factors. Temporal bone cell dynamics are modeled using ordinary differential equations (ODEs) (<xref rid="T2" ref-type="table">Tables 2</xref>&#x02013;<xref rid="T4" ref-type="table">4</xref>), while spatiotemporal dynamics are modeled using partial differential equations (PDEs) and/or agent-based models (ABMs) (<xref rid="T1" ref-type="table">Table 1</xref>). ODEs can incorporate processes such as bone cell proliferation, differentiation, and death. Most bone remodeling ODEs are single-compartment models focusing on cells and signals locally within the bone microenvironment. ODEs can also describe multiple physiological compartments simultaneously to show how factors outside the bone microenvironment affect bone remodeling.</p><p id="P43">ODEs are the most common technique for mathematical modeling of bone remodeling but cannot explicitly include geometric and transport effects (<xref rid="T2" ref-type="table">Tables 2</xref>&#x02013;<xref rid="T4" ref-type="table">4</xref>). Spatiotemporal models that incorporate these effects more accurately depict the bone remodeling process. For example, continuous PDEs can model the migration of osteoclasts and osteoblasts to specific locations within the remodeling site. These are important steps in bone remodeling that ODEs cannot resolve. However, PDEs are more computationally expensive to solve than ODEs because they include spatial and temporal effects. ABMs are less widely adopted for spatiotemporal modeling of bone remodeling (<xref rid="R8" ref-type="bibr">Araujo et al., 2014</xref>; <xref rid="R9" ref-type="bibr">Arias et al., 2018</xref>). Like PDEs, ABMs can model cell movement and how the spatial positioning influences the bone remodeling cycle. However, ABMs are discrete rather than continuous, so their computational intensity depends on the number of agents and the algorithms used to execute their interaction rules. In ABMs, cells are represented as agents that follow rules to move, proliferate, transform, die, and/or secrete signaling factors. The rules governing these cell actions consider the surrounding cell environment and probabilities for introducing stochasticity into the rules.</p><p id="P44">Two prevailing mathematical formulations that describe bone cell population dynamics and their biochemical signaling dynamics in the BMU are commonly incorporated into models of bone remodeling using ODEs, PDEs, and ABMs. One formulation is based on the power law approach, popularized for bone remodeling by <xref rid="R135" ref-type="bibr">Komarova et al. (2003)</xref>. The second formulation uses the mass action kinetics as in the models of <xref rid="R147" ref-type="bibr">Lemaire et al. (2004)</xref> and <xref rid="R192" ref-type="bibr">Pivonka et al. (2008)</xref>. These distinct approaches form the basis of many temporal and spatiotemporal models of bone remodeling (<xref rid="F5" ref-type="fig">Figure 5</xref>, which includes all publications from <xref rid="T1" ref-type="table">Tables 1</xref>&#x02013;<xref rid="T3" ref-type="table">3</xref> and <xref rid="SD1" ref-type="supplementary-material">Supplementary Tables S1</xref>&#x02013;<xref rid="SD1" ref-type="supplementary-material">S2</xref> but not all labels are shown because of space constraints). Models that do not explicitly follow either approach (<xref rid="R139" ref-type="bibr">Kroll, 2000</xref>; <xref rid="R200" ref-type="bibr">Rattanakul et al., 2003</xref>; <xref rid="R162" ref-type="bibr">Martin and Buckland-Wright, 2004</xref>; <xref rid="R169" ref-type="bibr">Moroz et al., 2006</xref>; <xref rid="R170" ref-type="bibr">Moroz and Wimpenny, 2007</xref>; <xref rid="R4" ref-type="bibr">Akchurin et al., 2008</xref>; <xref rid="R125" ref-type="bibr">Ji et al., 2012</xref>; <xref rid="R197" ref-type="bibr">Proctor and Gartland, 2016</xref>; <xref rid="R43" ref-type="bibr">Chaiya and Rattanakul, 2017</xref>; <xref rid="R118" ref-type="bibr">Javed et al., 2018</xref>; <xref rid="R267" ref-type="bibr">Zhao and Zhang, 2019</xref>; <xref rid="R117" ref-type="bibr">Javed et al., 2020</xref>; <xref rid="R174" ref-type="bibr">Nutini et al., 2021</xref>; <xref rid="R127" ref-type="bibr">Jorg et al., 2022</xref>) (<xref rid="T4" ref-type="table">Table 4</xref>) are not included in <xref rid="F5" ref-type="fig">Figure 5</xref>; however, most of those detailed in <xref rid="SD1" ref-type="supplementary-material">Supplementary Table S3</xref> show citation connections for the field&#x02019;s literature.</p><sec id="S17"><label>4.1</label><title>Power law approach</title><p id="P45">In biochemical models of bone remodeling, researchers represent the effects of signaling molecules on bone cell populations using different functional forms. The power law approach uses nonlinear functional relationships where output effects depend on an input raised to some power. These approximations are frequently used to model nonlinear biological systems because they capture complex dynamics relatively simply (<xref rid="R212" ref-type="bibr">Savageau, 1970</xref>; <xref rid="R248" ref-type="bibr">Vera et al., 2007</xref>; <xref rid="R230" ref-type="bibr">Srinath and Gunawan, 2010</xref>).</p><p id="P46">Models following the power law approach represent the lumped effects of types of signaling molecules on bone cell populations through the exponent terms in the power law functions. In the case of the <xref rid="R135" ref-type="bibr">Komarova et al. (2003)</xref> model, signaling molecules are grouped into general autocrine and paracrine signaling terms. The autocrine terms encompass all the signals released for self-regulation, e.g., osteoclast-derived signals that regulate the osteoclast population. The paracrine terms encompass all the signals other cells release, e.g., osteoblast-derived signals that regulate the osteoclast population. The general form for describing bone cell dynamics following the power law approach is
<disp-formula id="FD1">
<label>(1)</label>
<mml:math id="M53" display="block"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi mathvariant="normal">A</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">A</mml:mi></mml:mrow></mml:msub><mml:msup><mml:mrow><mml:mi mathvariant="normal">A</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mn>11</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msup><mml:msup><mml:mrow><mml:mspace width="1pt"/><mml:mi mathvariant="normal">B</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mn>21</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msup><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">A</mml:mi></mml:mrow></mml:msub><mml:mi mathvariant="normal">A</mml:mi></mml:math>
</disp-formula>
where A represents the number of cells of type A, B represents the number of cells of type B that interact with A through paracrine signaling, <inline-formula><mml:math id="M54" display="inline"><mml:msub><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mn>11</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> represents autocrine (A to A) signaling action, <inline-formula><mml:math id="M55" display="inline"><mml:msub><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mn>21</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> represents paracrine (B to A) signaling action, and <inline-formula><mml:math id="M56" display="inline"><mml:msub><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow><mml:mrow><mml:mi>A</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> and <inline-formula><mml:math id="M57" display="inline"><mml:msub><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow><mml:mrow><mml:mi>A</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> represent proliferation and degradation rate constants, respectively. Generally, <inline-formula><mml:math id="M58" display="inline"><mml:msub><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> denotes the combined effects of signals produced from cell type <inline-formula><mml:math id="M59" display="inline"><mml:mi>i</mml:mi></mml:math></inline-formula> (or a cascade involving this cell type) that regulate cell type <inline-formula><mml:math id="M60" display="inline"><mml:mi>j</mml:mi></mml:math></inline-formula>. Here, the proliferation of <inline-formula><mml:math id="M61" display="inline"><mml:mi mathvariant="normal">A</mml:mi><mml:mo>(</mml:mo><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>)</mml:mo></mml:math></inline-formula> depends on autocrine from <inline-formula><mml:math id="M62" display="inline"><mml:mi mathvariant="normal">A</mml:mi><mml:mo>(</mml:mo><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>)</mml:mo></mml:math></inline-formula> and paracrine from <inline-formula><mml:math id="M63" display="inline"><mml:mi mathvariant="normal">B</mml:mi><mml:mo>(</mml:mo><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>2</mml:mn><mml:mo>)</mml:mo></mml:math></inline-formula> signaling effects. The degradation rate is commonly assumed to be proportional to the current population.</p><p id="P47">The power law approach results in small parameter spaces. For example, the model in <xref rid="R135" ref-type="bibr">Komarova et al. (2003)</xref> contains only ten parameters fitted for a single BMU using experimental data from <xref rid="R184" ref-type="bibr">Parfitt (1994)</xref>. A small parameter space requires fewer data for model calibration and validation and enables quick exploration of cell population balances through parameter sweeps. The lower computational complexity also allows researchers to connect the power law model to other biological system models, particularly for physiological homeostasis conditions. However, the empirical nature of power law models leads to ambiguity about which signaling factors control the bone remodeling cycle and how they interact mechanistically. The power law models cannot be easily extended for situations like diseases or treatments when these signals are perturbed outside the conditions used to fit the power law parameters. The lack of direct mechanistic interpretation is a common criticism of the power law approach (<xref rid="R170" ref-type="bibr">Moroz and Wimpenny, 2007</xref>).</p></sec><sec id="S18"><label>4.2</label><title>Mass action kinetics approach</title><p id="P48">Another common form for ODE models of bone remodeling uses mass action kinetics. This fundamental concept is commonly used to model chemical and biological reactions, such as those seen in enzyme kinetics, ecological systems, and disease dynamics (<xref rid="R249" ref-type="bibr">Voit et al., 2015</xref>). In our classification, mass action kinetics includes Michaelis-Menten and Hill equations for enzyme and ligand binding kinetics. The mass action kinetics model structure for bone remodeling leverages the foundational model by <xref rid="R147" ref-type="bibr">Lemaire et al. (2004)</xref> and refinement by <xref rid="R192" ref-type="bibr">Pivonka et al. (2008)</xref> (<xref rid="F5" ref-type="fig">Figure 5</xref>). The mass action kinetics approach is a major alternative to the power law approach as it better identifies how specific signaling factors affect the balance between osteoblast and osteoclast populations.</p><p id="P49">Bone models following the mass action kinetics approach capture the effects of signaling factors on cell dynamics with <inline-formula><mml:math id="M64" display="inline"><mml:mi>&#x003c0;</mml:mi></mml:math></inline-formula> terms. These terms represent the fraction of occupied receptors and are first defined by <xref rid="R147" ref-type="bibr">Lemaire et al. (2004)</xref>. The model by <xref rid="R192" ref-type="bibr">Pivonka et al. (2008)</xref> simplifies the <inline-formula><mml:math id="M65" display="inline"><mml:mi>&#x003c0;</mml:mi></mml:math></inline-formula> terms using Hill functions defined in <xref rid="FD3" ref-type="disp-formula">Eqs 3</xref>, <xref rid="FD4" ref-type="disp-formula">4</xref> that represent ligand-receptor binding kinetics as activating or repressing processes, generalizing the work of <xref rid="R147" ref-type="bibr">Lemaire et al. (2004)</xref>. Despite some differences between the <inline-formula><mml:math id="M66" display="inline"><mml:mi>&#x003c0;</mml:mi></mml:math></inline-formula> terms and models of <xref rid="R147" ref-type="bibr">Lemaire et al. (2004)</xref> and <xref rid="R192" ref-type="bibr">Pivonka et al. (2008)</xref>, they share fundamental derivation steps. In the mass action kinetics approach, bone signaling factor actions are commonly represented by the reversible ligand-receptor relationship:
<disp-formula id="FD2">
<label>(2)</label>
<mml:math id="M67" display="block"><mml:mi>L</mml:mi><mml:mo>+</mml:mo><mml:mi>R</mml:mi><mml:mo>&#x02194;</mml:mo><mml:mi>L</mml:mi><mml:mo>&#x022c5;</mml:mo><mml:mi>R</mml:mi></mml:math>
</disp-formula>
where <inline-formula><mml:math id="M68" display="inline"><mml:mi>L</mml:mi></mml:math></inline-formula> is the ligand, <inline-formula><mml:math id="M69" display="inline"><mml:mi>R</mml:mi></mml:math></inline-formula> is the receptor for the ligand, and <inline-formula><mml:math id="M70" display="inline"><mml:mi>L</mml:mi><mml:mo>&#x022c5;</mml:mo><mml:mi>R</mml:mi></mml:math></inline-formula> is the bound ligand-receptor complex. These ligand-receptor binding reactions in <xref rid="FD2" ref-type="disp-formula">Eq. 2</xref> for all ligands and receptors are converted into ODEs by applying mass action kinetics with the pseudo-steady state approximation. This assumes that the cellular response to signals is much slower than the dynamics of ligand-receptor binding. The <inline-formula><mml:math id="M71" display="inline"><mml:mi>&#x003c0;</mml:mi></mml:math></inline-formula> terms in <xref rid="R147" ref-type="bibr">Lemaire et al. (2004)</xref> are derived by finding the ratio of the ligand-receptor complex to the unbound ligand. <xref rid="R192" ref-type="bibr">Pivonka et al. (2008)</xref> generalizes these equations to obtain ligand concentrations for the formulaic <inline-formula><mml:math id="M72" display="inline"><mml:mi>&#x003c0;</mml:mi></mml:math></inline-formula> terms. Rather than deriving <inline-formula><mml:math id="M73" display="inline"><mml:mi>&#x003c0;</mml:mi></mml:math></inline-formula> terms from each ligand-receptor binding combination, <xref rid="R192" ref-type="bibr">Pivonka et al. (2008)</xref> assumes that Hill functions represent stimulation and inhibition of cell activity due to the presence of a signaling factor. Readers are referred to <xref rid="R147" ref-type="bibr">Lemaire et al. (2004)</xref> and <xref rid="R192" ref-type="bibr">Pivonka et al. (2008)</xref> for full derivation details. There are two forms of these Hill functions: one for activating signaling factors (<xref rid="R192" ref-type="bibr">Pivonka et al., 2008</xref>)
<disp-formula id="FD3">
<label>(3)</label>
<mml:math id="M74" display="block"><mml:msubsup><mml:mrow><mml:mi>&#x003c0;</mml:mi></mml:mrow><mml:mrow><mml:mtext>act</mml:mtext><mml:mo>,</mml:mo><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>X</mml:mi></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:math>
</disp-formula>
and another for repressing signaling factors (<xref rid="R192" ref-type="bibr">Pivonka et al., 2008</xref>)
<disp-formula id="FD4">
<label>(4)</label>
<mml:math id="M75" display="block"><mml:msubsup><mml:mrow><mml:mi>&#x003c0;</mml:mi></mml:mrow><mml:mrow><mml:mtext>rep</mml:mtext><mml:mo>,</mml:mo><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>Y</mml:mi></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:mfenced separators="|"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>Y</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:math>
</disp-formula>
where <inline-formula><mml:math id="M76" display="inline"><mml:mi>X</mml:mi></mml:math></inline-formula> is the concentration of an activating signaling factor that affects cell type <inline-formula><mml:math id="M77" display="inline"><mml:mi>m</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> is the activation coefficient, <inline-formula><mml:math id="M78" display="inline"><mml:mi>n</mml:mi></mml:math></inline-formula> is the Hill coefficient, <inline-formula><mml:math id="M79" display="inline"><mml:mi>Y</mml:mi></mml:math></inline-formula> is the concentration of a repressive signaling factor that affects cell type <inline-formula><mml:math id="M80" display="inline"><mml:mi>m</mml:mi></mml:math></inline-formula>, and <inline-formula><mml:math id="M81" display="inline"><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> is the repression coefficient. Unlike enzyme kinetics, <inline-formula><mml:math id="M82" display="inline"><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> and <inline-formula><mml:math id="M83" display="inline"><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> are related to a cell response, not strictly biochemical dissociation constants. The concentrations of <inline-formula><mml:math id="M84" display="inline"><mml:mi>X</mml:mi></mml:math></inline-formula> and <inline-formula><mml:math id="M85" display="inline"><mml:mi>Y</mml:mi></mml:math></inline-formula> can be defined by ODEs or algebraic equations. It is important to note that a signaling factor can perform both activating and repressing actions and impact different cells, so it can have multiple corresponding <inline-formula><mml:math id="M86" display="inline"><mml:mi>&#x003c0;</mml:mi></mml:math></inline-formula> terms.</p><p id="P50">Although the <inline-formula><mml:math id="M87" display="inline"><mml:mi>&#x003c0;</mml:mi></mml:math></inline-formula> terms in <xref rid="R147" ref-type="bibr">Lemaire et al. (2004)</xref> and <xref rid="R192" ref-type="bibr">Pivonka et al. (2008)</xref> have slight derivation differences and biological assumptions, the resulting models are functionally similar. Consider a cell type A that is formed by the differentiation of precursor cells pA. This differentiation process is activated by signaling factor <inline-formula><mml:math id="M88" display="inline"><mml:msub><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> and inhibited by signaling factor <inline-formula><mml:math id="M89" display="inline"><mml:msub><mml:mrow><mml:mi>Y</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula>. Apoptosis of A is activated by signaling factor <inline-formula><mml:math id="M90" display="inline"><mml:msub><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> and inhibited by signaling factor <inline-formula><mml:math id="M91" display="inline"><mml:msub><mml:mrow><mml:mi>Y</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula>. Following the examples from (<xref rid="R192" ref-type="bibr">Pivonka et al., 2008</xref>), we provide the general form for describing bone cell dynamics following the mass action kinetics approach as
<disp-formula id="FD5">
<label>(5)</label>
<mml:math id="M92" display="block"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi mathvariant="normal">A</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow><mml:mrow><mml:mtext>pA</mml:mtext></mml:mrow></mml:msub><mml:mtext>pA</mml:mtext><mml:msubsup><mml:mrow><mml:mi>&#x003c0;</mml:mi></mml:mrow><mml:mrow><mml:mtext>act</mml:mtext><mml:mo>,</mml:mo><mml:mtext>pA</mml:mtext></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msubsup><mml:msubsup><mml:mrow><mml:mi>&#x003c0;</mml:mi></mml:mrow><mml:mrow><mml:mtext>rep</mml:mtext><mml:mo>,</mml:mo><mml:mtext>pA</mml:mtext></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>Y</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msubsup><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">A</mml:mi></mml:mrow></mml:msub><mml:mi mathvariant="normal">A</mml:mi><mml:msubsup><mml:mrow><mml:mi>&#x003c0;</mml:mi></mml:mrow><mml:mrow><mml:mtext>act</mml:mtext><mml:mo>,</mml:mo><mml:mi mathvariant="normal">A</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msubsup><mml:msubsup><mml:mrow><mml:mi>&#x003c0;</mml:mi></mml:mrow><mml:mrow><mml:mtext>rep</mml:mtext><mml:mo>,</mml:mo><mml:mi mathvariant="normal">A</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>Y</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msubsup></mml:math>
</disp-formula>
where A is the population of cells of type A, pA is the population of precursor pA cells, <inline-formula><mml:math id="M93" display="inline"><mml:msubsup><mml:mrow><mml:mi>&#x003c0;</mml:mi></mml:mrow><mml:mrow><mml:mtext>act</mml:mtext><mml:mi>,</mml:mi><mml:mtext>pA</mml:mtext></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msubsup></mml:math></inline-formula> is the activation from signaling factor <inline-formula><mml:math id="M94" display="inline"><mml:msub><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mspace width="1pt"/><mml:msubsup><mml:mrow><mml:mi>&#x003c0;</mml:mi></mml:mrow><mml:mrow><mml:mtext>rep,pA</mml:mtext></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>Y</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msubsup></mml:math></inline-formula> is the repression from signaling factor <inline-formula><mml:math id="M95" display="inline"><mml:msub><mml:mrow><mml:mi>Y</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msubsup><mml:mrow><mml:mi>&#x003c0;</mml:mi></mml:mrow><mml:mrow><mml:mtext>act,A</mml:mtext></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msubsup></mml:math></inline-formula> is the activation from signaling factor <inline-formula><mml:math id="M96" display="inline"><mml:msub><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msubsup><mml:mrow><mml:mi>&#x003c0;</mml:mi></mml:mrow><mml:mrow><mml:mtext>rep,A</mml:mtext></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>Y</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msubsup></mml:math></inline-formula> is the repression from signaling factor <inline-formula><mml:math id="M97" display="inline"><mml:msub><mml:mrow><mml:mi>Y</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula>, and <inline-formula><mml:math id="M98" display="inline"><mml:msub><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow><mml:mrow><mml:mtext>pA</mml:mtext></mml:mrow></mml:msub></mml:math></inline-formula> and <inline-formula><mml:math id="M99" display="inline"><mml:msub><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">A</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> represent differentiation and apoptosis rate constants, respectively. The <inline-formula><mml:math id="M100" display="inline"><mml:mi>&#x003c0;</mml:mi></mml:math></inline-formula> terms replace the autocrine and paracrine exponents from <xref rid="FD1" ref-type="disp-formula">Eq. 1</xref> but still account for bone cells&#x02019; autocrine and paracrine signaling. Unlike the exponents in <xref rid="FD1" ref-type="disp-formula">Eq. 1</xref>, the <inline-formula><mml:math id="M101" display="inline"><mml:mi>&#x003c0;</mml:mi></mml:math></inline-formula> terms allow the concentrations of signaling factors to depend on the population of BMU cells. <xref rid="FD5" ref-type="disp-formula">Eq. 5</xref> considers activating and repressing signals acting on both the source and sink terms. For different model scenarios considering various biological mechanisms, only one or neither of these signals may impact a term or more than one signal of the same type may be applied to a term.</p><p id="P51">The mass action kinetics approach results in larger parameter spaces than the power law approach. Whereas the power law model by <xref rid="R135" ref-type="bibr">Komarova et al. (2003)</xref> contains ten unknown parameters, the mass action kinetics models by <xref rid="R147" ref-type="bibr">Lemaire et al. (2004)</xref> and <xref rid="R192" ref-type="bibr">Pivonka et al. (2008)</xref> contain 23 and 30 parameters, respectively. The parameter increase is a consequence of the mechanistic incorporation of signaling factor effects. As a result, the mass action kinetics approach helps determine the importance of signaling factors within a specific study and how changes in their levels alter the bone remodeling cycle. The caveat of this approach is that more parameters can lead to overfitting of limited data. The mass action kinetics approach is also more computationally complex and expensive, limiting its use in larger multiscale models of biological systems.</p></sec><sec id="S19"><label>4.3</label><title>Representative mathematical forms for modeling the BMU</title><p id="P52">In the following, we provide example mathematical forms for changes to bone volume due to remodeling and for bone cell population balances that are frequently considered in mathematical models for bone remodeling from a local perspective (i.e., focusing on the BMU).</p><sec id="S20"><label>4.3.1</label><title>Bone volume</title><p id="P53">Regardless of the approach, models of bone remodeling generally include the dynamics of osteoblast and osteoclast cells. While cell populations&#x02019; evolution and signaling interactions vary between models, osteoblasts always form bone, and osteoclasts always break down bone. The net effect of bone regulation by these cells can generally be represented in ODE form by (<xref rid="R79" ref-type="bibr">Frost, 1964b</xref>)
<disp-formula id="FD6">
<label>(6)</label>
<mml:math id="M102" display="block"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>z</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi>f</mml:mi></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi>r</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>f</mml:mi></mml:mrow></mml:msub><mml:mtext>OBL</mml:mtext><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>r</mml:mi></mml:mrow></mml:msub><mml:mtext>OCL</mml:mtext></mml:math>
</disp-formula>
where <inline-formula><mml:math id="M103" display="inline"><mml:mi>z</mml:mi></mml:math></inline-formula> is bone volume fraction, often corresponding to the ratio of bone volume to tissue volume (BV/TV) bone histomorphometric quantity (<xref rid="R29" ref-type="bibr">Bouxsein et al., 2010</xref>; <xref rid="R60" ref-type="bibr">Dempster et al., 2013</xref>), TV is frequently the trabecular volume (<xref rid="R39" ref-type="bibr">Burr and Akkus, 2014</xref>), <inline-formula><mml:math id="M104" display="inline"><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi>f</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is the formation rate, <inline-formula><mml:math id="M105" display="inline"><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi>r</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is the resorption rate, <inline-formula><mml:math id="M106" display="inline"><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>f</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is the formation rate constant for the action of the osteoblasts, and <inline-formula><mml:math id="M107" display="inline"><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>r</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is the resorption rate constant for the osteoclast activity. The variables OBL and OCL in <xref rid="FD6" ref-type="disp-formula">Eq. 6</xref> usually represent changes from the steady state population, sometimes called active cell populations. Additionally, bone volume may be replaced with bone mass or other relevant bone properties. Bone volume, total osteoblast population, and total osteoclast population cannot have negative values.</p></sec><sec id="S21"><label>4.3.2</label><title>Osteoclasts</title><p id="P54">A thorough understanding of osteoclast bone resorptive activity and population dynamics is crucial to predicting how much bone is resorbed during a remodeling cycle. The difference between the net formation and degradation terms determines the osteoclast population dynamics. The power law approach is used to mathematically represent these dynamics following <xref rid="FD1" ref-type="disp-formula">Eq. 1</xref> as (<xref rid="R135" ref-type="bibr">Komarova et al., 2003</xref>)
<disp-formula id="FD7">
<label>(7)</label>
<mml:math id="M108" display="block"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mtext>OCL</mml:mtext></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow><mml:mrow><mml:mtext>OCL</mml:mtext></mml:mrow></mml:msub><mml:msup><mml:mrow><mml:mtext>OCL</mml:mtext></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mn>11</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msup><mml:msup><mml:mrow><mml:mtext>OBL</mml:mtext></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mn>21</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msup><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow><mml:mrow><mml:mtext>OCL</mml:mtext></mml:mrow></mml:msub><mml:mtext>OCL</mml:mtext></mml:math>
</disp-formula>
where OCL represents the number of osteoclasts, OBL represents the number of osteoblasts, <inline-formula><mml:math id="M109" display="inline"><mml:msub><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mn>11</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> represents autocrine (osteoclast to osteoclast) signaling action, <inline-formula><mml:math id="M110" display="inline"><mml:msub><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mn>21</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> represents paracrine (osteoblast to osteoclast) signaling action, and <inline-formula><mml:math id="M111" display="inline"><mml:msub><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow><mml:mrow><mml:mtext>OCL</mml:mtext></mml:mrow></mml:msub></mml:math></inline-formula> and <inline-formula><mml:math id="M112" display="inline"><mml:msub><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow><mml:mrow><mml:mtext>OCL</mml:mtext></mml:mrow></mml:msub></mml:math></inline-formula> represent proliferation and degradation rate constants, respectively. The proliferation of osteoclasts <inline-formula><mml:math id="M113" display="inline"><mml:mo>(</mml:mo><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>)</mml:mo></mml:math></inline-formula> depends on autocrine from osteoclasts <inline-formula><mml:math id="M114" display="inline"><mml:mo>(</mml:mo><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>)</mml:mo></mml:math></inline-formula> and paracrine from osteoblasts <inline-formula><mml:math id="M115" display="inline"><mml:mo>(</mml:mo><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>2</mml:mn><mml:mo>)</mml:mo></mml:math></inline-formula> signaling effects. The degradation rate of osteoclasts is assumed to be proportional to the current population.</p><p id="P55">Some power law models modify the signaling dynamics to account for a specific molecular factor by reformulating the population dynamics and recalculating general signaling exponents (<xref rid="R134" ref-type="bibr">Komarova, 2005</xref>; <xref rid="R95" ref-type="bibr">Graham et al., 2013</xref>). For instance, if a signaling factor <inline-formula><mml:math id="M116" display="inline"><mml:msub><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mrow><mml:mtext>OCL</mml:mtext></mml:mrow></mml:msub></mml:math></inline-formula> alters osteoclast proliferation, the osteoclast equation is modified to become
<disp-formula id="FD8">
<label>(8)</label>
<mml:math id="M117" display="block"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mtext>OCL</mml:mtext></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mrow><mml:mtext>OCL</mml:mtext></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow><mml:mrow><mml:mtext>OCL</mml:mtext></mml:mrow></mml:msub><mml:msup><mml:mrow><mml:mtext>OCL</mml:mtext></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mn>11</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msup><mml:msup><mml:mrow><mml:mtext>OBL</mml:mtext></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mn>21</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msup><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow><mml:mrow><mml:mtext>OCL</mml:mtext></mml:mrow></mml:msub><mml:mtext>OCL</mml:mtext></mml:math>
</disp-formula>
with new values for <inline-formula><mml:math id="M118" display="inline"><mml:msub><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mn>11</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> and <inline-formula><mml:math id="M119" display="inline"><mml:msub><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mn>21</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> as compared to <xref rid="FD7" ref-type="disp-formula">Eq. 7</xref>.</p><p id="P56">By the mass action kinetics approach following <xref rid="FD5" ref-type="disp-formula">Eq. 5</xref>, the population of osteoclasts is given by (<xref rid="R192" ref-type="bibr">Pivonka et al., 2008</xref>)
<disp-formula id="FD9">
<label>(9)</label>
<mml:math id="M120" display="block"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mtext>OCL</mml:mtext></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow><mml:mrow><mml:mtext>pOCL</mml:mtext></mml:mrow></mml:msub><mml:mtext>pOCL</mml:mtext><mml:msubsup><mml:mrow><mml:mi>&#x003c0;</mml:mi></mml:mrow><mml:mrow><mml:mtext>act</mml:mtext><mml:mo>,</mml:mo><mml:mtext>pOCL</mml:mtext></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msubsup><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow><mml:mrow><mml:mtext>OCL</mml:mtext></mml:mrow></mml:msub><mml:mtext>OCL</mml:mtext><mml:msubsup><mml:mrow><mml:mi>&#x003c0;</mml:mi></mml:mrow><mml:mrow><mml:mtext>act</mml:mtext><mml:mo>,</mml:mo><mml:mtext>OCL</mml:mtext></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">X</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msubsup></mml:math>
</disp-formula>
where OCL is the osteoclast population, pOCL is the preosteoclast population, <inline-formula><mml:math id="M121" display="inline"><mml:msubsup><mml:mrow><mml:mi>&#x003c0;</mml:mi></mml:mrow><mml:mrow><mml:mtext>act,pOCL</mml:mtext></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msubsup></mml:math></inline-formula> is the activation from signaling factor <inline-formula><mml:math id="M122" display="inline"><mml:msub><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msubsup><mml:mrow><mml:mi>&#x003c0;</mml:mi></mml:mrow><mml:mrow><mml:mtext>act</mml:mtext><mml:mo>,</mml:mo><mml:mtext>OCL</mml:mtext></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msubsup></mml:math></inline-formula> is the activation from signaling factor <inline-formula><mml:math id="M123" display="inline"><mml:msub><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula>, and <inline-formula><mml:math id="M124" display="inline"><mml:msub><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow><mml:mrow><mml:mtext>pOCL</mml:mtext></mml:mrow></mml:msub></mml:math></inline-formula> and <inline-formula><mml:math id="M125" display="inline"><mml:msub><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow><mml:mrow><mml:mtext>OCL</mml:mtext></mml:mrow></mml:msub></mml:math></inline-formula> represent differentiation and apoptosis rate constants, respectively. In <xref rid="R192" ref-type="bibr">Pivonka et al. (2008)</xref>, differentiation and apoptosis terms are both activated and not inhibited. <inline-formula><mml:math id="M126" display="inline"><mml:msub><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> is RANKL, and <inline-formula><mml:math id="M127" display="inline"><mml:msub><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> is TGF-<inline-formula><mml:math id="M128" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula>. Different combinations of activating and repressing <inline-formula><mml:math id="M129" display="inline"><mml:mi>&#x003c0;</mml:mi></mml:math></inline-formula> terms are proposed in models from other publications. When following the mass action kinetics approach, researchers typically examine individual signaling factors during formulation. As a result, the overall structure of the osteoclast equation rarely undergoes drastic changes. Instead, new signaling factors are simply added through more <inline-formula><mml:math id="M130" display="inline"><mml:mi>&#x003c0;</mml:mi></mml:math></inline-formula> terms in the mass actions kinetics approach.</p><p id="P57">Uncommitted monocytes and preosteoclasts are rarely modeled as dynamic populations (thus, pOCL is a constant in <xref rid="FD9" ref-type="disp-formula">Eq. 9</xref>). Osteoclasts are assumed to differentiate from a large pool of hematopoietic stem cells, so the uncommitted population is usually modeled as a fixed quantity. Although this assumption is reasonable for healthy bone remodeling, it loses validity when studying diseases where hematopoietic stem cell numbers are reduced (<xref rid="R258" ref-type="bibr">Weilbaecher, 2000</xref>; <xref rid="R165" ref-type="bibr">Matatall et al., 2016</xref>). Preosteoclasts are usually omitted for simplification under the assumption that remodeling is already occurring, i.e., the activation stage is assumed to occur instantaneously (<xref rid="F1" ref-type="fig">Figure 1</xref>). However, this neglects the time needed to initiate this remodeling stage.</p></sec><sec id="S22"><label>4.3.3</label><title>Osteoblasts</title><p id="P58">Mathematical models must include osteoblast cell dynamics to understand changes in bone formation rates. Osteoblast population balances are similar to those of osteoclasts given in <xref rid="FD7" ref-type="disp-formula">Eqs 7</xref>, <xref rid="FD9" ref-type="disp-formula">9</xref>, and these balances are modeled by the power law approach following <xref rid="FD1" ref-type="disp-formula">Eq. 1</xref> as (<xref rid="R135" ref-type="bibr">Komarova et al., 2003</xref>)
<disp-formula id="FD10">
<label>(10)</label>
<mml:math id="M131" display="block"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mtext>OBL</mml:mtext></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow><mml:mrow><mml:mtext>OBL</mml:mtext></mml:mrow></mml:msub><mml:msup><mml:mrow><mml:mtext>OCL</mml:mtext></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mn>12</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msup><mml:msup><mml:mrow><mml:mtext>OBL</mml:mtext></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mn>22</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msup><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow><mml:mrow><mml:mtext>OBL</mml:mtext></mml:mrow></mml:msub><mml:mtext>OBL</mml:mtext></mml:math>
</disp-formula>
and by the mass action kinetics approach following <xref rid="FD5" ref-type="disp-formula">Eq. 5</xref> as (<xref rid="R192" ref-type="bibr">Pivonka et al., 2008</xref>)
<disp-formula id="FD11">
<label>(11)</label>
<mml:math id="M132" display="block"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mtext>OBL</mml:mtext></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow><mml:mrow><mml:mtext>pOBL</mml:mtext></mml:mrow></mml:msub><mml:mtext>pOBL</mml:mtext><mml:msubsup><mml:mrow><mml:mi>&#x003c0;</mml:mi></mml:mrow><mml:mrow><mml:mtext>rep</mml:mtext><mml:mo>,</mml:mo><mml:mtext>pOBL</mml:mtext></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>Y</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msubsup><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow><mml:mrow><mml:mtext>OBL</mml:mtext></mml:mrow></mml:msub><mml:mtext>OBL</mml:mtext></mml:math>
</disp-formula>
where the parameters here correspond to osteoblast (cell type <inline-formula><mml:math id="M133" display="inline"><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>2</mml:mn></mml:math></inline-formula>) dynamics and pOBL is the preosteoblast population. In <xref rid="R192" ref-type="bibr">Pivonka et al. (2008)</xref>, differentiation is inhibited, and apoptosis is neither activated nor inhibited. <inline-formula><mml:math id="M134" display="inline"><mml:msub><mml:mrow><mml:mi>Y</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> is TGF-<inline-formula><mml:math id="M135" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula>. Unlike osteoclasts, osteoblasts are modeled with one or two consumption terms. The use of one consumption term encapsulates osteoblast apoptosis and its conversion to other bone cells, such as osteocytes and bone lining cells. When models include two consumption terms, one tracks osteoblast conversion to osteocytes. The other consumption term tracks osteoblast apoptosis and other osteoblast cell losses.</p><p id="P59">Another difference between osteoblast and osteoclast population balances is that preosteoblast dynamics are commonly modeled. A study analyzing a generalized model of bone remodeling highlights the importance of preosteoblast populations (<xref rid="R268" ref-type="bibr">Zumsande et al., 2011</xref>). For instance, preosteoblasts release key signaling molecules that initiate the resorption phase of bone remodeling. Additionally, preosteoblast cell dynamics must be modeled because the number of osteoblasts is dictated by the preosteoblast population after proliferation (<xref rid="R36" ref-type="bibr">Buenzli et al., 2012b</xref>). Since osteoblasts do not proliferate, a decrease in bone formation may result from fewer preosteoblasts. Preosteoblast population balances follow the same form as those of osteoblasts and osteoclasts. The formation term represents differentiation from uncommitted osteoblasts, while the consumption term represents conversion to osteoblasts.</p></sec><sec id="S23"><label>4.3.4</label><title>Osteocytes</title><p id="P60">As research continues to indicate that osteocytes are essential coordinators of bone remodeling, it is vital to include their dynamics and populations in mathematical models. Osteocyte population balances are less commonly found in mathematical models than osteoclast and osteoblast balances but generally follow similar principles. In power law models, osteocytes are modeled following <xref rid="FD8" ref-type="disp-formula">Eqs 8</xref>, <xref rid="FD10" ref-type="disp-formula">10</xref> as (<xref rid="R95" ref-type="bibr">Graham et al., 2013</xref>; <xref rid="R52" ref-type="bibr">Cook et al., 2022</xref>)
<disp-formula id="FD12">
<label>(12)</label>
<mml:math id="M136" display="block"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mtext>OCY</mml:mtext></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mrow><mml:mtext>OCY</mml:mtext></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow><mml:mrow><mml:mtext>OCY</mml:mtext></mml:mrow></mml:msub><mml:msup><mml:mrow><mml:mtext>OBL</mml:mtext></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mn>23</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msup></mml:math>
</disp-formula>
where OCY is the osteocyte population, <inline-formula><mml:math id="M137" display="inline"><mml:msub><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow><mml:mrow><mml:mtext>OCY</mml:mtext></mml:mrow></mml:msub></mml:math></inline-formula> is the rate of conversion from osteoblasts, and <inline-formula><mml:math id="M138" display="inline"><mml:msub><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mn>23</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> is osteoblast signals that influence the production of osteocytes (cell type <inline-formula><mml:math id="M139" display="inline"><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>3</mml:mn></mml:math></inline-formula>) via osteoblast embedding. The factor <inline-formula><mml:math id="M140" display="inline"><mml:msub><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mrow><mml:mtext>OCY</mml:mtext></mml:mrow></mml:msub></mml:math></inline-formula> represents osteocyte signaling that activates and terminates the bone remodeling cycle.</p><p id="P61">Differently, models following the mass action kinetics approach base their osteocyte population on the change in bone volume as (<xref rid="R160" ref-type="bibr">Martin et al., 2019</xref>; <xref rid="R161" ref-type="bibr">Martin et al., 2020</xref>; <xref rid="R40" ref-type="bibr">Calvo-Gallego et al., 2023</xref>)
<disp-formula id="FD13">
<label>(13)</label>
<mml:math id="M141" display="block"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mtext>OCY</mml:mtext></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mi>&#x003b7;</mml:mi><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>z</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:math>
</disp-formula>
where <inline-formula><mml:math id="M142" display="inline"><mml:mi>&#x003b7;</mml:mi></mml:math></inline-formula> is the average concentration of osteocytes embedded in the bone matrix and <inline-formula><mml:math id="M143" display="inline"><mml:mi>z</mml:mi></mml:math></inline-formula> is the bone volume fraction. Note the lack of degradation terms for long-lived osteocytes in <xref rid="FD12" ref-type="disp-formula">Eqs 12</xref>, <xref rid="FD13" ref-type="disp-formula">13</xref>. Some disease or injury conditions may explicitly induce loss of osteocytes, which can be incorporated by including a loss term or by reducing the osteocyte initial condition (<xref rid="R95" ref-type="bibr">Graham et al., 2013</xref>; <xref rid="R52" ref-type="bibr">Cook et al., 2022</xref>).</p></sec></sec></sec><sec id="S24"><label>5</label><title>Mathematical models of bone remodeling</title><p id="P62">Bone cells are typically represented similarly across spatiotemporal and temporal models. In the terminology adopted here, models that &#x0201c;include&#x0201d; a cell incorporate that cell as a state variable or dynamic variable, and &#x0201c;included&#x0201d; signals may be state variables, dynamic variables, constants, or implied. Although models following the power law approach imply several signaling molecules, this is indicated by their general autocrine and paracrine signaling representation, so only signaling features that are distinguished with a unique mathematical term are considered as &#x0201c;included&#x0201d; in the model. <xref rid="F6" ref-type="fig">Figure 6</xref> shows a quantitative comparison of the cells (top row) and chemical signals (bottom row) commonly included in the 88 mathematical models of bone remodeling detailed in <xref rid="T1" ref-type="table">Tables 1</xref>&#x02013;<xref rid="T4" ref-type="table">4</xref>.</p><p id="P63">Osteoblast and osteoclast dynamics are included in almost every spatiotemporal and temporal model, whereas osteocyte dynamics are less commonly modeled (<xref rid="F6" ref-type="fig">Figure 6</xref>; <xref rid="T1" ref-type="table">Tables 1</xref>&#x02013;<xref rid="T4" ref-type="table">4</xref>). This is probably due to early assumptions about inert osteocytes, as described in <xref rid="S4" ref-type="sec">Section 2.2</xref>. However, after osteocytes were found to play a mechanosensory role in bone remodeling, mathematical models began to include them when investigating mechanical effects on bone. For example, <xref rid="R169" ref-type="bibr">Moroz et al. (2006)</xref> is the earliest model with osteocytes, and the model includes mechanical stress. <xref rid="R170" ref-type="bibr">Moroz and Wimpenny (2007)</xref> introduces osteocyte regulation and, similar to <xref rid="R192" ref-type="bibr">Pivonka et al. (2008)</xref>, defines autocrine and paracrine regulation mechanisms with more biologically accurate formulas, exploring four different receptor-ligand binding equations (Michaelis-Menten, Hill, Koshland-Nemethy-Filmer, and Monod-Wyman-Changeux) through stability analysis, ultimately concluding that the simpler Michaelis-Menten and Hill equations are most useful&#x02014;consistent with models that adopt the mass action kinetics approach. Osteocytes are also typically included in mechano-chemo-biological models (<xref rid="R214" ref-type="bibr">Scheiner et al., 2013</xref>; <xref rid="R160" ref-type="bibr">Martin et al., 2019</xref>; <xref rid="R15" ref-type="bibr">Ashrafi et al., 2020</xref>; <xref rid="R40" ref-type="bibr">Calvo-Gallego et al., 2023</xref>). Other models with osteocytes aim to understand the effect of sclerostin, a product of osteocytes, on Wnt activation (<xref rid="R95" ref-type="bibr">Graham et al., 2013</xref>; <xref rid="R70" ref-type="bibr">Eudy et al., 2015</xref>; <xref rid="R52" ref-type="bibr">Cook et al., 2022</xref>). Although spatiotemporal and temporal models are remarkably similar in how often and which bone cells they explicitly model, they differ substantially in the number and combinations of signaling molecules modeled. Spatiotemporal models are discussed distinctly in <xref rid="S25" ref-type="sec">Section 5.1</xref>.</p><p id="P64">The signaling molecules represented in ODEs for bone remodeling (<xref rid="F6" ref-type="fig">Figure 6</xref>) differ partly due to the choice between the power law approach or the mass action kinetics approach. The power law approach uses general autocrine and paracrine signaling (<xref rid="T2" ref-type="table">Table 2</xref>). In contrast, the mass action kinetics approach explicitly models signaling interactions individually, such as RANK, RANKL, OPG, PTH, and TGF-<inline-formula><mml:math id="M144" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula> (<xref rid="T3" ref-type="table">Table 3</xref>). Furthermore, most power law models extend <xref rid="R135" ref-type="bibr">Komarova et al. (2003)</xref>, and most mass action kinetics models extend <xref rid="R147" ref-type="bibr">Lemaire et al. (2004)</xref> or <xref rid="R192" ref-type="bibr">Pivonka et al. (2008)</xref> (<xref rid="F5" ref-type="fig">Figure 5</xref>). Therefore, model extensions generally retain the signaling interactions of the original models. <xref rid="S26" ref-type="sec">Sections 5.2</xref>, <xref rid="S27" ref-type="sec">5.3</xref> address the evolution of signaling molecule representations since these foundational models. <xref rid="T2" ref-type="table">Table 2</xref> and <xref rid="SD1" ref-type="supplementary-material">Supplementary Table S1</xref> itemize the temporal mathematical models that follow the power law approach. <xref rid="T3" ref-type="table">Table 3</xref> and <xref rid="SD1" ref-type="supplementary-material">Supplementary Table S2</xref> focus on those that follow the mass action kinetics approach. <xref rid="T4" ref-type="table">Table 4</xref> and <xref rid="SD1" ref-type="supplementary-material">Supplementary Table S3</xref> include those temporal models that cannot be readily categorized as following either approach. Note that spatiotemporal models are also classified by approach in <xref rid="SD1" ref-type="supplementary-material">Supplementary Tables S1</xref>&#x02013;<xref rid="SD1" ref-type="supplementary-material">S3</xref>.</p><sec id="S25"><label>5.1</label><title>Spatiotemporal models</title><p id="P65">The two most comprehensive spatiotemporal models are mechano-chemo-biological models that combine detailed biochemical and biomechanical processes (<xref rid="T1" ref-type="table">Table 1</xref>). One model uses a traditional transport-based approach that defines site-specific kinetic rate terms for each cell population equation (<xref rid="R148" ref-type="bibr">Lerebours et al., 2016</xref>). Another formulation uses a finite-element approach where each mesh point contains at most one BMU, and conditions are set to prevent the activation of bone formation or resorption in a BMU adjacent to another active BMU (<xref rid="R40" ref-type="bibr">Calvo-Gallego et al., 2023</xref>). Although both models include explicit parameters for RANK, RANKL, OPG, and TGF-<inline-formula><mml:math id="M145" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula>, these mechano-chemo-biological models have limited reuse for studying spatial variations for chemical interventions.</p><p id="P66">In contrast, only two non-biomechanical spatiotemporal models of bone remodeling explicitly model RANK-RANKL-OPG and TGF-<inline-formula><mml:math id="M146" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula> (<xref rid="T1" ref-type="table">Table 1</xref>). These models, <xref rid="R37" ref-type="bibr">Buenzli et al. (2011)</xref> and <xref rid="R38" ref-type="bibr">Buenzli et al. (2014)</xref>, are 1D spatial extensions of the same temporal model. <xref rid="R37" ref-type="bibr">Buenzli et al. (2011)</xref> evaluates whether the biological pathways in <xref rid="R192" ref-type="bibr">Pivonka et al. (2008)</xref> are necessary and sufficient to capture the expected arrangement of cells in cortical bone and concludes that the model requires an additional differentiation stage for osteoclasts. Although this model includes more explicit parameters than other biochemical models, the values are not quantitatively compared to data. The <xref rid="R37" ref-type="bibr">Buenzli et al. (2011)</xref> model relies on theoretical simulation results and temporal study parameters and only estimates new parameters as needed. This is a common approach in spatiotemporal models, including those by <xref rid="R16" ref-type="bibr">Ayati et al. (2010)</xref> and <xref rid="R209" ref-type="bibr">Ryser and Murgas (2017)</xref>. <xref rid="R9" ref-type="bibr">Arias et al. (2018)</xref> notes that there is no parameter fitting in their study and acknowledges that experimental data are necessary to quantify and validate the model. Yet, even though <xref rid="R208" ref-type="bibr">Ryser et al. (2010)</xref> calibrates a model with multiple datasets, the model is limited to fewer parameters and fewer explicit biological interactions. The authors of <xref rid="R208" ref-type="bibr">Ryser et al. (2010)</xref> offer the perspective that more parameters &#x0201c;compromise the balance between reliability and realism&#x0201d; by increasing the uncertainty of the model (<xref rid="R208" ref-type="bibr">Ryser et al., 2010</xref>).</p><p id="P67">Several spatiotemporal models focus on one phase of remodeling, such as osteoclast resorption (<xref rid="R247" ref-type="bibr">van Oers et al., 2008</xref>; <xref rid="R35" ref-type="bibr">Buenzli et al., 2012a</xref>; <xref rid="R9" ref-type="bibr">Arias et al., 2018</xref>), osteoblast formation (<xref rid="R238" ref-type="bibr">Taylor-King et al., 2020</xref>), or osteocyte dynamics (<xref rid="R209" ref-type="bibr">Ryser and Murgas, 2017</xref>). These models do not explicitly model multiple cell-cell or cell-signal interactions. Instead, they implicitly model the roles of RANK-RANKL-OPG, TGF-<inline-formula><mml:math id="M147" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula>, Wnt, and other signals using general autocrine and paracrine signaling parameters (<xref rid="R209" ref-type="bibr">Ryser and Murgas, 2017</xref>; <xref rid="R9" ref-type="bibr">Arias et al., 2018</xref>). In some cases, the models exclude the signaling mentioned above interactions in favor of more distinctive mechanisms and parameters. For instance, <xref rid="R35" ref-type="bibr">Buenzli et al. (2012a)</xref> includes parameters related to the involvement of blood vessels in osteoclast generation. <xref rid="R238" ref-type="bibr">Taylor-King et al. (2020)</xref>, on the other hand, incorporates parameters for the shape and growth of osteocyte dendrites. Another example considers the energy-dependent dynamics of osteocytes (<xref rid="R247" ref-type="bibr">van Oers et al., 2008</xref>). The lack of explicit cell-cell and typical cell-signal interactions in these models may be attributed to their research motivations. The fewer bone cells and explicit signals seen in spatiotemporal models compared to temporal models (<xref rid="F6" ref-type="fig">Figure 6</xref>) may also be due to their higher computational expense and complexity or to the lack of detailed spatial information for calibration and validation of such models at the cellular and molecular scales.</p></sec><sec id="S26"><label>5.2</label><title>Power law models</title><p id="P68">The power law approach is discussed in <xref rid="S17" ref-type="sec">Section 4.1</xref>, and its general application to the bone volume and cells of the BMU is shown in <xref rid="S19" ref-type="sec">Section 4.3</xref>. Some adaptations based on <xref rid="R135" ref-type="bibr">Komarova et al. (2003)</xref> aim to explicitly capture signals that are only implicitly included in the original model, and others add new cells or signals (<xref rid="T2" ref-type="table">Table 2</xref>; <xref rid="SD1" ref-type="supplementary-material">Supplementary Table S1</xref>). In the latter group, <xref rid="R95" ref-type="bibr">Graham et al. (2013)</xref> adds state variables for osteocytes and preosteoblasts, along with implicit sclerostin/Wnt signaling terms. <xref rid="R52" ref-type="bibr">Cook et al. (2022)</xref> alters <xref rid="R95" ref-type="bibr">Graham et al. (2013)</xref> to explicitly account for systemic changes in Wnt-10b by using an enzyme kinetics approach to represent changes in Wnt-10b with a Hill function that modulates cell populations. Among the models that focus on explicitly capturing certain autocrine and paracrine signals is the spatial extension by <xref rid="R210" ref-type="bibr">Ryser et al. (2009)</xref>. This model adds explicit state variables for RANKL and OPG by setting one of the original paracrine power parameters equal to zero, namely the one corresponding to osteoblast-derived osteoclast regulation, and formulating separate equations for RANKL and OPG levels. <xref rid="R42" ref-type="bibr">Camacho and Jerez (2021)</xref> follows <xref rid="R210" ref-type="bibr">Ryser et al. (2009)</xref> by dropping paracrine signal exponents to explicitly model TGF-<inline-formula><mml:math id="M148" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula> and Wnt as state variables in a temporal model. <xref rid="R42" ref-type="bibr">Camacho and Jerez (2021)</xref> also updates the cell population equations to incorporate TGF-<inline-formula><mml:math id="M149" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula>-induced osteoclast apoptosis and Wnt-induced osteoblast proliferation. In the bone metastasis model by <xref rid="R87" ref-type="bibr">Garz&#x000f3;n-Alvarado (2012)</xref>, tumor-induced changes in TGF-<inline-formula><mml:math id="M150" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula> and parathyroid hormone-related protein (PTHrP) are added as state variables.</p></sec><sec id="S27"><label>5.3</label><title>Mass action kinetics models</title><p id="P69">The mass action kinetics approach is discussed in <xref rid="S18" ref-type="sec">Section 4.2</xref>, and its general application to the bone volume and cells of the BMU is shown in <xref rid="S19" ref-type="sec">Section 4.3</xref>. Extensions of <xref rid="R147" ref-type="bibr">Lemaire et al. (2004)</xref>, aside from those based on <xref rid="R192" ref-type="bibr">Pivonka et al. (2008)</xref>, integrate physiologically based models for calcium homeostasis (<xref rid="R187" ref-type="bibr">Peterson and Riggs, 2010</xref>; <xref rid="R188" ref-type="bibr">Peterson and Riggs, 2012</xref>; <xref rid="R206" ref-type="bibr">Ross et al., 2017</xref>) or integrate pharmacokinetics/pharmacodynamics (PKPD) to study the treatment of multiple myeloma (<xref rid="R158" ref-type="bibr">Marathe et al., 2008</xref>; <xref rid="R266" ref-type="bibr">Zhang and Mager, 2019</xref>) and osteoporosis (<xref rid="R159" ref-type="bibr">Marathe et al., 2011</xref>; <xref rid="R146" ref-type="bibr">Lemaire and Cox, 2019</xref>) (<xref rid="T3" ref-type="table">Table 3</xref>; <xref rid="SD1" ref-type="supplementary-material">Supplementary Table S2</xref>). So the signals and biological mechanisms added to models following <xref rid="R147" ref-type="bibr">Lemaire et al. (2004)</xref> focus on modifications necessary to capture disease dynamics or calcium homeostasis. For example, <xref rid="R187" ref-type="bibr">Peterson and Riggs (2010)</xref> adds equations for calcium across bone, plasma, kidneys, and gut. Their multi-compartment model consists of 28 ODEs incorporating molecules such as phosphate (PO<sub>4</sub>), non-bone PTH, calcitriol, and multiple intracellular osteoblast signals. Other models, such as <xref rid="R158" ref-type="bibr">Marathe et al. (2008)</xref>, connect the PKPD models to the dynamics of bone remodeling through bone biomarkers that correlate with osteoclast activity. However, neither <xref rid="R158" ref-type="bibr">Marathe et al. (2008)</xref> nor <xref rid="R159" ref-type="bibr">Marathe et al. (2011)</xref> modify the bone dynamics to account for the onset of disease-related effects. Instead, the clinical data sets used for calibration and validation are from patients with the disease under study. The PKPD extension by <xref rid="R266" ref-type="bibr">Zhang and Mager (2019)</xref> amends the bone dynamics to account for the upregulation of DKK1 by multiple myeloma cancer cells. Two other models following <xref rid="R147" ref-type="bibr">Lemaire et al. (2004)</xref> consider Wnt-related signaling molecules. <xref rid="R70" ref-type="bibr">Eudy et al. (2015)</xref>, based on <xref rid="R187" ref-type="bibr">Peterson and Riggs (2010)</xref>, incorporates sclerostin effects and osteocyte activity in a PKPD model for the sclerostin antibody romosozumab. <xref rid="R146" ref-type="bibr">Lemaire and Cox (2019)</xref> also adds Wnt-related effects to study anti-sclerostin treatments for osteoporosis and derives a <inline-formula><mml:math id="M152" display="inline"><mml:mi>&#x003c0;</mml:mi></mml:math></inline-formula> term for sclerostin inhibition of the Wnt pathway based on mass action kinetics, assuming a constant Wnt concentration. While most models extend <xref rid="R147" ref-type="bibr">Lemaire et al. (2004)</xref>, <xref rid="R217" ref-type="bibr">Schmidt et al. (2011)</xref> reduces the model to a system of two dependent variables (osteoblasts and osteoclasts) and uses dimensional analysis to determine important aspects of the model that control the dynamics. The reduction is achieved by changing the cell concentrations to vary with respect to the initial values given in <xref rid="R147" ref-type="bibr">Lemaire et al. (2004)</xref>, casting the system into dimensionless variables, eliminating variables, and applying a quasi-steady-state approximation. The work also demonstrates negligible differences from the <xref rid="R147" ref-type="bibr">Lemaire et al. (2004)</xref> model for slow processes such as aging and estrogen deficiency. Like other models following <xref rid="R147" ref-type="bibr">Lemaire et al. (2004)</xref>, the reduced model (<xref rid="R217" ref-type="bibr">Schmidt et al., 2011</xref>) is further extended to study postmenopausal osteoporosis and its treatment in other models including <xref rid="R196" ref-type="bibr">Post et al. (2013)</xref>; <xref rid="R25" ref-type="bibr">Berkhout et al. (2015)</xref>; <xref rid="R24" ref-type="bibr">Berkhout et al. (2016)</xref>.</p><p id="P70">The biochemical ODEs derived from <xref rid="R192" ref-type="bibr">Pivonka et al. (2008)</xref> focus on adding mechanical or geometric effects, as well as PKPD models to study the treatment of osteoporosis and metastatic cancer-based bone diseases. Here, we highlight changes in bone cell dynamics and biochemical additions, but we forgo detailed descriptions of the mechanical and geometric model features (<xref rid="T3" ref-type="table">Table 3</xref>). <xref rid="R190" ref-type="bibr">Pivonka et al. (2013)</xref> modifies the bone population equations to incorporate specific surface-dependent geometric regulation effects. In <xref rid="R214" ref-type="bibr">Scheiner et al. (2013)</xref>, TGF-<inline-formula><mml:math id="M153" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula> upregulation of progenitor cell differentiation is added, as well as mechanical strain-based regulation of preosteoblast proliferation and RANKL production of osteocytes. <xref rid="R215" ref-type="bibr">Scheiner et al. (2014)</xref> extends this model to study postmenopausal osteoporosis and its treatment with denosumab. In another extension of <xref rid="R214" ref-type="bibr">Scheiner et al. (2013)</xref>, <xref rid="R160" ref-type="bibr">Martin et al. (2019)</xref> opts for a more biochemically focused model of osteocyte-driven mechanical regulation of bone remodeling. Osteocytes are added as a state variable proportional to the bone matrix fraction. A separate function accounts for nitric oxide (NO) production by osteocytes and co-regulation of RANKL by PTH and NO. For the Wnt/sclerostin-related effects of osteocytes, a multi-ligand Hill activator function is derived that assumes a constant Wnt concentration and equal binding affinities for DKK1 and sclerostin. Other models based on <xref rid="R192" ref-type="bibr">Pivonka et al. (2008)</xref> focus on disease and treatment. <xref rid="R254" ref-type="bibr">Wang et al. (2011)</xref> adds a state variable for multiple myeloma cancer cells and disease-specific regulatory mechanisms. <xref rid="R124" ref-type="bibr">Ji et al. (2014)</xref> extends the model to add VCAM1 regulation of preosteoblast and osteoblast cell populations and adds the role of small leucine-rich proteoglycans in multiple myeloma to study related treatments. <xref rid="R72" ref-type="bibr">Farhat et al. (2017)</xref> extends the <xref rid="R254" ref-type="bibr">Wang et al. (2011)</xref> prostate cancer model by adding the effects of calcium, active and latent TGF-<inline-formula><mml:math id="M154" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula>, and cancer-induced Wnt and DKK1. <xref rid="R245" ref-type="bibr">Trichilo et al. (2019)</xref> quantifies PTH administration under various conditions by combining features from several models, along with the intracellular osteoblast signaling equations in <xref rid="R187" ref-type="bibr">Peterson and Riggs (2010)</xref>. Unlike most of the models discussed here, <xref rid="R245" ref-type="bibr">Trichilo et al. (2019)</xref> retains the state variable formulations for TGF-<inline-formula><mml:math id="M155" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula>, OPG, RANK, RANKL, OPG-RANKL binding, and RANK-RANKL binding to account for non-steady-state regulation during intermittent PTH administration. Additionally, the expression for preosteoblast expression of RANKL is modified to be more biologically accurate.</p></sec><sec id="S28"><label>5.4</label><title>Systems biology models and discussion of opportunities for future models</title><p id="P71">Biochemical and cellular processes are the targets for most pharmaceutical and dietary interventions for bone diseases (<xref rid="S6" ref-type="sec">Section 3</xref>). Considerable evidence from <italic toggle="yes">in vivo</italic> and <italic toggle="yes">in vitro</italic> studies have shown that prebiotics alter more than one aspect of the gut-bone axis (see <xref rid="R129" ref-type="bibr">Keirns et al. (2020)</xref> and references therein). Multifactorial aspects of the pathologies of bone loss in aging and menopause compounded with impacts of dietary factors on interactions between the immune, gastrointestinal, endocrine, and skeletal systems compel us to advocate for systems biology approaches to understand better this complex network of processes that connect dietary prebiotic and probiotic treatments to immune modulation and bone outcomes. Additionally, connecting the gut to bone through biological mechanisms is relevant more generally for orally administered bone therapeutics. Ultimately, bone loss is a systemic problem with multi-organ involvement. Improved mechanistic understanding of these complex relationships is needed to enhance interventions for bone loss. Multi-organ-system mathematical models of physiological and pathophysiological bone remodeling can help unravel these mechanisms while reducing the experimental costs associated with animal testing. There are few multi-compartment models of bone remodeling (<xref rid="R187" ref-type="bibr">Peterson and Riggs, 2010</xref>; <xref rid="R114" ref-type="bibr">Islam et al., 2021</xref>), and this approach warrants exploration in future models. Additional opportunities exist for creating multiscale models of bone remodeling by using ODEs, PDEs, and/or ABMs for interacting processes across temporal and spatial scales (<xref rid="R77" ref-type="bibr">Ford Versypt, 2021</xref>).</p><sec id="S29"><label>5.4.1</label><title>Reversal cells and bone lining cells</title><p id="P72">Most mathematical models of bone remodeling have overlooked reversal cells and bone lining cells. Their absence is reasonable, given that these cells&#x02019; importance and mechanistic behavior are not well understood. Moreover, the modeling work of <xref rid="R9" ref-type="bibr">Arias et al. (2018)</xref> suggests that reversal and bone lining cells are not required to capture the dynamics of bone remodeling.</p><p id="P73">These cells are only included in one model each. <xref rid="R245" ref-type="bibr">Trichilo et al. (2019)</xref> models a constant population of bone lining cells. They also include a dynamic parameter that describes bone lining cell differentiation into osteoblasts. This parameter varies with PTH dosage, introducing another mechanistic avenue for PTH to regulate osteoblastogenesis. The mononuclear cells modeled in <xref rid="R162" ref-type="bibr">Martin and Buckland-Wright (2004)</xref> remove collagen fibrils from the bone surface during resorption. The behavior of these mononuclear cells is in line with current understanding of the role that reversal cells play in bone remodeling, indicating that the so-called mononuclear cells in <xref rid="R162" ref-type="bibr">Martin and Buckland-Wright (2004)</xref> are reversal cells. While reversal and bone lining cells have historically been excluded, future mathematical models paired with experimental work could help provide mechanistic insights into their functions.</p></sec><sec id="S30"><label>5.4.2</label><title>Cytokines</title><p id="P74">As mentioned earlier, Wnt plays an important role in modulating bone health. However, few models consider the details of this interaction. When mathematical models consider the Wnt/sclerostin interaction, Wnt levels are often excluded or assumed constant (<xref rid="SD1" ref-type="supplementary-material">Supplementary Tables S1</xref>&#x02013;<xref rid="SD1" ref-type="supplementary-material">S3</xref>). Instead, these models focus on sclerostin levels (<xref rid="F6" ref-type="fig">Figure 6</xref>) (<xref rid="R95" ref-type="bibr">Graham et al., 2013</xref>; <xref rid="R70" ref-type="bibr">Eudy et al., 2015</xref>; <xref rid="R146" ref-type="bibr">Lemaire and Cox, 2019</xref>; <xref rid="R160" ref-type="bibr">Martin et al., 2019</xref>). Two models with dynamic Wnt concentrations only allow Wnt to be altered through the presence of a tumor (<xref rid="R36" ref-type="bibr">Buenzli et al., 2012b</xref>; <xref rid="R72" ref-type="bibr">Farhat et al., 2017</xref>). <xref rid="R52" ref-type="bibr">Cook et al. (2022)</xref> includes a generalized dynamic concentration of Wnt-10b, where the amount of exogenous Wnt10b (from dietary sources) influences BMU cell populations and bone volume.</p><p id="P75">While the RANK-RANKL-OPG and Wnt pathways are key regulators of the bone remodeling cycle, other cytokines modulate these signals and bone cell activity. Despite this, there is a distinct lack of variety in the cytokines considered in mathematical formulations of bone remodeling. <xref rid="T5" ref-type="table">Table 5</xref> shows that only three cytokines aside from RANK-RANKL-OPG and TGF-<inline-formula><mml:math id="M156" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula> are explicted modeled: IL-6, MCSF, and IGF. One benefit of including other cytokines in bone models is the potential to explore their importance under various remodeling conditions, yet many models with cytokines lack this analysis. For example, IGF is included in <xref rid="R87" ref-type="bibr">Garz&#x000f3;n-Alvarado (2012)</xref> to simulate osteosclerosis because tumors are known to increase IGF levels and thus increase osteoblast activity. However, this work does not directly analyze the effect of IGF on bone cell dynamics. Although the modeling and analysis of IL-6 and MCSF is limited, some studies analyze their role in remodeling using perturbation or sensitivity analysis.</p><p id="P76">Only two of the five models that include dynamic IL-6 levels analyze its effect on bone cell dynamics during the bone remodeling cycle (<xref rid="T5" ref-type="table">Table 5</xref>). IL-6 is included in <xref rid="R139" ref-type="bibr">Kroll (2000)</xref> in their study of the effects of PTH on bone dynamics, albeit in a simplified manner. Following <xref rid="R139" ref-type="bibr">Kroll (2000)</xref>, <xref rid="R112" ref-type="bibr">Idrees et al. (2019)</xref> adapts <xref rid="R135" ref-type="bibr">Komarova et al. (2003)</xref> to include IL-6 in the simulation of intermittent versus continuous PTH treatment. Whereas <xref rid="R139" ref-type="bibr">Kroll (2000)</xref> scales theoretical parameter values so that osteoblast counts remain below 1000 cells, <xref rid="R112" ref-type="bibr">Idrees et al. (2019)</xref> performs a meta-analysis of various experiments to estimate parameter values statistically. This is an improvement over many other bone models that extract experimental values from multiple studies or rely on sparse and disparate clinical data sets.</p><p id="P77">The dynamics of IL-6 in PTH treatment models are simplistic compared to multiple myeloma models. <xref rid="R254" ref-type="bibr">Wang et al. (2011)</xref> accounts for IL-6 stimulation of multiple myeloma cells and IL-6 activation of RANKL. <xref rid="R254" ref-type="bibr">Wang et al. (2011)</xref> also performs a perturbation analysis to investigate the relative degree of RANKL activation by PTH versus IL-6 in homeostatic and diseased remodeling states and finds that PTH dominates over IL-6 under healthy bone remodeling conditions. However, IL-6 activates RANKL more than PTH under elevated IL-6 conditions, representing multiple myeloma disease. A limitation here is that the model lacks other cytokines and mechanisms that can alter RANKL activation, which may dominate over PTH and IL-6.</p><p id="P78"><xref rid="R254" ref-type="bibr">Wang et al. (2011)</xref> is extended by <xref rid="R124" ref-type="bibr">Ji et al. (2014)</xref> without any change in the representation of IL-6. However, the models differ in their parameter estimation and sensitivity analysis approaches. <xref rid="R254" ref-type="bibr">Wang et al. (2011)</xref> fits the model to achieve adult bone and cancer cell densities corresponding to literature values, while <xref rid="R124" ref-type="bibr">Ji et al. (2014)</xref> uses genetic algorithms. Although both studies include sensitivity analysis, <xref rid="R124" ref-type="bibr">Ji et al. (2014)</xref> performs sensitivity analysis at a fixed time point rather than over time as in <xref rid="R254" ref-type="bibr">Wang et al. (2011)</xref>. Nonetheless, the results in <xref rid="R124" ref-type="bibr">Ji et al. (2014)</xref> support those in <xref rid="R254" ref-type="bibr">Wang et al. (2011)</xref>. Upon varying 11 parameter values from 50% to 150%, <xref rid="R124" ref-type="bibr">Ji et al. (2014)</xref> shows that bone volume is most sensitive to TGF-<inline-formula><mml:math id="M157" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula> and the progression of multiple myeloma disease is most sensitive to IL-6. Given these results and the biological evidence that IL-6 contributes to bone pathophysiology, exploring its inclusion in future mathematical models of bone remodeling is pertinent.</p><p id="P79">The cytokine MCSF is a key activator of osteoclastogenesis, yet analysis of its effects via mathematical models of bone remodeling is more sparse than IL-6. <xref rid="R162" ref-type="bibr">Martin and Buckland-Wright (2004)</xref> is the first model that includes the role of MCSF. This model investigates the depth and duration of osteoclast erosion during resorption and models MCSF as a scalar variable but assumes it is always present. A sensitivity analysis of resorption depth indicates that changes in MCSF levels are equivalent to changes in maximum osteoclast activity, and both effects are minor compared to TGF-<inline-formula><mml:math id="M158" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula>. <xref rid="R148" ref-type="bibr">Lerebours et al. (2016)</xref> and <xref rid="R190" ref-type="bibr">Pivonka et al. (2013)</xref> are biomechanical models that include MCSF activation of uncommitted osteoclasts. However, they assume the MCSF concentration is constant, resulting in a continuous activator function term.</p><p id="P80"><xref rid="R197" ref-type="bibr">Proctor and Gartland (2016)</xref> investigates the kinetics of MCSF via network-based ODEs. As with <xref rid="R148" ref-type="bibr">Lerebours et al. (2016)</xref> and <xref rid="R190" ref-type="bibr">Pivonka et al. (2013)</xref>, this work investigates the effect of mechanical loading and the effects of PTH and circadian rhythm. In contrast, the network analysis includes multiple parameters that capture the role of MCSF in remodeling (outlined in <xref rid="T5" ref-type="table">Table 5</xref>). Sensitivity analysis of the model shows that the secretion rate of MCSF by osteoblasts and preosteoclasts and the MCSF degradation rate result in a change of more than 5% in bone mass. When the rate of degradation doubles, bone mass increases by more than 60%. One limitation of this study is the assumption that MCSF secretion rates are considered equal across cell types. Still, these results warrant further mathematical investigation of MCSF in homeostatic and pathological bone remodeling. Ultimately, future mathematical models of bone biology should explore the complex and coordinated role of cytokines, growth factors, and hormones in bone remodeling.</p></sec><sec id="S31"><label>5.4.3</label><title>Immune cells</title><p id="P81">Despite the established interest in osteoimmunology, few bone models include immune cells (<xref rid="T6" ref-type="table">Table 6</xref>). Most bone models that investigate the role of immune cells do so in the context of bone injury and repair (<xref rid="R244" ref-type="bibr">Trejo et al., 2019</xref>; <xref rid="R242" ref-type="bibr">Tourolle et al., 2021</xref>; <xref rid="R19" ref-type="bibr">Baratchart et al., 2022</xref>). Of particular interest is the model by <xref rid="R19" ref-type="bibr">Baratchart et al. (2022)</xref>. Hypothesis testing of candidate models determines the interaction of monocytes, macrophages, injury factors, and inflammatory factors in bone cell dynamics. The model is supported by biological data, with the parameters calibrated with one set of experimental data and validated with another. These methods show how researchers can elucidate the mechanisms of complex bone-immune dynamics using mathematical models. However, bone injury and repair models describe the acute healing process of fractures, which has different signaling pathways than the continuous bone renewal or remodeling process for homeostasis and skeletal integrity over a lifetime. Therefore, bone healing models cannot be directly applied to the bone remodeling processes.</p><p id="P82">The few mathematical models of bone remodeling that incorporate immune cells are outlined in <xref rid="T6" ref-type="table">Table 6</xref>. Although the models by <xref rid="R4" ref-type="bibr">Akchurin et al. (2008)</xref> and <xref rid="R197" ref-type="bibr">Proctor and Gartland (2016)</xref> seemingly include immune cells (mononuclear cells and hematopoietic stem cells), these are simply different osteoclast progenitors. As mentioned earlier, these cells are often lumped into a general class of uncommitted osteoclasts or preosteoclasts.</p><p id="P83">Of the models listed in <xref rid="T6" ref-type="table">Table 6</xref>, only <xref rid="R114" ref-type="bibr">Islam et al. (2021)</xref> investigates the dynamic effect of multiple immune cells in bone remodeling. The work includes a three-compartment physiologically based PK model for differentiating na&#x000ef;ve CD4<sup>+</sup> T cells into Treg cells in the gut, blood, and bone. These Tregs then influence TGF-<inline-formula><mml:math id="M160" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula> production in the bone and induce Wnt-10b production. The physiologically based PK model is then linked to a bone remodeling model that includes the local effects of systemic changes in Wnt-10b (<xref rid="R52" ref-type="bibr">Cook et al., 2022</xref>). Since this is the only mathematical description of nonlocal immune effects on bone dynamics, significant opportunities remain for future research to explore multi-organ systemic interactions between the skeletal and immune systems.</p></sec><sec id="S32"><label>5.4.4</label><title>Endocrine system and pharmaceuticals</title><p id="P84">Despite its documented importance in bone remodeling and estrogen-deficient osteoporosis, the incorporation of dynamic estrogen levels in mathematical models of bone remodeling is underwhelming (<xref rid="T7" ref-type="table">Table 7</xref>). Analysis of the 88 cell population-based bone modeling publications in <xref rid="T1" ref-type="table">Tables 1</xref>&#x02013;<xref rid="T4" ref-type="table">4</xref> reveals that roughly a third (30 of 88) mention or model estrogen. Of these 30 models, half (15) capture estrogen effects in their mathematical model, while the other half only mention estrogen briefly. Most models that mention estrogen cite evidence that estrogen deficiency is involved in osteoporosis or modulates bone remodeling (<xref rid="R139" ref-type="bibr">Kroll, 2000</xref>; <xref rid="R158" ref-type="bibr">Marathe et al., 2008</xref>; <xref rid="R192" ref-type="bibr">Pivonka et al., 2008</xref>; <xref rid="R159" ref-type="bibr">Marathe et al., 2011</xref>; <xref rid="R87" ref-type="bibr">Garz&#x000f3;n-Alvarado, 2012</xref>; <xref rid="R205" ref-type="bibr">Ross et al., 2012</xref>; <xref rid="R34" ref-type="bibr">Buenzli, 2015</xref>; <xref rid="R47" ref-type="bibr">Chen-Charpentier and Diakite, 2016</xref>; <xref rid="R143" ref-type="bibr">Lee and Okos, 2016</xref>; <xref rid="R122" ref-type="bibr">Jerez et al., 2018</xref>; <xref rid="R17" ref-type="bibr">Bahia et al., 2020</xref>; <xref rid="R117" ref-type="bibr">Javed et al., 2020</xref>). The remaining articles that mention estrogen acknowledge that estrogen is not incorporated into their model or that integration of estrogen is an opportunity for future models (<xref rid="R187" ref-type="bibr">Peterson and Riggs, 2010</xref>; <xref rid="R36" ref-type="bibr">Buenzli et al., 2012b</xref>; <xref rid="R49" ref-type="bibr">Coelho et al., 2016</xref>; <xref rid="R160" ref-type="bibr">Martin et al., 2019</xref>). Altogether, this indicates that only about 15% of all bone remodeling models mathematically account for estrogen-induced biochemical changes in bone cell dynamics.</p><p id="P85">All models with estrogen effects are osteoporosis-specific models, and their respective mathematical representations are outlined in <xref rid="T7" ref-type="table">Table 7</xref>. Several models do not consider dynamic estrogen levels (<xref rid="R147" ref-type="bibr">Lemaire et al., 2004</xref>; <xref rid="R214" ref-type="bibr">Scheiner et al., 2013</xref>; <xref rid="R146" ref-type="bibr">Lemaire and Cox, 2019</xref>; <xref rid="R146" ref-type="bibr">Lemaire and Cox, 2019</xref>; <xref rid="R160" ref-type="bibr">Martin et al., 2019</xref>; <xref rid="R245" ref-type="bibr">Trichilo et al., 2019</xref>; <xref rid="R140" ref-type="bibr">Larcher and Scheiner, 2021</xref>). Instead, they model the effects of estrogen deficiency by altering RANKL, OPG, PTH, and TGF-<inline-formula><mml:math id="M161" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula>. <xref rid="R147" ref-type="bibr">Lemaire et al. (2004)</xref> and <xref rid="R146" ref-type="bibr">Lemaire and Cox (2019)</xref> manually lower the OPG and TGF-<inline-formula><mml:math id="M162" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula> production parameters for osteoporotic scenarios. <xref rid="R245" ref-type="bibr">Trichilo et al. (2019)</xref> and <xref rid="R160" ref-type="bibr">Martin et al. (2019)</xref> increase RANKL levels with a RANKL dosage term fitted to OVX rat data and clinical postmenopause data. <xref rid="R215" ref-type="bibr">Scheiner et al. (2014)</xref> accounts for more estrogen-deficiency effect by using <inline-formula><mml:math id="M163" display="inline"><mml:mi>&#x003c0;</mml:mi></mml:math></inline-formula> terms to capture disease-related increases in RANKL, decreases in mechanical loading sensitivity, and denosumab competition with RANK and OPG.</p><p id="P86">Two models with dynamic estrogen levels aim to determine the most effective therapeutic dose to prevent bone loss. In <xref rid="R200" ref-type="bibr">Rattanakul et al. (2003)</xref>, periodic estrogen treatment is modeled with a linear increase in osteoclast removal. <xref rid="R43" ref-type="bibr">Chaiya and Rattanakul (2017)</xref> reformulates the model to be explicitly piecewise. Using the power law approach to illustrate, the osteoclast rate equation becomes
<disp-formula id="FD14">
<label>(14)</label>
<mml:math id="M164" display="block"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mtext>OCL</mml:mtext></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfenced open="{" close="" separators="|"><mml:mrow><mml:mtable columnalign="left"><mml:mtr><mml:mtd><mml:mi>&#x003b1;</mml:mi><mml:msup><mml:mrow><mml:mtext>OCL</mml:mtext></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mn>11</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msup><mml:msup><mml:mrow><mml:mtext>OBL</mml:mtext></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mn>21</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msup><mml:mo>-</mml:mo><mml:mi>&#x003b2;</mml:mi><mml:mtext>OCL</mml:mtext></mml:mtd><mml:mtd><mml:mtext>if</mml:mtext><mml:mspace width="1pt"/><mml:mi>t</mml:mi><mml:mo>&#x02260;</mml:mo><mml:mi>n</mml:mi><mml:mi>T</mml:mi></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mi>&#x003b1;</mml:mi><mml:msup><mml:mrow><mml:mtext>OCL</mml:mtext></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mn>11</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msup><mml:msup><mml:mrow><mml:mtext>OBL</mml:mtext></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mn>21</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msup><mml:mo>-</mml:mo><mml:mi>&#x003b2;</mml:mi><mml:mtext>OCL</mml:mtext><mml:mo>-</mml:mo><mml:mi>&#x003c1;</mml:mi><mml:mtext>OCL</mml:mtext></mml:mtd><mml:mtd><mml:mtext>if</mml:mtext><mml:mspace width="1pt"/><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mi>n</mml:mi><mml:mi>T</mml:mi></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced></mml:math>
</disp-formula>
where <inline-formula><mml:math id="M165" display="inline"><mml:mi>&#x003c1;</mml:mi></mml:math></inline-formula> is the parameter related to estrogen treatment, <inline-formula><mml:math id="M166" display="inline"><mml:mi>T</mml:mi></mml:math></inline-formula> is the prescribed dose time, and <inline-formula><mml:math id="M167" display="inline"><mml:mi>n</mml:mi></mml:math></inline-formula> is the treatment number. In addition to <xref rid="FD14" ref-type="disp-formula">Eq. 14</xref>, <xref rid="R43" ref-type="bibr">Chaiya and Rattanakul (2017)</xref> adds a constant term to capture the osteoblast-stimulating effects of estrogen treatment on the osteoblast rate equation. The motivation of this work is to understand alternative treatment regimes for ERT because long-term continuous treatment, while effective in increasing bone volume, has been shown in some studies to increase the risk for breast cancer and heart disease (<xref rid="R151" ref-type="bibr">Levin et al., 2018</xref>).</p><p id="P87">Models of dynamic estrogen loss often use an exponential decay equation for estrogen concentration or an estrogen-dependent dynamic parameter (<xref rid="R217" ref-type="bibr">Schmidt et al., 2011</xref>; <xref rid="R196" ref-type="bibr">Post et al., 2013</xref>; <xref rid="R25" ref-type="bibr">Berkhout et al., 2015</xref>; <xref rid="R24" ref-type="bibr">Berkhout et al., 2016</xref>). Although <xref rid="R25" ref-type="bibr">Berkhout et al. (2015)</xref> notes that estrogen concentration could better explain disease dynamics, they opt for the decay equation instead due to the high uncertainty in their model. In addition to estrogen decay, <xref rid="R217" ref-type="bibr">Schmidt et al. (2011)</xref> and <xref rid="R196" ref-type="bibr">Post et al. (2013)</xref> modify the OPG production parameter following <xref rid="R147" ref-type="bibr">Lemaire et al. (2004)</xref>. <xref rid="R118" ref-type="bibr">Javed et al. (2018)</xref> derives an alternate formulation for remodeling altogether to simplify the mass action kinetics models proposed by <xref rid="R147" ref-type="bibr">Lemaire et al. (2004)</xref> and <xref rid="R192" ref-type="bibr">Pivonka et al. (2008)</xref>. Estrogen changes are represented by a hyperbolically scaled estrogen term that modulates the RANKL state variable. In contrast, <xref rid="R127" ref-type="bibr">Jorg et al. (2022)</xref> models estrogen as an age-dependent concentration with a characteristic time scale of menopause onset that is fit to clinical data. This model also considers how estrogen alters sclerostin levels.</p><p id="P88">Most models of estrogen dynamics only consider bone cell or RANK-RANKL-OPG interactions, despite accumulating evidence that estrogen modulates other mechanisms of bone remodeling such as Wnt signaling and immune-bone interactions (see <xref rid="S12" ref-type="sec">Section 3.2.2</xref>). Future models need to incorporate these complex dynamics in the ongoing effort to improve mechanistic understanding of estrogen-deficient osteoporosis.</p><p id="P89">Many bone remodeling models explore the effects of one or more drugs on bone health (<xref rid="R202" ref-type="bibr">Riggs and Cremers, 2019</xref>; <xref rid="R3" ref-type="bibr">Ait Oumghar et al., 2020</xref>) (<xref rid="SD1" ref-type="supplementary-material">Supplementary Tables S1</xref>&#x02013;<xref rid="SD1" ref-type="supplementary-material">S3</xref>). Researchers typically start by modeling a healthy or diseased remodeling cycle (or leveraging existing models) and then extend the process to include drug effects. For example, glucocorticoid therapies and their interactions with the bone remodeling cycle are modeled in <xref rid="R147" ref-type="bibr">Lemaire et al. (2004)</xref>, <xref rid="R217" ref-type="bibr">Schmidt et al. (2011)</xref>, and <xref rid="R146" ref-type="bibr">Lemaire and Cox (2019)</xref>. These models alter one parameter related to a symptom of glucocorticoid treatment, specifically reduced osteoblast populations. This essentially involves reducing <inline-formula><mml:math id="M168" display="inline"><mml:msub><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow><mml:mrow><mml:mtext>OBL</mml:mtext></mml:mrow></mml:msub></mml:math></inline-formula> in <xref rid="FD10" ref-type="disp-formula">Eq. 10</xref> or <xref rid="FD11" ref-type="disp-formula">Eq. 11</xref>. However, reducing one parameter corresponding to an effect observed with glucocorticoid treatment is a simplistic approach that may miss important mechanistic impacts on the bone remodeling cycle.</p><p id="P90">Other models (e.g., <xref rid="R127" ref-type="bibr">Jorg et al. (2022)</xref>) study bisphosphonates, denosumab, or romosozumab. The antiresorptive drugs are modeled by combining the PKPD information of the drug of interest and an already-established mathematical model of the BMU. PK information consists of factors that explain how the drug disperses in the body. These are usually differential equations that track the amount of a drug in a target area. PD information describes how the drug interacts with the body. The effects can be shown directly through new parameters in the model or implicitly applied by changing an existing parameter.</p></sec><sec id="S33"><label>5.4.5</label><title>Gut metabolites and immune connections</title><p id="P91">Whereas the immune-bone connection gained traction in the 2000s, the link between gut and bone metabolism is more recent. So it follows that fewer mathematical models of bone remodeling consider gut-mediated impacts on bone health. Only one mathematical model of bone remodeling incorporates gut and immune cells (<xref rid="R114" ref-type="bibr">Islam et al., 2021</xref>). This model explores butyrate treatment of bone through T-cell-mediated changes in Wnt-10b. Although much is still unknown about the gut-bone connection, the <xref rid="R114" ref-type="bibr">Islam et al. (2021)</xref> model is initialized with data from mouse experiments that complement the mathematical model. Sensitivity analysis and <italic toggle="yes">in silico</italic> hypothesis generation link the calculated parameters to experimental conditions that can be modified to explore new treatments. This highlights the benefit of experimentally supported mathematical models of bone remodeling. The multi-compartment modeling approach of <xref rid="R114" ref-type="bibr">Islam et al. (2021)</xref> and <xref rid="R187" ref-type="bibr">Peterson and Riggs (2010)</xref> provide examples of how mathematical models of bone remodeling may explore relationships of systemic multi-organ effects.</p></sec><sec id="S34"><label>5.4.6</label><title>Metastatic cancer cells</title><p id="P92">Similar to pharmaceutical modeling, most cancer models start by modeling normal bone homeostasis and supplement it with an equation for tumor dynamics (<xref rid="R158" ref-type="bibr">Marathe et al., 2008</xref>; <xref rid="R16" ref-type="bibr">Ayati et al., 2010</xref>; <xref rid="R8" ref-type="bibr">Araujo et al., 2014</xref>; <xref rid="R124" ref-type="bibr">Ji et al., 2014</xref>; <xref rid="R49" ref-type="bibr">Coelho et al., 2016</xref>; <xref rid="R72" ref-type="bibr">Farhat et al., 2017</xref>). Many cancer models also add or adjust parameters such as RANKL, TGF-<inline-formula><mml:math id="M169" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula>, and PTH, which are known to be modified by tumors. The populations of these cancer tumor cells (T) are usually modeled in one of two ways. The first modeling method is based on growth curves, as in
<disp-formula id="FD15">
<label>(15)</label>
<mml:math id="M170" display="block"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mi>&#x003b3;</mml:mi><mml:mtext>Tdensity</mml:mtext><mml:mi>&#x003bb;</mml:mi><mml:mo>-</mml:mo><mml:mi>&#x003b7;</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:math>
</disp-formula>
where <inline-formula><mml:math id="M171" display="inline"><mml:mi>&#x003b3;</mml:mi></mml:math></inline-formula> and <inline-formula><mml:math id="M172" display="inline"><mml:mi>&#x003b7;</mml:mi></mml:math></inline-formula> are growth and decay parameters, Tdensity is a relationship between the current and maximum cancer cell population, and <inline-formula><mml:math id="M173" display="inline"><mml:mi>&#x003bb;</mml:mi></mml:math></inline-formula> is an additional relationship term to capture the effects of other cancer interactions considered (<xref rid="R16" ref-type="bibr">Ayati et al., 2010</xref>; <xref rid="R36" ref-type="bibr">Buenzli et al., 2012b</xref>; <xref rid="R49" ref-type="bibr">Coelho et al., 2016</xref>; <xref rid="R266" ref-type="bibr">Zhang and Mager, 2019</xref>; <xref rid="R168" ref-type="bibr">Miranda et al., 2020</xref>). For example, in the <xref rid="R49" ref-type="bibr">Coelho et al. (2016)</xref> model, <inline-formula><mml:math id="M174" display="inline"><mml:mi>&#x003bb;</mml:mi></mml:math></inline-formula> in <xref rid="FD15" ref-type="disp-formula">Eq. 15</xref> corresponds to the concentration of osteoclasts.</p><p id="P93">The second common way to model cancer populations follows the mass action kinetics approach. Here, the populations are controlled by different signaling factors represented by <inline-formula><mml:math id="M175" display="inline"><mml:mi>&#x003c0;</mml:mi></mml:math></inline-formula> terms (<xref rid="R254" ref-type="bibr">Wang et al., 2011</xref>; <xref rid="R124" ref-type="bibr">Ji et al., 2014</xref>). In a publication that uses both modeling methods, the growth curve is better for early cancer, and the mass action kinetics structure is better for established cancer (<xref rid="R72" ref-type="bibr">Farhat et al., 2017</xref>).</p><p id="P94">The mechanisms of tumor growth and metastasis have important spatial considerations. This is the primary motivation behind existing bone remodeling PDEs and ABMs of cancer (<xref rid="R16" ref-type="bibr">Ayati et al., 2010</xref>; <xref rid="R211" ref-type="bibr">Ryser et al., 2012</xref>; <xref rid="R8" ref-type="bibr">Araujo et al., 2014</xref>), which track the movement of cancer cells in space.</p></sec></sec></sec><sec id="S35"><label>6</label><title>Conclusion</title><p id="P95">Understanding the controlling factors in bone remodeling is vital for treating bone-related diseases. Existing mathematical models of remodeling have provided valuable insight into the mechanisms of remodeling. However, the scattered and varied parameter fitting techniques are a common limitation across these models. It is essential to calibrate and validate the models with more robust datasets through collaborations or rigorous collation of existing data, e.g., <xref rid="R142" ref-type="bibr">Ledoux et al. (2022)</xref>, to develop biologically accurate and reusable bone models. With the emergence of new technologies for measuring single-cell and spatially resolved &#x02019;omics and for <italic toggle="yes">in vivo</italic> dynamic imaging modalities, static and dynamic data at the tissue, cellular, and molecular scales should be leveraged increasingly to enhance modeling efforts for bone remodeling. As modeling grows in popularity, many more insights will be drawn from mathematical models, such as the ones discussed in this review. Systems biology is needed to meet the challenges associated with viewing bone remodeling as a systemically controlled process in health and disease.</p></sec><sec sec-type="supplementary-material" id="SM1"><title>Supplementary Material</title><supplementary-material id="SD1" position="float" content-type="local-data"><label>supplementary material</label><media xlink:href="NIHMS2015369-supplement-supplementary_material.pdf" id="d67e5070" position="anchor"/></supplementary-material></sec></body><back><ack id="S36"><title>Acknowledgments</title><p id="P96">The authors would like to thank lab members for their feedback on this manuscript and acknowledge Dr. Rudiyanto Gunawan, Dr. Viviana Monje, Dr. David Kofke, and Dr. Stelios Andreadis from the University at Buffalo for critical feedback on drafts of this manuscript prepared for Ph.D. qualifying exams for CC and AL. A preprint version of this manuscript has been previously released (<xref rid="R53" ref-type="bibr">Cook et al., 2024</xref>).</p><sec id="S37"><title>Funding</title><p id="P97">The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by National Institutes of Health grants R35GM133763 to AF, R21AG077640 to AF and BS, R15AT010725 to BS and AF, and the University at Buffalo. AL and CC are also partially supported by the Arthur A. Schomburg Fellowship Program at the University at Buffalo.</p></sec></ack><fn-group><fn fn-type="COI-statement" id="FN3"><p id="P98">Conflict of interest</p><p id="P99">The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></fn><fn id="FN5"><p id="P100">Supplementary material</p><p id="P101">The Supplementary Material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fsysb.2024.1368555/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fsysb.2024.1368555/full#supplementary-material</ext-link></p></fn></fn-group><ref-list><title>References</title><ref id="R1"><mixed-citation publication-type="journal"><name><surname>Abrams</surname><given-names>SA</given-names></name>, <name><surname>Griffin</surname><given-names>IJ</given-names></name>, <name><surname>Hawthorne</surname><given-names>KM</given-names></name>, <name><surname>Liang</surname><given-names>L</given-names></name>, <name><surname>Gunn</surname><given-names>SK</given-names></name>, <name><surname>Darlington</surname><given-names>G</given-names></name>, <etal/> (<year>2005</year>). <article-title>A combination of prebiotic short- and long-chain inulin-type fructans enhances calcium absorption and bone mineralization in young adolescents</article-title>. <source>Am. J. Clin Nutr</source>
<volume>82</volume>, <fpage>471</fpage>&#x02013;<lpage>476</lpage>. doi:<pub-id pub-id-type="doi">10.1093/ajen.82.2.471</pub-id><pub-id pub-id-type="pmid">16087995</pub-id>
</mixed-citation></ref><ref id="R2"><mixed-citation publication-type="journal"><name><surname>Aibar-Almaz&#x000e1;n</surname><given-names>A</given-names></name>, <name><surname>Voltes-Mart&#x000ed;nez</surname><given-names>A</given-names></name>, <name><surname>Castellote-Caballero</surname><given-names>Y</given-names></name>, <name><surname>Afanador-Restrepo</surname><given-names>DF</given-names></name>, <name><surname>del Carmen Carcel&#x000e9;n-Fraile</surname><given-names>M</given-names></name>, and <name><surname>L&#x000f3;pez-Ruiz</surname><given-names>E</given-names></name> (<year>2022</year>). <article-title>Current status of the diagnosi and management of osteoporosis</article-title>. <source>Int. J. Mol. Sci</source>
<volume>23</volume>, <fpage>9465</fpage>. doi:<pub-id pub-id-type="doi">10.3390/ijms23169465</pub-id><pub-id pub-id-type="pmid">36012730</pub-id>
</mixed-citation></ref><ref id="R3"><mixed-citation publication-type="journal"><name><surname>Ait Oumghar</surname><given-names>I</given-names></name>, <name><surname>Barkaoui</surname><given-names>A</given-names></name>, and <name><surname>Chabrand</surname><given-names>P</given-names></name> (<year>2020</year>). <article-title>Toward a mathematical modeling of diseases&#x02019; impact on bone remodeling: technical review</article-title>. <source>Front. Bioeng Biotechnol</source>
<volume>8</volume>, <fpage>584198</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fbioe.2020.584198</pub-id><pub-id pub-id-type="pmid">33224935</pub-id>
</mixed-citation></ref><ref id="R4"><mixed-citation publication-type="journal"><name><surname>Akchurin</surname><given-names>T</given-names></name>, <name><surname>Aissiou</surname><given-names>T</given-names></name>, <name><surname>Kemeny</surname><given-names>N</given-names></name>, <name><surname>Prosk</surname><given-names>E</given-names></name>, <name><surname>Nigam</surname><given-names>N</given-names></name>, and <name><surname>Komarova</surname><given-names>SV</given-names></name> (<year>2008</year>). <article-title>Complex dynamics of osteoclast formation and death in long-term cultures</article-title>. <source>PLoS ONE</source>
<volume>3</volume>, <fpage>e2104</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0002104</pub-id><pub-id pub-id-type="pmid">18461134</pub-id>
</mixed-citation></ref><ref id="R5"><mixed-citation publication-type="book"><name><surname>Allen</surname><given-names>MR</given-names></name>, and <name><surname>Burr</surname><given-names>DB</given-names></name> (<year>2014</year>). &#x0201c;<part-title>Bone modeling and remodeling</part-title>,&#x0201d; in <source>Basic and applied bone biology</source> Editors <name><surname>Burr</surname><given-names>DB</given-names></name> and <name><surname>Allen</surname><given-names>MR</given-names></name> (<publisher-loc>New York</publisher-loc>: <publisher-name>Academic Press</publisher-name>), <fpage>75</fpage>&#x02013;<lpage>90</lpage>. doi:<pub-id pub-id-type="doi">10.1016/B978-0-12-416015-6.00004-6</pub-id></mixed-citation></ref><ref id="R6"><mixed-citation publication-type="journal"><name><surname>Almeida</surname><given-names>M</given-names></name>, <name><surname>Laurent</surname><given-names>MR</given-names></name>, <name><surname>Dubois</surname><given-names>V</given-names></name>, <name><surname>Claessens</surname><given-names>F</given-names></name>, <name><surname>O&#x02019;Brien</surname><given-names>CA</given-names></name>, <name><surname>Bouillon</surname><given-names>R</given-names></name>, <etal/> (<year>2017</year>). <article-title>Estrogens and androgens in skeletal physiology and pathophysiology</article-title>. <source>Physiol. Rev</source>
<volume>97</volume>, <fpage>135</fpage>&#x02013;<lpage>187</lpage>. doi:<pub-id pub-id-type="doi">10.1152/physrev.00033.2015</pub-id><pub-id pub-id-type="pmid">27807202</pub-id>
</mixed-citation></ref><ref id="R7"><mixed-citation publication-type="journal"><name><surname>Anderson</surname><given-names>RC</given-names></name>, <name><surname>Cookson</surname><given-names>AL</given-names></name>, <name><surname>McNabb</surname><given-names>WC</given-names></name>, <name><surname>Kelly</surname><given-names>WJ</given-names></name>, and <name><surname>Roy</surname><given-names>NC</given-names></name> (<year>2010</year>), <article-title>Lactobacillus plantarum DSM 2648 is a potential probiotic that enhances intestinal barrier function</article-title>. <source>FEMS Microbiol. Lett</source>
<volume>309</volume>, <fpage>184</fpage>&#x02013;<lpage>192</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1574-6968.2010.02038.x</pub-id><pub-id pub-id-type="pmid">20618863</pub-id>
</mixed-citation></ref><ref id="R8"><mixed-citation publication-type="journal"><name><surname>Araujo</surname><given-names>A</given-names></name>, <name><surname>Cook</surname><given-names>LM</given-names></name>, <name><surname>Lynch</surname><given-names>CC</given-names></name>, and <name><surname>Basanta</surname><given-names>D</given-names></name> (<year>2014</year>). <article-title>An integrated computational model of the bone microenvironment in bone-metastatic prostate cancer</article-title>. <source>Cancer Res</source>. <volume>74</volume>, <fpage>2391</fpage>&#x02013;<lpage>2401</lpage>. doi:<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-13-2652</pub-id><pub-id pub-id-type="pmid">24788098</pub-id>
</mixed-citation></ref><ref id="R9"><mixed-citation publication-type="journal"><name><surname>Arias</surname><given-names>CF</given-names></name>, <name><surname>Herrero</surname><given-names>MA</given-names></name>, <name><surname>Echeverri</surname><given-names>LF</given-names></name>, <name><surname>Oleaga</surname><given-names>GE</given-names></name>, and <name><surname>L&#x000f3;pez</surname><given-names>JM</given-names></name> (<year>2018</year>). <article-title>Bone remodeling: a tissue-level process emerging from cell-level molecular algorithms</article-title>. <source>PLoS ONE</source>
<volume>13</volume>, <fpage>e0204171</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0204171</pub-id><pub-id pub-id-type="pmid">30231062</pub-id>
</mixed-citation></ref><ref id="R10"><mixed-citation publication-type="journal"><name><surname>Arjmandi</surname><given-names>BH</given-names></name>, <name><surname>Khalil</surname><given-names>DA</given-names></name>, <name><surname>Lucas</surname><given-names>EA</given-names></name>, <name><surname>Smith</surname><given-names>BJ</given-names></name>, <name><surname>Sinichi</surname><given-names>N</given-names></name>, <name><surname>Hodges</surname><given-names>SB</given-names></name>, <etal/> (<year>2004</year>). <article-title>Soy protein may alleviate osteoarthritis symptoms</article-title>. <source>Phytomedicine</source>
<volume>11</volume>, <fpage>567</fpage>&#x02013;<lpage>575</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.phymed.2003.11.001</pub-id><pub-id pub-id-type="pmid">15636169</pub-id>
</mixed-citation></ref><ref id="R11"><mixed-citation publication-type="journal"><name><surname>Arnold</surname><given-names>JW</given-names></name>, <name><surname>Roach</surname><given-names>J</given-names></name>, <name><surname>Fabela</surname><given-names>S</given-names></name>, <name><surname>Moorfield</surname><given-names>E</given-names></name>, <name><surname>Ding</surname><given-names>S</given-names></name>, <name><surname>Blue</surname><given-names>E</given-names></name>, <etal/> (<year>2021</year>). <article-title>The pleiotropic effects of prebiotic galacto-oligosaccharides on the aging gut</article-title>. <source>Microbiome</source>
<volume>9</volume>, <fpage>31</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s40168-020-00980-0</pub-id><pub-id pub-id-type="pmid">33509277</pub-id>
</mixed-citation></ref><ref id="R12"><mixed-citation publication-type="journal"><name><surname>Arpaia</surname><given-names>N</given-names></name>, <name><surname>Campbell</surname><given-names>C</given-names></name>, <name><surname>Xiying Fan</surname><given-names>SD</given-names></name>, <name><surname>van der Veeken</surname><given-names>J</given-names></name>, <name><surname>deRoos</surname><given-names>P</given-names></name>, <name><surname>Liu</surname><given-names>H</given-names></name>, <etal/> (<year>2013</year>). <article-title>Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation</article-title>. <source>Nature</source>
<volume>504</volume>, <fpage>451</fpage>&#x02013;<lpage>455</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature12726</pub-id><pub-id pub-id-type="pmid">24226773</pub-id>
</mixed-citation></ref><ref id="R13"><mixed-citation publication-type="journal"><name><surname>Arron</surname><given-names>JR</given-names></name>, and <name><surname>Choi</surname><given-names>Y</given-names></name> (<year>2000</year>). <article-title>Bone versus immune system</article-title>. <source>Nature</source>
<volume>408</volume>, <fpage>535</fpage>&#x02013;<lpage>536</lpage> doi:<pub-id pub-id-type="doi">10.1038/35046196</pub-id></mixed-citation></ref><ref id="R14"><mixed-citation publication-type="journal"><name><surname>Asadipooya</surname><given-names>K</given-names></name>, and <name><surname>Weinstock</surname><given-names>A</given-names></name> (<year>2019</year>). <article-title>Cardiovascular outcomes of romosozumab and protective role of alendronate</article-title>. <source>Arterioscler. Thromb. Vasc. Biol</source>
<volume>39</volume>, <fpage>1343</fpage>&#x02013;<lpage>1350</lpage>. doi:<pub-id pub-id-type="doi">10.1161/atvbaha.119.312371</pub-id><pub-id pub-id-type="pmid">31242037</pub-id>
</mixed-citation></ref><ref id="R15"><mixed-citation publication-type="journal"><name><surname>Ashrafi</surname><given-names>M</given-names></name>, <name><surname>Gubaua</surname><given-names>JE</given-names></name>, <name><surname>Pereira</surname><given-names>JT</given-names></name>, <name><surname>Gahlichi</surname><given-names>F</given-names></name>, and <name><surname>Doblar&#x000e9;</surname><given-names>M</given-names></name> (<year>2020</year>). <article-title>A mechano-chemo-biological model for bone remodeling with a new mechano-chemo-transduction approach</article-title>. <source>Biomech. Model. Mechan</source>
<volume>19</volume>, <fpage>2499</fpage>&#x02013;<lpage>2523</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s10237-020-01353-0</pub-id></mixed-citation></ref><ref id="R16"><mixed-citation publication-type="journal"><name><surname>Ayati</surname><given-names>BP</given-names></name>, <name><surname>Edwards</surname><given-names>CM</given-names></name>, <name><surname>Webb</surname><given-names>GF</given-names></name>, and <name><surname>Wikswo</surname><given-names>JP</given-names></name> (<year>2010</year>). <article-title>A mathematica model of bone remodeling dynamics for normal bone cell populations and myeloma bone disease</article-title>. <source>Biol. Direct</source>
<volume>5</volume>, <fpage>28</fpage>. doi:<pub-id pub-id-type="doi">10.1186/1745-6150-5-28</pub-id><pub-id pub-id-type="pmid">20406449</pub-id>
</mixed-citation></ref><ref id="R17"><mixed-citation publication-type="journal"><name><surname>Bahia</surname><given-names>M</given-names></name>, <name><surname>Hecke</surname><given-names>M</given-names></name>, <name><surname>Mercuri</surname><given-names>E</given-names></name>, and <name><surname>Pinheiro</surname><given-names>M</given-names></name> (<year>2020</year>). <article-title>A bone remodeling model governed by cellular micromechanics and physiologically based pharmacokinetics</article-title>. <source>J. Mech. Behav. Biomed. Mat</source>
<volume>104</volume>, <fpage>103657</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jmbbm.2020.103657</pub-id></mixed-citation></ref><ref id="R18"><mixed-citation publication-type="journal"><name><surname>Baldonedo</surname><given-names>JG</given-names></name>, <name><surname>Fern&#x000e1;ndez</surname><given-names>JR</given-names></name>, and <name><surname>Segade</surname><given-names>A</given-names></name> (<year>2021</year>). <article-title>Spatial extension of a bone remodeling dynamics model and its finite element analysis</article-title>. <source>Int. J. Numer. Meth. Bio</source>
<volume>37</volume>
<fpage>e3429</fpage>. doi:<pub-id pub-id-type="doi">10.1002/cnm.3429</pub-id></mixed-citation></ref><ref id="R19"><mixed-citation publication-type="journal"><name><surname>Baratchart</surname><given-names>E</given-names></name>, <name><surname>Lo</surname><given-names>CH</given-names></name>, <name><surname>Lynch</surname><given-names>CC</given-names></name>, and <name><surname>Basanta</surname><given-names>D</given-names></name> (<year>2022</year>). <article-title>Integrated computational and <italic toggle="yes">in vivo</italic> models reveal key insights into macrophage behavio during bone healing</article-title>. <source>PLoS Comput. Biol</source>
<volume>18</volume>, <fpage>e1009839</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pcbi.1009839</pub-id><pub-id pub-id-type="pmid">35559958</pub-id>
</mixed-citation></ref><ref id="R20"><mixed-citation publication-type="journal"><name><surname>Behera</surname><given-names>J</given-names></name>, <name><surname>Ison</surname><given-names>J</given-names></name>, <name><surname>Tyagi</surname><given-names>SC</given-names></name>, and <name><surname>Tyagi</surname><given-names>N</given-names></name> (<year>2020</year>). <article-title>The role of gut microbiota in bone homeostasis</article-title>. <source>Bone</source>
<volume>135</volume>, <fpage>115317</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bone.2020.115317</pub-id><pub-id pub-id-type="pmid">32169602</pub-id>
</mixed-citation></ref><ref id="R21"><mixed-citation publication-type="book"><name><surname>Bellido</surname><given-names>T</given-names></name>, <name><surname>Plotkin</surname><given-names>LI</given-names></name>, and <name><surname>Bruzzaniti</surname><given-names>A</given-names></name> (<year>2014</year>). &#x0201c;<part-title>Bone cells</part-title>,&#x0201d; in <source>Basic and applied bone biology</source>. Editors <name><surname>Burr</surname><given-names>DB</given-names></name> and <name><surname>Allen</surname><given-names>MR</given-names></name> (<publisher-loc>New York</publisher-loc>: <publisher-name>Academic Press</publisher-name>), <fpage>27</fpage>&#x02013;<lpage>45</lpage> doi:<pub-id pub-id-type="doi">10.1016/B978-0-12-416015-6.00002-2</pub-id></mixed-citation></ref><ref id="R22"><mixed-citation publication-type="journal"><name><surname>Bennett</surname><given-names>CN</given-names></name>, <name><surname>Longo</surname><given-names>KA</given-names></name>, <name><surname>Wright</surname><given-names>WS</given-names></name>, <name><surname>Suva</surname><given-names>LJ</given-names></name>, <name><surname>Lane</surname><given-names>TF</given-names></name>, <name><surname>Hankenson</surname><given-names>KD</given-names></name>, <etal/> (<year>2005</year>). <article-title>Regulation of osteoblastogenesis and bone mass by Wnt10b</article-title>. <source>Proc. Natl Acad. Sci. U.S.A</source>
<volume>102</volume>, <fpage>3324</fpage>&#x02013;<lpage>3329</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.0408742102</pub-id><pub-id pub-id-type="pmid">15728361</pub-id>
</mixed-citation></ref><ref id="R23"><mixed-citation publication-type="journal"><name><surname>Bennett</surname><given-names>CN</given-names></name>, <name><surname>Ouyang</surname><given-names>H</given-names></name>, <name><surname>Ma</surname><given-names>YL</given-names></name>, <name><surname>Zeng</surname><given-names>Q</given-names></name>, <name><surname>Gerin</surname><given-names>I</given-names></name>, <name><surname>Sousa</surname><given-names>KM</given-names></name>, <etal/> (<year>2007</year>). <article-title>Wnt10b increases postnatal bone formation by enhancing osteoblast differentiation</article-title>. <source>J. Bone Min. Res</source>
<volume>22</volume>, <fpage>1924</fpage>&#x02013;<lpage>1932</lpage>. doi:<pub-id pub-id-type="doi">10.1359/jbmr.070810</pub-id></mixed-citation></ref><ref id="R24"><mixed-citation publication-type="journal"><name><surname>Berkhout</surname><given-names>J</given-names></name>, <name><surname>Stone</surname><given-names>J</given-names></name>, <name><surname>Verhamme</surname><given-names>K</given-names></name>, <name><surname>Danhof</surname><given-names>M</given-names></name>, and <name><surname>Post</surname><given-names>T</given-names></name> (<year>2016</year>). <article-title>Disease systems analysis of bone mineral density and bone turnover markers in response to alendronate, placebo, and washout in postmenopausal women</article-title>. <source>CPT Pharmacometrics Syst. Pharmacol</source>
<volume>5</volume>, <fpage>656</fpage>&#x02013;<lpage>664</lpage>. doi:<pub-id pub-id-type="doi">10.1002/psp4.12135</pub-id><pub-id pub-id-type="pmid">27869358</pub-id>
</mixed-citation></ref><ref id="R25"><mixed-citation publication-type="journal"><name><surname>Berkhout</surname><given-names>J</given-names></name>, <name><surname>Stone</surname><given-names>J</given-names></name>, <name><surname>Verhamme</surname><given-names>K</given-names></name>, <name><surname>Stricker</surname><given-names>B</given-names></name>, <name><surname>Sturkenboom</surname><given-names>M</given-names></name>, <name><surname>Danhof</surname><given-names>M</given-names></name>, <etal/> (<year>2015</year>). <article-title>Application of a systems pharmacology-based placebo population model to analyze long-term data of postmenopausal osteoporosis</article-title>. <source>CPT Pharmacometrics Syst. Pharmacol</source>
<volume>4</volume>, <fpage>516</fpage>&#x02013;<lpage>526</lpage>. doi:<pub-id pub-id-type="doi">10.1002/psp4.12006</pub-id><pub-id pub-id-type="pmid">26451331</pub-id>
</mixed-citation></ref><ref id="R26"><mixed-citation publication-type="journal"><name><surname>Bonewald</surname><given-names>LF</given-names></name> (<year>2011</year>). <article-title>The amazing osteocyte</article-title>. <source>J. Bone Min. Res</source>
<volume>26</volume>, <fpage>229</fpage>&#x02013;<lpage>238</lpage>. doi:<pub-id pub-id-type="doi">10.1002/jbmr.320</pub-id></mixed-citation></ref><ref id="R27"><mixed-citation publication-type="journal"><name><surname>Bonewald</surname><given-names>LF</given-names></name>, and <name><surname>Johnson</surname><given-names>ML</given-names></name> (<year>2008</year>). <article-title>Osteocytes, mechanosensing and Wnt signaling</article-title>. <source>Bone</source>
<volume>42</volume>, <fpage>606</fpage>&#x02013;<lpage>615</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bone.2007.12.224</pub-id><pub-id pub-id-type="pmid">18280232</pub-id>
</mixed-citation></ref><ref id="R28"><mixed-citation publication-type="journal"><name><surname>Bonomo</surname><given-names>A</given-names></name>, <name><surname>Monteiro</surname><given-names>AC</given-names></name>, <name><surname>Gon&#x000e7;alves-Silva</surname><given-names>T</given-names></name>, <name><surname>Cordeiro-Spinetti</surname><given-names>E</given-names></name>, <name><surname>Galvani</surname><given-names>RG</given-names></name>, and <name><surname>Balduino</surname><given-names>A</given-names></name> (<year>2016</year>). <article-title>A T cell view of the bone marrow</article-title>. <source>Front. Immunol</source>
<volume>7</volume>, <fpage>184</fpage> doi:<pub-id pub-id-type="doi">10.3389/fimmu.2016.00184</pub-id><pub-id pub-id-type="pmid">27242791</pub-id>
</mixed-citation></ref><ref id="R29"><mixed-citation publication-type="journal"><name><surname>Bouxsein</surname><given-names>ML</given-names></name>, <name><surname>Boyd</surname><given-names>SK</given-names></name>, <name><surname>Christiansen</surname><given-names>BA</given-names></name>, <name><surname>Guldberg</surname><given-names>RE</given-names></name>, <name><surname>Jepsen</surname><given-names>KJ</given-names></name>, and <name><surname>M&#x000fc;ller</surname><given-names>R</given-names></name> (<year>2010</year>). <article-title>Guidelines for assessment of bone microstructure in rodents using micro-computed tomography</article-title>. <source>J. Bone Min. Res</source>
<volume>25</volume>, <fpage>1468</fpage>&#x02013;<lpage>1486</lpage>. doi:<pub-id pub-id-type="doi">10.1002/jbmr.14</pub-id></mixed-citation></ref><ref id="R30"><mixed-citation publication-type="journal"><name><surname>Boyle</surname><given-names>WJ</given-names></name>, <name><surname>Simonet</surname><given-names>WS</given-names></name>, and <name><surname>Lacey</surname><given-names>DL</given-names></name> (<year>2003</year>). <article-title>Osteoclast differentiation and activation</article-title>. <source>Nature</source>
<volume>423</volume>, <fpage>337</fpage>&#x02013;<lpage>342</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature01658</pub-id><pub-id pub-id-type="pmid">12748652</pub-id>
</mixed-citation></ref><ref id="R31"><mixed-citation publication-type="journal"><name><surname>Braniste</surname><given-names>V</given-names></name>, <name><surname>Leveque</surname><given-names>M</given-names></name>, <name><surname>Buisson-Brenac</surname><given-names>C</given-names></name>, <name><surname>Bueno</surname><given-names>L</given-names></name>, <name><surname>Fioramonti</surname><given-names>J</given-names></name>, and <name><surname>Houdeau</surname><given-names>E</given-names></name> (<year>2009</year>). <article-title>Oestradiol decreases colonic permeability through oestrogen receptor beta-mediated up-regulation of occludin and junctional adhesion molecule-A in epithelia cells</article-title>. <source>J. Physiol</source>
<volume>587</volume>, <fpage>3317</fpage>&#x02013;<lpage>3328</lpage>. doi:<pub-id pub-id-type="doi">10.1113/jphysiol.2009.169300</pub-id><pub-id pub-id-type="pmid">19433574</pub-id>
</mixed-citation></ref><ref id="R32"><mixed-citation publication-type="journal"><name><surname>Britton</surname><given-names>RA</given-names></name>, <name><surname>Irwin</surname><given-names>R</given-names></name>, <name><surname>Quach</surname><given-names>D</given-names></name>, <name><surname>Schaefer</surname><given-names>L</given-names></name>, <name><surname>Zhang</surname><given-names>J</given-names></name>, <name><surname>Lee</surname><given-names>T</given-names></name>, <etal/> (<year>2014</year>). <article-title>Probiotic L. reuteri treatment prevents bone loss in a menopausal ovariectomized mouse model</article-title>. <source>J. Cell. Physiol</source>
<volume>229</volume>, <fpage>1822</fpage>&#x02013;<lpage>1830</lpage>. doi:<pub-id pub-id-type="doi">10.1002/jcp.24636</pub-id><pub-id pub-id-type="pmid">24677054</pub-id>
</mixed-citation></ref><ref id="R33"><mixed-citation publication-type="journal"><name><surname>Bu</surname><given-names>SY</given-names></name>, <name><surname>Hunt</surname><given-names>TS</given-names></name>, and <name><surname>Smith</surname><given-names>BJ</given-names></name> (<year>2009</year>). <article-title>Dried plum polyphenols attenuate the detrimental effects of TNF-alpha on osteoblast function coincident with up-regulation of Runx2, Osterix and IGF-I</article-title>. <source>J. Nutr. Biochem</source>
<volume>20</volume>, <fpage>35</fpage>&#x02013;<lpage>44</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jnutbio.2007.11.012</pub-id><pub-id pub-id-type="pmid">18495459</pub-id>
</mixed-citation></ref><ref id="R34"><mixed-citation publication-type="journal"><name><surname>Buenzli</surname><given-names>PR</given-names></name> (<year>2015</year>). <article-title>Osteocytes as a record of bone formation dynamics: a mathematical model of osteocyte generation in bone matrix</article-title>. <source>J. Theor. Biol</source>
<volume>364</volume>
<fpage>418</fpage>&#x02013;<lpage>427</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jtbi.2014.09.028</pub-id><pub-id pub-id-type="pmid">25285894</pub-id>
</mixed-citation></ref><ref id="R35"><mixed-citation publication-type="journal"><name><surname>Buenzli</surname><given-names>PR</given-names></name>, <name><surname>Jeon</surname><given-names>J</given-names></name>, <name><surname>Pivonka</surname><given-names>P</given-names></name>, <name><surname>Smith</surname><given-names>DW</given-names></name>, and <name><surname>Cummings</surname><given-names>PT</given-names></name> (<year>2012a</year>). <article-title>Investigation of bone resorption within a cortical basic multicellular unit using a lattice-based computational model</article-title>. <source>Bone</source>
<volume>50</volume>, <fpage>378</fpage>&#x02013;<lpage>389</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bone.2011.10.021</pub-id><pub-id pub-id-type="pmid">22100414</pub-id>
</mixed-citation></ref><ref id="R36"><mixed-citation publication-type="journal"><name><surname>Buenzli</surname><given-names>PR</given-names></name>, <name><surname>Pivonka</surname><given-names>P</given-names></name>, <name><surname>Gardiner</surname><given-names>BS</given-names></name>, and <name><surname>Smith</surname><given-names>DW</given-names></name> (<year>2012b</year>). <article-title>Modelling the anabolic response of bone using a cell population model</article-title>. <source>J. Theor. Biol</source>
<volume>307</volume>, <fpage>42</fpage>&#x02013;<lpage>52</lpage> doi:<pub-id pub-id-type="doi">10.1016/j.jtbi.2012.04.019</pub-id><pub-id pub-id-type="pmid">22579551</pub-id>
</mixed-citation></ref><ref id="R37"><mixed-citation publication-type="journal"><name><surname>Buenzli</surname><given-names>PR</given-names></name>, <name><surname>Pivonka</surname><given-names>P</given-names></name>, and <name><surname>Smith</surname><given-names>DW</given-names></name> (<year>2011</year>). <article-title>Spatio-temporal structure of cel distribution in cortical bone multicellular units: a mathematical model</article-title>. <source>Bone</source>
<volume>48</volume>, <fpage>918</fpage>&#x02013;<lpage>926</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bone.2010.12.009</pub-id><pub-id pub-id-type="pmid">21172465</pub-id>
</mixed-citation></ref><ref id="R38"><mixed-citation publication-type="journal"><name><surname>Buenzli</surname><given-names>PR</given-names></name>, <name><surname>Pivonka</surname><given-names>P</given-names></name>, and <name><surname>Smith</surname><given-names>DW</given-names></name> (<year>2014</year>). <article-title>Bone refilling in cortical basic multicellular units: insights into tetracycline double labelling from a computational model</article-title>. <source>Biomech. Model. Mechan</source>
<volume>13</volume>, <fpage>185</fpage>&#x02013;<lpage>203</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s10237-013-0495-y</pub-id></mixed-citation></ref><ref id="R39"><mixed-citation publication-type="book"><name><surname>Burr</surname><given-names>DB</given-names></name>, and <name><surname>Akkus</surname><given-names>O</given-names></name> (<year>2014</year>). &#x0201c;<part-title>Bone morphology and organization</part-title>,&#x0201d; in <source>Basic and applied bone biology</source>. Editors <name><surname>Burr</surname><given-names>DB</given-names></name> and <name><surname>Allen</surname><given-names>MR</given-names></name> (<publisher-loc>New York</publisher-loc>: <publisher-name>Academic Press</publisher-name>), <fpage>3</fpage>&#x02013;<lpage>25</lpage>. doi:<pub-id pub-id-type="doi">10.1016/B978-0-12-416015-6.00001-0</pub-id></mixed-citation></ref><ref id="R40"><mixed-citation publication-type="journal"><name><surname>Calvo-Gallego</surname><given-names>JL</given-names></name>, <name><surname>Manchado-Morales</surname><given-names>P</given-names></name>, <name><surname>Pivonka</surname><given-names>P</given-names></name>, and <name><surname>Mart&#x000ed;nez-Reina</surname><given-names>J</given-names></name> (<year>2023</year>). <article-title>Spatio-temporal simulations of bone remodelling using a bone cell population model based on cell availability</article-title>. <source>Front. Bioeng. Biotechnol</source>
<volume>11</volume>, <fpage>1060158</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fbioe.2023.1060158</pub-id><pub-id pub-id-type="pmid">36959906</pub-id>
</mixed-citation></ref><ref id="R41"><mixed-citation publication-type="journal"><name><surname>Camacho</surname><given-names>A</given-names></name>, and <name><surname>Jerez</surname><given-names>S</given-names></name> (<year>2019</year>). <article-title>Bone metastasis treatment modeling via optima control</article-title>. <source>J. Math. Biol</source>
<volume>78</volume>, <fpage>497</fpage>&#x02013;<lpage>526</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00285-018-1281-3</pub-id><pub-id pub-id-type="pmid">30132065</pub-id>
</mixed-citation></ref><ref id="R42"><mixed-citation publication-type="journal"><name><surname>Camacho</surname><given-names>A</given-names></name>, and <name><surname>Jerez</surname><given-names>S</given-names></name> (<year>2021</year>). <article-title>Nonlinear modeling and control strategies for bone diseases based on TGF&#x000df; and Wnt factors</article-title>. <source>Commun. Nonlinear Sci. Numer. Simul</source>
<volume>100</volume>
<fpage>105842</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cnsns.2021.105842</pub-id></mixed-citation></ref><ref id="R43"><mixed-citation publication-type="journal"><name><surname>Chaiya</surname><given-names>I</given-names></name>, and <name><surname>Rattanakul</surname><given-names>C</given-names></name> (<year>2017</year>). <article-title>An impulsive mathematical model of bone formation and resorption: effects of parathyroid hormone, calcitonin and impulsiv estrogen supplement</article-title>. <source>Adv. Differ. Equ</source>
<volume>2017</volume>, <fpage>153</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s13662-017-1206-2</pub-id></mixed-citation></ref><ref id="R44"><mixed-citation publication-type="journal"><name><surname>Chang</surname><given-names>SY</given-names></name>, <name><surname>Ko</surname><given-names>HJ</given-names></name>, and <name><surname>Kweon</surname><given-names>MN</given-names></name> (<year>2014</year>). <article-title>Mucosal dendritic cells shape mucosal immunity</article-title>. <source>Exp. Mol. Med</source>
<volume>46</volume>, <fpage>e84</fpage>. doi:<pub-id pub-id-type="doi">10.1038/emm.2014.16</pub-id><pub-id pub-id-type="pmid">24626170</pub-id>
</mixed-citation></ref><ref id="R45"><mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>K</given-names></name>, <name><surname>Chen</surname><given-names>H</given-names></name>, <name><surname>Faas</surname><given-names>MM</given-names></name>, <name><surname>de Haan</surname><given-names>BJ</given-names></name>, <name><surname>Li</surname><given-names>J</given-names></name>, <name><surname>Xiao</surname><given-names>P</given-names></name>, <etal/> (<year>2017</year>). <article-title>Specific inulin-type fructan fibers protect against autoimmune diabetes by modulating gut immunity, barrier function, and microbiota homeostasis</article-title>. <source>Mol. Nutr. Food Res</source>
<volume>61</volume> doi:<pub-id pub-id-type="doi">10.1002/mnfr.201601006</pub-id></mixed-citation></ref><ref id="R46"><mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>X</given-names></name>, <name><surname>Zhang</surname><given-names>Z</given-names></name>, <name><surname>Hu</surname><given-names>Y</given-names></name>, <name><surname>Cui</surname><given-names>J</given-names></name>, <name><surname>Zhi</surname><given-names>X</given-names></name>, <name><surname>Li</surname><given-names>X</given-names></name>, <etal/> (<year>2020</year>). <article-title>Lactulose suppresse osteoclastogenesis and ameliorates estrogen deficiency-induced bone loss in mice</article-title>. <source>Aging Dis</source>. <volume>11</volume>, <fpage>629</fpage>&#x02013;<lpage>641</lpage>. doi:<pub-id pub-id-type="doi">10.14336/ad.2019.0613</pub-id><pub-id pub-id-type="pmid">32489707</pub-id>
</mixed-citation></ref><ref id="R47"><mixed-citation publication-type="journal"><name><surname>Chen-Charpentier</surname><given-names>BM</given-names></name>, and <name><surname>Diakite</surname><given-names>I</given-names></name> (<year>2016</year>). <article-title>A mathematical model of bone remodeling with delays</article-title>. <source>J. Comput. Appl. Math</source>
<volume>291</volume>, <fpage>76</fpage>&#x02013;<lpage>84</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cam.201411.025</pub-id></mixed-citation></ref><ref id="R48"><mixed-citation publication-type="journal"><name><surname>Chonan</surname><given-names>O</given-names></name>, <name><surname>Matsumoto</surname><given-names>K</given-names></name>, and <name><surname>Watanuki</surname><given-names>M</given-names></name> (<year>1995</year>). <article-title>Effect of galactooligosaccharides on calcium absorption and preventing bone loss in ovariectomized rats</article-title>. <source>Biosci. Biotechnol. Biochem</source>
<volume>59</volume>, <fpage>236</fpage>&#x02013;<lpage>239</lpage>. doi:<pub-id pub-id-type="doi">10.1271/bbb.59.236</pub-id><pub-id pub-id-type="pmid">7766023</pub-id>
</mixed-citation></ref><ref id="R49"><mixed-citation publication-type="journal"><name><surname>Coelho</surname><given-names>RM</given-names></name>, <name><surname>Lemos</surname><given-names>JM</given-names></name>, <name><surname>Alho</surname><given-names>I</given-names></name>, <name><surname>Val&#x000e9;rio</surname><given-names>D</given-names></name>, <name><surname>Ferreira</surname><given-names>AR</given-names></name>, <name><surname>Costa</surname><given-names>L</given-names></name>, <etal/> (<year>2016</year>) <article-title>Dynamic modeling of bone metastasis, microenvironment and therapy: integrating parathyroid hormone (PTH) effect, anti-resorptive and anti-cancer therapy</article-title>. <source>J. Theor Biol</source>
<volume>391</volume>, <fpage>1</fpage>&#x02013;<lpage>12</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jtbi.2015.11.024</pub-id><pub-id pub-id-type="pmid">26657065</pub-id>
</mixed-citation></ref><ref id="R50"><mixed-citation publication-type="book"><name><surname>Coelho</surname><given-names>RM</given-names></name>, <name><surname>Neto</surname><given-names>JP</given-names></name>, <name><surname>Val&#x000e9;rio</surname><given-names>D</given-names></name>, and <name><surname>Vinga</surname><given-names>S</given-names></name> (<year>2020</year>). &#x0201c;<part-title>Dynamic biochemical and cellular models of bone physiology: integrating remodeling processes, tumor growth, and therapy</part-title>,&#x0201d; in <source>The computational mechanics of bone tissue: biological behaviour, remodelling algorithms and numerical applications of lecture notes in computational vision and biomechanics</source>. Editors <name><surname>Belinha</surname><given-names>J</given-names></name>, <name><surname>Manzanares-C&#x000e9;spedes</surname><given-names>M-C</given-names></name>, and <name><surname>Completo</surname><given-names>AMG</given-names></name> (<publisher-loc>Cham</publisher-loc>: <publisher-name>Springer</publisher-name>), <volume>35</volume>, <fpage>95</fpage>&#x02013;<lpage>128</lpage>. doi:<pub-id pub-id-type="doi">10.1007/978-3-030-37541-6_4</pub-id></mixed-citation></ref><ref id="R51"><mixed-citation publication-type="journal"><name><surname>Coleman</surname><given-names>RE</given-names></name>, <name><surname>Croucher</surname><given-names>PI</given-names></name>, <name><surname>Padhani</surname><given-names>AR</given-names></name>, <name><surname>Cl&#x000e9;zardin</surname><given-names>P</given-names></name>, <name><surname>Chow</surname><given-names>E</given-names></name>, <name><surname>Fallon</surname><given-names>M</given-names></name>
<etal/> (<year>2020</year>). <article-title>Bone metastases</article-title>. <source>Nat. Rev. Dis. Prim</source>
<volume>6</volume>, <fpage>83</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41572-020-00216-3</pub-id><pub-id pub-id-type="pmid">33060614</pub-id>
</mixed-citation></ref><ref id="R52"><mixed-citation publication-type="journal"><name><surname>Cook</surname><given-names>CV</given-names></name>, <name><surname>Islam</surname><given-names>MA</given-names></name>, <name><surname>Smith</surname><given-names>BJ</given-names></name>, and <name><surname>Ford Versypt</surname><given-names>AN</given-names></name> (<year>2022</year>). <article-title>Mathematica modeling of the effects of Wnt-10b on bone metabolism</article-title>. <source>AIChE J</source>. <volume>68</volume>, <fpage>e17809</fpage>. doi:<pub-id pub-id-type="doi">10.1002/aic.17809</pub-id><pub-id pub-id-type="pmid">36567819</pub-id>
</mixed-citation></ref><ref id="R53"><mixed-citation publication-type="journal"><name><surname>Cook</surname><given-names>CV</given-names></name>, <name><surname>Lighty</surname><given-names>AM</given-names></name>, <name><surname>Smith</surname><given-names>BJ</given-names></name>, and <name><surname>Ford Versypt</surname><given-names>AN</given-names></name> (<year>2024</year>). <article-title>A review of mathematical modeling of bone remodeling from a systems biology perspective</article-title>. <source>ChemRxiv Prepr</source>. doi:<pub-id pub-id-type="doi">10.26434/chemrxiv-2024-5vrcc</pub-id></mixed-citation></ref><ref id="R54"><mixed-citation publication-type="journal"><name><surname>Creecy</surname><given-names>A</given-names></name>, <name><surname>Damrath</surname><given-names>JG</given-names></name>, and <name><surname>Wallace</surname><given-names>JM</given-names></name> (<year>2021</year>). <article-title>Control of bone matrix properties by osteocytes</article-title>. <source>Front. Endocrinol</source>
<volume>11</volume>, <fpage>578477</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fendo.2020.578477</pub-id></mixed-citation></ref><ref id="R55"><mixed-citation publication-type="journal"><name><surname>Damani</surname><given-names>JJ</given-names></name>, <name><surname>Souza</surname><given-names>MJD</given-names></name>, <name><surname>Strock</surname><given-names>NCA</given-names></name>, <name><surname>Koltun</surname><given-names>KJ</given-names></name>, <name><surname>Williams</surname><given-names>NI</given-names></name>, <name><surname>Weaver</surname><given-names>C</given-names></name>, <etal/> (<year>2023</year>). <article-title>Associations between inflammatory mediators and bone outcomes in postmenopausal women: a cross-sectional analysis of baseline data from the prune study</article-title>. <source>J. Inflamm. Res</source>
<volume>16</volume>, <fpage>639</fpage>&#x02013;<lpage>663</lpage>. doi:<pub-id pub-id-type="doi">10.2147/jir.s397837</pub-id><pub-id pub-id-type="pmid">36814438</pub-id>
</mixed-citation></ref><ref id="R56"><mixed-citation publication-type="journal"><name><surname>Dar</surname><given-names>HY</given-names></name>, <name><surname>Azam</surname><given-names>Z</given-names></name>, <name><surname>Anupam</surname><given-names>R</given-names></name>, <name><surname>Mondal</surname><given-names>RK</given-names></name>, and <name><surname>Srivastava</surname><given-names>RK</given-names></name> (<year>2018</year>) <article-title>Osteoimmunology: the nexus between bone and immune system</article-title>. <source>Front. Biosci</source>
<volume>23</volume>, <fpage>464</fpage>&#x02013;<lpage>492</lpage>. doi:<pub-id pub-id-type="doi">10.2741/4600</pub-id></mixed-citation></ref><ref id="R57"><mixed-citation publication-type="journal"><name><surname>Delaisse</surname><given-names>J-M</given-names></name>, <name><surname>Andersen</surname><given-names>TL</given-names></name>, <name><surname>Kristensen</surname><given-names>HB</given-names></name>, <name><surname>Jensen</surname><given-names>PR</given-names></name>, <name><surname>Andreasen</surname><given-names>CM</given-names></name>, and <name><surname>S&#x000f8;e</surname><given-names>K</given-names></name> (<year>2020</year>). <article-title>Re-thinking the bone remodeling cycle mechanism and the origin of bone loss</article-title>. <source>Bone</source>
<volume>141</volume>, <fpage>115628</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bone.2020.115628</pub-id><pub-id pub-id-type="pmid">32919109</pub-id>
</mixed-citation></ref><ref id="R58"><mixed-citation publication-type="journal"><name><surname>Delgado-Calle</surname><given-names>J</given-names></name>, and <name><surname>Bellido</surname><given-names>T</given-names></name> (<year>2022</year>). <article-title>The osteocyte as a signaling cell</article-title>. <source>Physiol. Rev</source>
<volume>102</volume>, <fpage>379</fpage>&#x02013;<lpage>410</lpage>. doi:<pub-id pub-id-type="doi">10.1152/physrev.00043.2020</pub-id><pub-id pub-id-type="pmid">34337974</pub-id>
</mixed-citation></ref><ref id="R59"><mixed-citation publication-type="journal"><name><surname>Della Corte</surname><given-names>A</given-names></name>, <name><surname>Giorgio</surname><given-names>I</given-names></name>, and <name><surname>Scerrato</surname><given-names>D</given-names></name> (<year>2020</year>). <article-title>A review of recent developments in mathematical modeling of bone remodeling</article-title>. <source>Proc. Inst. Mech. Eng. H. J. Eng. Med</source>
<volume>234</volume>, <fpage>273</fpage>&#x02013;<lpage>281</lpage>. doi:<pub-id pub-id-type="doi">10.1177/0954411919857599</pub-id></mixed-citation></ref><ref id="R60"><mixed-citation publication-type="journal"><name><surname>Dempster</surname><given-names>DW</given-names></name>, <name><surname>Compston</surname><given-names>JE</given-names></name>, <name><surname>Drezner</surname><given-names>MK</given-names></name>, <name><surname>Glorieux</surname><given-names>FH</given-names></name>, <name><surname>Kanis</surname><given-names>JA</given-names></name>, <name><surname>Malluche</surname><given-names>H</given-names></name>, <etal/> (<year>2013</year>). <article-title>Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the asbmr histomorphometry nomenclature committee</article-title>. <source>J. Bone Min. Res</source>
<volume>28</volume>, <fpage>2</fpage>&#x02013;<lpage>17</lpage>. doi:<pub-id pub-id-type="doi">10.1002/jbmr.1805</pub-id></mixed-citation></ref><ref id="R61"><mixed-citation publication-type="journal"><name><surname>Dodier</surname><given-names>T</given-names></name>, <name><surname>Anderson</surname><given-names>K</given-names></name>, <name><surname>Bothwell</surname><given-names>J</given-names></name>, <name><surname>Hermann</surname><given-names>J</given-names></name>, <name><surname>Lucas</surname><given-names>EA</given-names></name>, and <name><surname>Smith</surname><given-names>BJ</given-names></name> (<year>2021</year>). <article-title>U.S. montmorency tart cherry juice decreases bone resorption in women aged 65&#x02013;80 years</article-title>. <source>Nutrients</source>
<volume>13</volume>, <fpage>544</fpage>. doi:<pub-id pub-id-type="doi">10.3390/nu13020544</pub-id><pub-id pub-id-type="pmid">33562341</pub-id>
</mixed-citation></ref><ref id="R62"><mixed-citation publication-type="journal"><name><surname>Dougall</surname><given-names>WC</given-names></name>, <name><surname>Glaccum</surname><given-names>M</given-names></name>, <name><surname>Charrier</surname><given-names>K</given-names></name>, <name><surname>Rohrbach</surname><given-names>K</given-names></name>, <name><surname>Brasel</surname><given-names>K</given-names></name>, <name><surname>Smedt</surname><given-names>TD</given-names></name>, <etal/> (<year>1999</year>). <article-title>RANK is essential for osteoclast and lymph node development</article-title>. <source>Genes Dev</source>. <volume>13</volume>, <fpage>2412</fpage>&#x02013;<lpage>2424</lpage>. doi:<pub-id pub-id-type="doi">10.1101/gad.13.18.2412</pub-id><pub-id pub-id-type="pmid">10500098</pub-id>
</mixed-citation></ref><ref id="R63"><mixed-citation publication-type="journal"><name><surname>Drake</surname><given-names>MT</given-names></name> (<year>2013</year>). <article-title>Osteoporosis and cancer</article-title>. <source>Curr. Osteoporos. Rep</source>
<volume>11</volume>, <fpage>163</fpage>&#x02013;<lpage>170</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11914-013-0154-3</pub-id><pub-id pub-id-type="pmid">23877475</pub-id>
</mixed-citation></ref><ref id="R64"><mixed-citation publication-type="journal"><name><surname>Drake</surname><given-names>MT</given-names></name>, <name><surname>Clarke</surname><given-names>BL</given-names></name>, and <name><surname>Khosla</surname><given-names>S</given-names></name> (<year>2008</year>). <article-title>Bisphosphonates: mechanism of action and role in clinical practice</article-title>. <source>Mayo Clin. Proc</source>
<volume>83</volume>, <fpage>1032</fpage>&#x02013;<lpage>1045</lpage>. doi:<pub-id pub-id-type="doi">10.4065/83.9.1032</pub-id><pub-id pub-id-type="pmid">18775204</pub-id>
</mixed-citation></ref><ref id="R65"><mixed-citation publication-type="journal"><name><surname>Eastell</surname><given-names>R</given-names></name>, <name><surname>O&#x02019;Neill</surname><given-names>TW</given-names></name>, <name><surname>Hofbauer</surname><given-names>LC</given-names></name>, <name><surname>Langdahl</surname><given-names>B</given-names></name>, <name><surname>Reid</surname><given-names>IR</given-names></name>, <name><surname>Gold</surname><given-names>DT</given-names></name>, <etal/> (<year>2016</year>). <article-title>Postmenopausal osteoporosis</article-title>. <source>Nat. Rev. Dis. Prim</source>
<volume>2</volume>, <fpage>16069</fpage>. doi:<pub-id pub-id-type="doi">10.1038/nrdp.2016.69</pub-id><pub-id pub-id-type="pmid">27681935</pub-id>
</mixed-citation></ref><ref id="R66"><mixed-citation publication-type="journal"><name><surname>Ellis</surname><given-names>AJ</given-names></name>, <name><surname>Hendrick</surname><given-names>VM</given-names></name>, <name><surname>Williams</surname><given-names>R</given-names></name>, and <name><surname>Komm</surname><given-names>BS</given-names></name> (<year>2015</year>). <article-title>Selective estrogen receptor modulators in clinical practice: a safety overview</article-title>. <source>Expert Opin. Drug Saf</source>
<volume>14</volume>
<fpage>921</fpage>&#x02013;<lpage>934</lpage>. doi:<pub-id pub-id-type="doi">10.1517/14740338.2015.1014799</pub-id><pub-id pub-id-type="pmid">25936229</pub-id>
</mixed-citation></ref><ref id="R67"><mixed-citation publication-type="journal"><name><surname>Emerton</surname><given-names>KB</given-names></name>, <name><surname>Hu</surname><given-names>B</given-names></name>, <name><surname>Woo</surname><given-names>AA</given-names></name>, <name><surname>Sinofsky</surname><given-names>A</given-names></name>, <name><surname>Hernandez</surname><given-names>C</given-names></name>, <name><surname>Majeska</surname><given-names>RJ</given-names></name>, <etal/> (<year>2010</year>). <article-title>Osteocyte apoptosis and control of bone resorption following ovariectomy in mice</article-title>. <source>Bone</source>
<volume>46</volume>, <fpage>577</fpage>&#x02013;<lpage>583</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bone.2009.11.006</pub-id><pub-id pub-id-type="pmid">19925896</pub-id>
</mixed-citation></ref><ref id="R68"><mixed-citation publication-type="journal"><name><surname>Epsley</surname><given-names>S</given-names></name>, <name><surname>Tadros</surname><given-names>S</given-names></name>, <name><surname>Farid</surname><given-names>A</given-names></name>, <name><surname>Kargilis</surname><given-names>D</given-names></name>, <name><surname>Mehta</surname><given-names>S</given-names></name>, and <name><surname>Rajapakse</surname><given-names>CS</given-names></name> (<year>2021</year>). <article-title>The effect of inflammation on bone</article-title>. <source>Front. Physiol</source>
<volume>11</volume>, <fpage>511799</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fphys.2020511799</pub-id><pub-id pub-id-type="pmid">33584321</pub-id>
</mixed-citation></ref><ref id="R69"><mixed-citation publication-type="journal"><name><surname>Eriksen</surname><given-names>EF</given-names></name> (<year>2010</year>). <article-title>Cellular mechanisms of bone remodeling</article-title>. <source>Rev. Endocr. Metab. Dis</source>
<volume>11</volume>, <fpage>219</fpage>&#x02013;<lpage>227</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11154-010-9153-1</pub-id></mixed-citation></ref><ref id="R70"><mixed-citation publication-type="journal"><name><surname>Eudy</surname><given-names>RJ</given-names></name>, <name><surname>Gastonguay</surname><given-names>MR</given-names></name>, <name><surname>Baron</surname><given-names>KT</given-names></name>, and <name><surname>Riggs</surname><given-names>MM</given-names></name> (<year>2015</year>). <article-title>Connecting the dots: linking osteocyte activity and therapeutic modulation of sclerostin by extending a multiscale systems model</article-title>. <source>CPT Pharmacometrics Syst. Pharmacol</source>
<volume>4</volume>, <fpage>527</fpage>&#x02013;<lpage>536</lpage>. doi:<pub-id pub-id-type="doi">10.1002/psp4.12013</pub-id><pub-id pub-id-type="pmid">26451332</pub-id>
</mixed-citation></ref><ref id="R71"><mixed-citation publication-type="journal"><name><surname>Everts</surname><given-names>V</given-names></name>, <name><surname>Jansen</surname><given-names>IDC</given-names></name>, and <name><surname>de Vries</surname><given-names>TJ</given-names></name> (<year>2022</year>). <article-title>Mechanisms of bone resorption</article-title>. <source>Bone</source>
<volume>163</volume>, <fpage>116499</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bone.2022.116499</pub-id><pub-id pub-id-type="pmid">35872106</pub-id>
</mixed-citation></ref><ref id="R72"><mixed-citation publication-type="journal"><name><surname>Farhat</surname><given-names>A</given-names></name>, <name><surname>Jiang</surname><given-names>D</given-names></name>, <name><surname>Cui</surname><given-names>D</given-names></name>, <name><surname>Keller</surname><given-names>ET</given-names></name>, and <name><surname>Jackson</surname><given-names>TL</given-names></name> (<year>2017</year>). <article-title>An integrative model of prostate cancer interaction with the bone microenvironment</article-title>. <source>Math. Biosci</source>
<volume>294</volume>, <fpage>1</fpage>&#x02013;<lpage>14</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.mbs.2017.09.005</pub-id><pub-id pub-id-type="pmid">28919575</pub-id>
</mixed-citation></ref><ref id="R73"><mixed-citation publication-type="journal"><name><surname>Faubion</surname><given-names>SS</given-names></name>, <name><surname>Crandall</surname><given-names>CJ</given-names></name>, <name><surname>Davis</surname><given-names>L</given-names></name>, <name><surname>El Khoudary</surname><given-names>SR</given-names></name>, <name><surname>Hodis</surname><given-names>HN</given-names></name>, <name><surname>Lobo</surname><given-names>RA</given-names></name>, <etal/> (<year>2022</year>). <article-title>The 2022 hormone therapy position statement of the north american menopause society</article-title>. <source>Menopause</source>
<volume>29</volume>, <fpage>767</fpage>&#x02013;<lpage>794</lpage>. doi:<pub-id pub-id-type="doi">10.1097/GME.0000000000002028</pub-id><pub-id pub-id-type="pmid">35797481</pub-id>
</mixed-citation></ref><ref id="R74"><mixed-citation publication-type="journal"><name><surname>Fischer</surname><given-names>V</given-names></name>, and <name><surname>Haffner-Luntzer</surname><given-names>M</given-names></name> (<year>2022</year>). <article-title>Interaction between bone and immune cells: implications for postmenopausal osteoporosis</article-title>. <source>Semin. Cell Dev. Biol</source>
<volume>123</volume>, <fpage>14</fpage>&#x02013;<lpage>21</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.semcdb.2021.05.014</pub-id><pub-id pub-id-type="pmid">34024716</pub-id>
</mixed-citation></ref><ref id="R75"><mixed-citation publication-type="journal"><name><surname>Fizazi</surname><given-names>K</given-names></name>, <name><surname>Carducci</surname><given-names>M</given-names></name>, <name><surname>Smith</surname><given-names>M</given-names></name>, <name><surname>Dami&#x000e3;o</surname><given-names>R</given-names></name>, <name><surname>Brown</surname><given-names>J</given-names></name>, <name><surname>Karsh</surname><given-names>L</given-names></name>, <etal/> (<year>2011</year>). <article-title>Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study</article-title>. <source>Lancet</source>
<volume>377</volume>
<fpage>813</fpage>&#x02013;<lpage>822</lpage>. doi:<pub-id pub-id-type="doi">10.1016/s0140-6736(10)62344-6</pub-id><pub-id pub-id-type="pmid">21353695</pub-id>
</mixed-citation></ref><ref id="R76"><mixed-citation publication-type="journal"><name><surname>Florencio-Silva</surname><given-names>R</given-names></name>, <name><surname>Sasso</surname><given-names>GRDS</given-names></name>, <name><surname>Sasso-Cerri</surname><given-names>E</given-names></name>, <name><surname>Sim&#x000f5;es</surname><given-names>MJ</given-names></name>, and <name><surname>Cerri</surname><given-names>PS</given-names></name> (<year>2015</year>). <article-title>Biology of bone tissue: structure, function, and factors that influence bone cells</article-title>. <source>Biomed. Res. Int</source>
<volume>2015</volume>, <fpage>421746</fpage>. doi:<pub-id pub-id-type="doi">10.1155/2015/421746</pub-id><pub-id pub-id-type="pmid">26247020</pub-id>
</mixed-citation></ref><ref id="R77"><mixed-citation publication-type="journal"><name><surname>Ford Versypt</surname><given-names>AN</given-names></name> (<year>2021</year>). <article-title>Multiscale modeling in disease</article-title>. <source>Curr. Opin. Sys. Biol</source>
<volume>27</volume>
<fpage>100340</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.coisb.2021.05.001</pub-id></mixed-citation></ref><ref id="R78"><mixed-citation publication-type="book"><name><surname>Frost</surname><given-names>HM</given-names></name> (<year>1964a</year>). &#x0201c;<part-title>Dynamics of bone remodeling</part-title>,&#x0201d; in <source>Bone biodynamics</source>. Editor <name><surname>Frost</surname><given-names>HM</given-names></name> (<publisher-loc>Boston</publisher-loc>: <publisher-name>Little, Brown, and Company</publisher-name>), <fpage>315</fpage>&#x02013;<lpage>333</lpage>.</mixed-citation></ref><ref id="R79"><mixed-citation publication-type="book"><name><surname>Frost</surname><given-names>HM</given-names></name> (<year>1964b</year>). <source>Mathematical elements of lamellar bone remodelling</source>. <publisher-loc>Springfield, IL</publisher-loc>: <publisher-name>Charles C Thomas</publisher-name></mixed-citation></ref><ref id="R80"><mixed-citation publication-type="journal"><name><surname>Frost</surname><given-names>HM</given-names></name> (<year>1966a</year>). <article-title>Bone dynamics in metabolic bone disease</article-title>. <source>J. Bone Jt. Surg</source>
<volume>48</volume>
<fpage>1192</fpage>&#x02013;<lpage>1203</lpage>. doi:<pub-id pub-id-type="doi">10.2106/00004623-196648060-00018</pub-id></mixed-citation></ref><ref id="R81"><mixed-citation publication-type="book"><name><surname>Frost</surname><given-names>HM</given-names></name> (<year>1966b</year>). <source>The bone dynamics in osteoporosis and osteomalacia</source>. <publisher-loc>Springfield, IL</publisher-loc>: <publisher-name>Charles C Thomas</publisher-name>.</mixed-citation></ref><ref id="R82"><mixed-citation publication-type="book"><name><surname>Frost</surname><given-names>HM</given-names></name> (<year>1973</year>). <source>Bone remodeling and its relationship to metabolic bone diseases orthopaedic lectures volume III</source>. <publisher-loc>Springfield, IL</publisher-loc>: <publisher-name>Charles C Thomas</publisher-name>.</mixed-citation></ref><ref id="R83"><mixed-citation publication-type="journal"><name><surname>Fu</surname><given-names>P-A</given-names></name>, <name><surname>Shen</surname><given-names>C-Y</given-names></name>, <name><surname>Yang</surname><given-names>S</given-names></name>, <name><surname>Lee</surname><given-names>C-H</given-names></name>, <name><surname>Chen</surname><given-names>H-W</given-names></name>, <name><surname>Lai</surname><given-names>EC-C</given-names></name>, <etal/> (<year>2023</year>). <article-title>Long-term use of denosumab and its association with skeletal-related events and osteonecrosis of the jaw</article-title>. <source>Sci. Rep</source>
<volume>13</volume>, <fpage>8403</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41598-023-35308-z</pub-id><pub-id pub-id-type="pmid">37225727</pub-id>
</mixed-citation></ref><ref id="R84"><mixed-citation publication-type="journal"><name><surname>Fuller</surname><given-names>K</given-names></name>, <name><surname>Wong</surname><given-names>B</given-names></name>, <name><surname>Fox</surname><given-names>S</given-names></name>, <name><surname>Choi</surname><given-names>Y</given-names></name>, and <name><surname>Chambers</surname><given-names>TJ</given-names></name> (<year>1998</year>). <article-title>TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts</article-title>. <source>J. Exp. Med</source>
<volume>188</volume>, <fpage>997</fpage>&#x02013;<lpage>1001</lpage>. doi:<pub-id pub-id-type="doi">10.1084/jem.188.5.997</pub-id><pub-id pub-id-type="pmid">9730902</pub-id>
</mixed-citation></ref><ref id="R85"><mixed-citation publication-type="journal"><name><surname>Furusawa</surname><given-names>Y</given-names></name>, <name><surname>Obata</surname><given-names>Y</given-names></name>, <name><surname>Fukuda</surname><given-names>S</given-names></name>, <name><surname>Endo</surname><given-names>TA</given-names></name>, <name><surname>Nakato</surname><given-names>G</given-names></name>, <name><surname>Takahashi</surname><given-names>D</given-names></name>, <etal/> (<year>2013</year>). <article-title>Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells</article-title>. <source>Nature</source>
<volume>504</volume>, <fpage>446</fpage>&#x02013;<lpage>450</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature12721</pub-id><pub-id pub-id-type="pmid">24226770</pub-id>
</mixed-citation></ref><ref id="R86"><mixed-citation publication-type="journal"><name><surname>Gao</surname><given-names>Y</given-names></name>, <name><surname>Patil</surname><given-names>S</given-names></name>, and <name><surname>Jia</surname><given-names>J</given-names></name> (<year>2021</year>). <article-title>The development of molecular biology of osteoporosis</article-title>. <source>Int. J. Mol. Sci</source>
<volume>22</volume>, <fpage>8182</fpage>. doi:<pub-id pub-id-type="doi">10.3390/ijms22158182</pub-id><pub-id pub-id-type="pmid">34360948</pub-id>
</mixed-citation></ref><ref id="R87"><mixed-citation publication-type="journal"><name><surname>Garz&#x000f3;n-Alvarado</surname><given-names>DA</given-names></name> (<year>2012</year>). <article-title>A mathematical model for describing the metastasis of cancer in bone tissue</article-title>. <source>Comput. Methods Biomech. Biomed. Engin</source>
<volume>15</volume>, <fpage>333</fpage>&#x02013;<lpage>346</lpage>. doi:<pub-id pub-id-type="doi">10.1080/10255842.2010.535522</pub-id></mixed-citation></ref><ref id="R88"><mixed-citation publication-type="journal"><name><surname>Gerhard</surname><given-names>FA</given-names></name>, <name><surname>Webster</surname><given-names>DJ</given-names></name>, <name><surname>van Lenthe</surname><given-names>G</given-names></name>, and <name><surname>M&#x000fc;ller</surname><given-names>R</given-names></name> (<year>2009</year>). <article-title>In silico biology of bone modelling and remodelling: adaptation</article-title>. <source>Philos. Trans. R. Soc. A</source>
<volume>367</volume>, <fpage>2011</fpage>&#x02013;<lpage>2030</lpage> doi:<pub-id pub-id-type="doi">10.1098/rsta.2008.0297</pub-id></mixed-citation></ref><ref id="R89"><mixed-citation publication-type="journal"><name><surname>Geris</surname><given-names>L</given-names></name>, <name><surname>Vander Sloten</surname><given-names>J</given-names></name>, and <name><surname>Van Oosterwyck</surname><given-names>H</given-names></name> (<year>2009</year>). <article-title><italic toggle="yes">In silico</italic> biology of bone modelling and remodelling: regeneration</article-title>. <source>Philos. Trans. R. Soc. A</source>
<volume>367</volume>, <fpage>2031</fpage>&#x02013;<lpage>2053</lpage> doi:<pub-id pub-id-type="doi">10.1098/rsta.2008.0293</pub-id></mixed-citation></ref><ref id="R90"><mixed-citation publication-type="journal"><name><surname>Ghosh</surname><given-names>S</given-names></name>, <name><surname>Whitley</surname><given-names>CS</given-names></name>, <name><surname>Haribabu</surname><given-names>B</given-names></name>, and <name><surname>Jala</surname><given-names>VR</given-names></name> (<year>2021</year>). <article-title>Regulation of intestinal barrier function by microbial metabolites</article-title>. <source>Cell. Mol. Gastroenterol. Hepatol</source>
<volume>11</volume>
<fpage>1463</fpage>&#x02013;<lpage>1482</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jcmgh.2021.02.007</pub-id><pub-id pub-id-type="pmid">33610769</pub-id>
</mixed-citation></ref><ref id="R91"><mixed-citation publication-type="journal"><name><surname>Gizard</surname><given-names>F</given-names></name>, <name><surname>Fernandez</surname><given-names>A</given-names></name>, and <name><surname>De Vadder</surname><given-names>F</given-names></name> (<year>2020</year>). <article-title>Interactions between gut microbiota and skeletal muscle</article-title>. <source>Nutr. Metab. Insights</source>
<volume>13</volume>, <comment>1178638820980490.</comment> doi:<pub-id pub-id-type="doi">10.1177/1178638820980490</pub-id></mixed-citation></ref><ref id="R92"><mixed-citation publication-type="journal"><name><surname>Gori</surname><given-names>F</given-names></name>, <name><surname>Hofbauer</surname><given-names>LC</given-names></name>, <name><surname>Dunstan</surname><given-names>CR</given-names></name>, <name><surname>Spelsberg</surname><given-names>TC</given-names></name>, <name><surname>Khosla</surname><given-names>S</given-names></name>, and <name><surname>Riggs</surname><given-names>BL</given-names></name> (<year>2000</year>). <article-title>The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated</article-title>. <source>Endocrinology</source>
<volume>141</volume>, <fpage>4768</fpage>&#x02013;<lpage>4776</lpage>. doi:<pub-id pub-id-type="doi">10.1210/endo.141.12.7840</pub-id><pub-id pub-id-type="pmid">11108292</pub-id>
</mixed-citation></ref><ref id="R93"><mixed-citation publication-type="journal"><name><surname>Graef</surname><given-names>JL</given-names></name>, <name><surname>Ouyang</surname><given-names>P</given-names></name>, <name><surname>Wang</surname><given-names>Y</given-names></name>, <name><surname>Rendina-Ruedy</surname><given-names>E</given-names></name>, <name><surname>Marlow</surname><given-names>D</given-names></name>, <name><surname>Lucas</surname><given-names>EA</given-names></name>, <etal/> (<year>2018a</year>). <article-title>Dried plum polyphenolic extract combined with vitamin k and potassium restores trabecular and cortical bone in osteopenic model of postmenopausal bone loss</article-title>. <source>J. Funct. Foods</source>
<volume>42</volume>, <fpage>262</fpage>&#x02013;<lpage>270</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jff.2017.12.057</pub-id><pub-id pub-id-type="pmid">30319713</pub-id>
</mixed-citation></ref><ref id="R94"><mixed-citation publication-type="journal"><name><surname>Graef</surname><given-names>JL</given-names></name>, <name><surname>Rendina-Ruedy</surname><given-names>E</given-names></name>, <name><surname>Crockett</surname><given-names>EK</given-names></name>, <name><surname>Ouyang</surname><given-names>P</given-names></name>, <name><surname>King</surname><given-names>JB</given-names></name>, <name><surname>Cichewicz</surname><given-names>RH</given-names></name>, <etal/> (<year>2018b</year>). <article-title>Select polyphenolic fractions from dried plum enhance osteoblast activity through BMP-2 signaling</article-title>. <source>J. Nutr. Biochem</source>
<volume>55</volume>, <fpage>59</fpage>&#x02013;<lpage>67</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jnutbio2017.09.014</pub-id><pub-id pub-id-type="pmid">29413490</pub-id>
</mixed-citation></ref><ref id="R95"><mixed-citation publication-type="journal"><name><surname>Graham</surname><given-names>JM</given-names></name>, <name><surname>Ayati</surname><given-names>BP</given-names></name>, <name><surname>Holstein</surname><given-names>SA</given-names></name>, and <name><surname>Martin</surname><given-names>JA</given-names></name> (<year>2013</year>). <article-title>The role of osteocytes in targeted bone remodeling: a mathematical model</article-title>. <source>PLoS ONE</source>
<volume>8</volume>, <fpage>e63884</fpage> doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0063884</pub-id><pub-id pub-id-type="pmid">23717504</pub-id>
</mixed-citation></ref><ref id="R96"><mixed-citation publication-type="journal"><name><surname>Graham</surname><given-names>JM</given-names></name>, <name><surname>Ayati</surname><given-names>BP</given-names></name>, <name><surname>Ramakrishnan</surname><given-names>PS</given-names></name>, and <name><surname>Martin</surname><given-names>JA</given-names></name> (<year>2012</year>). <article-title>Towards a new spatial representation of bone remodeling</article-title>. <source>Math. Biosci. Eng</source>
<volume>9</volume>, <fpage>281</fpage>&#x02013;<lpage>295</lpage>. doi:<pub-id pub-id-type="doi">10.3934/mbe.2012.9.28</pub-id><pub-id pub-id-type="pmid">22901065</pub-id>
</mixed-citation></ref><ref id="R97"><mixed-citation publication-type="journal"><name><surname>Guder</surname><given-names>C</given-names></name>, <name><surname>Gravius</surname><given-names>S</given-names></name>, <name><surname>Burger</surname><given-names>C</given-names></name>, <name><surname>Wirtz</surname><given-names>DC</given-names></name>, and <name><surname>Schildberg</surname><given-names>FA</given-names></name> (<year>2020</year>). <article-title>Osteoimmunology: a current update of the interplay between bone and the immune system</article-title>. <source>Front. Immunol</source>
<volume>11</volume>, <fpage>58</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fimmu.2020.00058</pub-id><pub-id pub-id-type="pmid">32082321</pub-id>
</mixed-citation></ref><ref id="R98"><mixed-citation publication-type="journal"><name><surname>Hao</surname><given-names>X</given-names></name>, <name><surname>Shang</surname><given-names>X</given-names></name>, <name><surname>Liu</surname><given-names>J</given-names></name>, <name><surname>Chi</surname><given-names>R</given-names></name>, <name><surname>Zhang</surname><given-names>J</given-names></name>, and <name><surname>Xu</surname><given-names>T</given-names></name> (<year>2021</year>). <article-title>The gut microbiota in osteoarthritis: where do we stand and what can we do?</article-title>
<source>Arthritis Res. Ther</source>
<volume>23</volume>, <fpage>42</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s13075-021-02427-9</pub-id><pub-id pub-id-type="pmid">33504365</pub-id>
</mixed-citation></ref><ref id="R99"><mixed-citation publication-type="journal"><name><surname>Hardy</surname><given-names>R</given-names></name>, <name><surname>Zhou</surname><given-names>H</given-names></name>, <name><surname>Seibel</surname><given-names>M</given-names></name>, and <name><surname>Cooper</surname><given-names>M</given-names></name> (<year>2018</year>). <article-title>Glucocorticoids and bone consequences of endogenous and exogenous excess and replacement therapy</article-title>. <source>Endocr. Rev</source>
<volume>39</volume>, <fpage>519</fpage>&#x02013;<lpage>548</lpage>. doi:<pub-id pub-id-type="doi">10.1210/er.2018-00097</pub-id><pub-id pub-id-type="pmid">29905835</pub-id>
</mixed-citation></ref><ref id="R100"><mixed-citation publication-type="journal"><name><surname>Hasegawa</surname><given-names>C</given-names></name>, and <name><surname>Duffull</surname><given-names>SB</given-names></name> (<year>2018</year>). <article-title>Automated scale reduction of nonlinear QSP models with an illustrative application to a bone biology system</article-title>. <source>CPT Pharmacometrics Syst. Pharmacol</source>
<volume>7</volume>, <fpage>562</fpage>&#x02013;<lpage>572</lpage>. doi:<pub-id pub-id-type="doi">10.1002/psp4.12324</pub-id><pub-id pub-id-type="pmid">30043496</pub-id>
</mixed-citation></ref><ref id="R101"><mixed-citation publication-type="journal"><name><surname>Haugeberg</surname><given-names>G</given-names></name>, <name><surname>Uhlig</surname><given-names>T</given-names></name>, <name><surname>Falch</surname><given-names>JA</given-names></name>, <name><surname>Halse</surname><given-names>JI</given-names></name>, and <name><surname>Kvien</surname><given-names>TK</given-names></name> (<year>2000</year>). <article-title>Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County rheumatoid arthritis register</article-title>. <source>Arthritis Rheum</source>. <volume>43</volume>, <fpage>522</fpage>&#x02013;<lpage>530</lpage>. doi:<pub-id pub-id-type="doi">10.1002/1529-0131(200003)43:3&#x0003c;522::AID-ANR7&#x0003e;3.0.CO;2-Y</pub-id><pub-id pub-id-type="pmid">10728744</pub-id>
</mixed-citation></ref><ref id="R102"><mixed-citation publication-type="journal"><name><surname>Hauser</surname><given-names>B</given-names></name>, <name><surname>Riches</surname><given-names>PL</given-names></name>, <name><surname>Wilson</surname><given-names>JF</given-names></name>, <name><surname>Horne</surname><given-names>AE</given-names></name>, and <name><surname>Ralston</surname><given-names>SH</given-names></name> (<year>2014</year>). <article-title>Prevalence and clinical prediction of osteoporosis in a contemporary cohort of patients with rheumatoid arthritis</article-title>. <source>Rheumatology</source>
<volume>53</volume>, <fpage>1759</fpage>&#x02013;<lpage>1766</lpage>. doi:<pub-id pub-id-type="doi">10.1093/rheumatology/keul62</pub-id><pub-id pub-id-type="pmid">24764264</pub-id>
</mixed-citation></ref><ref id="R103"><mixed-citation publication-type="journal"><name><surname>Henry</surname><given-names>DH</given-names></name>, <name><surname>Costa</surname><given-names>L</given-names></name>, <name><surname>Goldwasser</surname><given-names>F</given-names></name>, <name><surname>Hirsh</surname><given-names>V</given-names></name>, <name><surname>Hungria</surname><given-names>V</given-names></name>, <name><surname>Prausova</surname><given-names>J</given-names></name>, <etal/> (<year>2011</year>). <article-title>Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma</article-title>. <source>J. Clin. Oncol</source>
<volume>29</volume>, <fpage>1125</fpage>&#x02013;<lpage>1132</lpage>. doi:<pub-id pub-id-type="doi">10.1200/jco.2010.31.3304</pub-id><pub-id pub-id-type="pmid">21343556</pub-id>
</mixed-citation></ref><ref id="R104"><mixed-citation publication-type="journal"><name><surname>Hodis</surname><given-names>HN</given-names></name>, and <name><surname>Sarrel</surname><given-names>PM</given-names></name> (<year>2018</year>). <article-title>Menopausal hormone therapy and breast cancer: what is the evidence from randomized trials?</article-title>
<source>Climacteric</source>
<volume>21</volume>, <fpage>521</fpage>&#x02013;<lpage>528</lpage>. doi:<pub-id pub-id-type="doi">10.1080/13697137.2018.1514008</pub-id><pub-id pub-id-type="pmid">30296850</pub-id>
</mixed-citation></ref><ref id="R105"><mixed-citation publication-type="journal"><name><surname>Hodsman</surname><given-names>AB</given-names></name>, <name><surname>Bauer</surname><given-names>DC</given-names></name>, <name><surname>Dempster</surname><given-names>DW</given-names></name>, <name><surname>Dian</surname><given-names>L</given-names></name>, <name><surname>Hanley</surname><given-names>DA</given-names></name>, <name><surname>Harris</surname><given-names>ST</given-names></name>, <etal/> (<year>2005</year>). <article-title>Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use</article-title>. <source>Endocr. Rev</source>
<volume>26</volume>, <fpage>688</fpage>&#x02013;<lpage>703</lpage>. doi:<pub-id pub-id-type="doi">10.1210/er.2004-0006</pub-id><pub-id pub-id-type="pmid">15769903</pub-id>
</mixed-citation></ref><ref id="R106"><mixed-citation publication-type="journal"><name><surname>Horton</surname><given-names>JE</given-names></name>, <name><surname>Raisz</surname><given-names>LG</given-names></name>, <name><surname>Simmons</surname><given-names>HA</given-names></name>, <name><surname>Oppenheim</surname><given-names>JJ</given-names></name>, and <name><surname>Mergenhagen</surname><given-names>SE</given-names></name> (<year>1972</year>). <article-title>Bone resorbing activity in supernatant fluid from cultured human peripheral blood leukocytes</article-title>. <source>Science</source>
<volume>177</volume>, <fpage>793</fpage>&#x02013;<lpage>795</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.177.4051.793</pub-id><pub-id pub-id-type="pmid">5052733</pub-id>
</mixed-citation></ref><ref id="R107"><mixed-citation publication-type="journal"><name><surname>Hosseinkhani</surname><given-names>F</given-names></name>, <name><surname>Heinken</surname><given-names>A</given-names></name>, <name><surname>Thiele</surname><given-names>I</given-names></name>, <name><surname>Lindenburg</surname><given-names>PW</given-names></name>, <name><surname>Harms</surname><given-names>AC</given-names></name>, and <name><surname>Hankemeier</surname><given-names>T</given-names></name> (<year>2021</year>). <article-title>The contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases</article-title>. <source>Gut Microbes</source>
<volume>13</volume>, <fpage>1</fpage>&#x02013;<lpage>22</lpage>. doi:<pub-id pub-id-type="doi">10.1080/19490976.2021.1882927</pub-id></mixed-citation></ref><ref id="R108"><mixed-citation publication-type="journal"><name><surname>Houschyar</surname><given-names>KS</given-names></name>, <name><surname>Tapking</surname><given-names>C</given-names></name>, <name><surname>Borrelli</surname><given-names>MR</given-names></name>, <name><surname>Popp</surname><given-names>D</given-names></name>, <name><surname>Duscher</surname><given-names>D</given-names></name>, <name><surname>Maan</surname><given-names>ZN</given-names></name>, <etal/> (<year>2019</year>). <article-title>Wnt pathway in bone repair and regeneration - what do we know so far</article-title>. <source>Front. Cell Dev. Biol</source>
<volume>6</volume>, <fpage>170</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fcell.2018.00170</pub-id><pub-id pub-id-type="pmid">30666305</pub-id>
</mixed-citation></ref><ref id="R109"><mixed-citation publication-type="journal"><name><surname>Hu</surname><given-names>E-D</given-names></name>, <name><surname>Chen</surname><given-names>D-Z</given-names></name>, <name><surname>Wu</surname><given-names>J-L</given-names></name>, <name><surname>Lu</surname><given-names>F-B</given-names></name>, <name><surname>Chen</surname><given-names>L</given-names></name>, <name><surname>Zheng</surname><given-names>M-H</given-names></name>, <etal/> (<year>2018</year>). <article-title>High fiber dietary and sodium butyrate attenuate experimental autoimmune hepatitis through regulation of immune regulatory cells and intestinal barrier</article-title>. <source>Cell Immunol</source>. <volume>328</volume>, <fpage>24</fpage>&#x02013;<lpage>32</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cellimm.2018.03.003</pub-id><pub-id pub-id-type="pmid">29627063</pub-id>
</mixed-citation></ref><ref id="R110"><mixed-citation publication-type="journal"><name><surname>Idrees</surname><given-names>M</given-names></name>, and <name><surname>Sohail</surname><given-names>A</given-names></name> (<year>2020</year>). <article-title>A computational framework and sensitivity analysis for the hormonal treatment of bone</article-title>. <source>Clin. Biomech</source>
<volume>73</volume>, <fpage>9</fpage>&#x02013;<lpage>16</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.clinbiomech.2019.12.015</pub-id></mixed-citation></ref><ref id="R111"><mixed-citation publication-type="journal"><name><surname>Idrees</surname><given-names>M</given-names></name>, and <name><surname>Sohail</surname><given-names>A</given-names></name> (<year>2023</year>). <article-title>Optimizing the dynamics of bone turnover with genetic algorithm</article-title>. <source>Model. Earth Syst. Environ</source>
<volume>9</volume>, <fpage>1937</fpage>&#x02013;<lpage>1947</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s40808-022-01606-0</pub-id><pub-id pub-id-type="pmid">36465412</pub-id>
</mixed-citation></ref><ref id="R112"><mixed-citation publication-type="journal"><name><surname>Idrees</surname><given-names>M</given-names></name>, <name><surname>Sohail</surname><given-names>A</given-names></name>, and <name><surname>Javed</surname><given-names>S</given-names></name> (<year>2019</year>). <article-title>Forecasting the critical role of intermitten therapies for the control of bone resorption</article-title>. <source>Clin. Biomech</source>
<volume>68</volume>, <fpage>128</fpage>&#x02013;<lpage>136</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.clinbiomech.2019.04.023</pub-id></mixed-citation></ref><ref id="R113"><mixed-citation publication-type="journal"><name><surname>Iotsova</surname><given-names>V</given-names></name>, <name><surname>Caama&#x000f1;o</surname><given-names>J</given-names></name>, <name><surname>Loy</surname><given-names>J</given-names></name>, <name><surname>Yang</surname><given-names>Y</given-names></name>, <name><surname>Lewin</surname><given-names>A</given-names></name>, and <name><surname>Bravo</surname><given-names>R</given-names></name> (<year>1997</year>). <article-title>Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2</article-title>. <source>Nat. Med</source>
<volume>3</volume>
<fpage>1285</fpage>&#x02013;<lpage>1289</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nm1197-1285</pub-id><pub-id pub-id-type="pmid">9359707</pub-id>
</mixed-citation></ref><ref id="R114"><mixed-citation publication-type="journal"><name><surname>Islam</surname><given-names>MA</given-names></name>, <name><surname>Cook</surname><given-names>CV</given-names></name>, <name><surname>Smith</surname><given-names>BJ</given-names></name>, and <name><surname>Ford Versypt</surname><given-names>AN</given-names></name> (<year>2021</year>). <article-title>Mathematical modeling of the gut-bone axis and implications of butyrate treatment on osteoimmunology</article-title>. <source>Ind. Eng. Chem. Res</source>
<volume>60</volume>, <fpage>17814</fpage>&#x02013;<lpage>17825</lpage>. doi:<pub-id pub-id-type="doi">10.1021/acs.iecr.1c02949</pub-id><pub-id pub-id-type="pmid">34992331</pub-id>
</mixed-citation></ref><ref id="R115"><mixed-citation publication-type="journal"><name><surname>J&#x000e4;hn</surname><given-names>K</given-names></name>, <name><surname>Kelkar</surname><given-names>S</given-names></name>, <name><surname>Zhao</surname><given-names>H</given-names></name>, <name><surname>Xie</surname><given-names>Y</given-names></name>, <name><surname>Tiede-Lewis</surname><given-names>LM</given-names></name>, <name><surname>Dusevich</surname><given-names>V</given-names></name>, <etal/> (<year>2017</year>). <article-title>Osteocytes acidify their microenvironment in response to PTHrP <italic toggle="yes">in vitro</italic> and in lactating mice <italic toggle="yes">in vivo</italic></article-title>. <source>J. Bone Min. Res</source>
<volume>32</volume>, <fpage>1761</fpage>&#x02013;<lpage>1772</lpage>. doi:<pub-id pub-id-type="doi">10.1002/jbmr.3167</pub-id></mixed-citation></ref><ref id="R116"><mixed-citation publication-type="journal"><name><surname>Janssens</surname><given-names>K</given-names></name>, <name><surname>Ten Dijke</surname><given-names>P</given-names></name>, <name><surname>Janssens</surname><given-names>S</given-names></name>, and <name><surname>Van Hul</surname><given-names>W</given-names></name> (<year>2005</year>). <article-title>Transforming growth factor-beta1 to the bone</article-title>. <source>Endocr. Rev</source>
<volume>26</volume>, <fpage>743</fpage>&#x02013;<lpage>774</lpage>. doi:<pub-id pub-id-type="doi">10.1210/er.2004-0001</pub-id><pub-id pub-id-type="pmid">15901668</pub-id>
</mixed-citation></ref><ref id="R117"><mixed-citation publication-type="journal"><name><surname>Javed</surname><given-names>S</given-names></name>, <name><surname>Sohail</surname><given-names>A</given-names></name>, <name><surname>Asif</surname><given-names>A</given-names></name>, and <name><surname>Nutini</surname><given-names>A</given-names></name> (<year>2020</year>). <article-title>Biophysics and the nonlinea dynamics instigated by a special hormone</article-title>. <source>Prog. Biophys. Mol. Biol</source>
<volume>150</volume>, <fpage>62</fpage>&#x02013;<lpage>66</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.pbiomolbio.2019.05.005</pub-id><pub-id pub-id-type="pmid">31121190</pub-id>
</mixed-citation></ref><ref id="R118"><mixed-citation publication-type="journal"><name><surname>Javed</surname><given-names>S</given-names></name>, <name><surname>Sohail</surname><given-names>A</given-names></name>, and <name><surname>Nutini</surname><given-names>A</given-names></name> (<year>2018</year>). <article-title>Integrative modeling of drug therapy and the bone turnover</article-title>. <source>Clin. Biomech</source>
<volume>60</volume>, <fpage>141</fpage>&#x02013;<lpage>148</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.clinbiomech.2018.10.019</pub-id></mixed-citation></ref><ref id="R119"><mixed-citation publication-type="journal"><name><surname>Javed</surname><given-names>S</given-names></name>, <name><surname>Younas</surname><given-names>M</given-names></name>, <name><surname>Bhatti</surname><given-names>MY</given-names></name>, <name><surname>Sohail</surname><given-names>A</given-names></name>, and <name><surname>Sattar</surname><given-names>A</given-names></name> (<year>2019</year>). <article-title>Analytic approach to explore dynamical osteoporotic bone turnover</article-title>. <source>Adv. Differ. Equ</source>
<volume>2019</volume>, <fpage>61</fpage>.doi:<pub-id pub-id-type="doi">10.1186/s13662-019-1986-7</pub-id></mixed-citation></ref><ref id="R120"><mixed-citation publication-type="book"><name><surname>Jee</surname><given-names>WSS</given-names></name> (<year>2001</year>). &#x0201c;<part-title>Integrated bone tissue physiology: anatomy and physiology</part-title>,&#x0201d; in <source>Bone mechanics handbook</source>. Editor <name><surname>Cowin</surname><given-names>SC</given-names></name>
<edition>2nd edn.</edition> (<publisher-loc>Boca Raton, FL</publisher-loc>: <publisher-name>CRC Press</publisher-name>), <fpage>1</fpage>&#x02013;<lpage>68</lpage>.</mixed-citation></ref><ref id="R121"><mixed-citation publication-type="journal"><name><surname>Jerez</surname><given-names>S</given-names></name>, and <name><surname>Chen</surname><given-names>B</given-names></name> (<year>2015</year>). <article-title>Stability analysis of a Komarova type model for the interactions of osteoblast and osteoclast cells during bone remodeling</article-title>. <source>Math. Biosci</source>
<volume>264</volume>
<fpage>29</fpage>&#x02013;<lpage>37</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.mbs.2015.03.003</pub-id><pub-id pub-id-type="pmid">25784536</pub-id>
</mixed-citation></ref><ref id="R122"><mixed-citation publication-type="journal"><name><surname>Jerez</surname><given-names>S</given-names></name>, <name><surname>D&#x000ed;az-Infante</surname><given-names>S</given-names></name>, and <name><surname>Chen</surname><given-names>B</given-names></name> (<year>2018</year>). <article-title>Fluctuating periodic solutions and moment boundedness of a stochastic model for the bone remodeling process</article-title>. <source>Math. Biosci</source>
<volume>299</volume>, <fpage>153</fpage>&#x02013;<lpage>164</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.mbs.2018.03.006</pub-id><pub-id pub-id-type="pmid">29526549</pub-id>
</mixed-citation></ref><ref id="R123"><mixed-citation publication-type="journal"><name><surname>Ji</surname><given-names>B</given-names></name>, <name><surname>Chen</surname><given-names>J</given-names></name>, <name><surname>Zhen</surname><given-names>C</given-names></name>, <name><surname>Yang</surname><given-names>Q</given-names></name>, and <name><surname>Yu</surname><given-names>N</given-names></name> (<year>2020</year>). <article-title>Mathematical modelling of the role of Endo180 network in the development of metastatic bone disease in prostate cancer</article-title>. <source>Comput. Biol. Med</source>
<volume>117</volume>, <fpage>103619</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.compbiomed.2020.103619</pub-id><pub-id pub-id-type="pmid">32072971</pub-id>
</mixed-citation></ref><ref id="R124"><mixed-citation publication-type="journal"><name><surname>Ji</surname><given-names>B</given-names></name>, <name><surname>Genever</surname><given-names>PG</given-names></name>, <name><surname>Patton</surname><given-names>RJ</given-names></name>, and <name><surname>Fagan</surname><given-names>MJ</given-names></name> (<year>2014</year>). <article-title>Mathematical modelling of the pathogenesis of multiple myeloma-induced bone disease</article-title>. <source>Int. J. Numer. Method Biomed. Eng</source>
<volume>30</volume>, <fpage>1085</fpage>&#x02013;<lpage>1102</lpage>. doi:<pub-id pub-id-type="doi">10.1002/cnm.2645</pub-id><pub-id pub-id-type="pmid">24817420</pub-id>
</mixed-citation></ref><ref id="R125"><mixed-citation publication-type="journal"><name><surname>Ji</surname><given-names>B</given-names></name>, <name><surname>Genever</surname><given-names>PG</given-names></name>, <name><surname>Patton</surname><given-names>RJ</given-names></name>, <name><surname>Putra</surname><given-names>D</given-names></name>, and <name><surname>Fagan</surname><given-names>MJ</given-names></name> (<year>2012</year>). <article-title>A nove mathematical model of bone remodelling cycles for trabecular bone at the cellular level</article-title>. <source>Biomech. Model. Mechanobiol</source>
<volume>11</volume>, <fpage>973</fpage>&#x02013;<lpage>982</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s10237-011-0366-3</pub-id><pub-id pub-id-type="pmid">22218996</pub-id>
</mixed-citation></ref><ref id="R126"><mixed-citation publication-type="journal"><name><surname>Ji</surname><given-names>B</given-names></name>, <name><surname>Zhang</surname><given-names>Y</given-names></name>, <name><surname>Zhen</surname><given-names>C</given-names></name>, <name><surname>Fagan</surname><given-names>MJ</given-names></name>, and <name><surname>Yang</surname><given-names>Q</given-names></name> (<year>2019</year>). <article-title>Mathematical modelling of bone remodelling cycles including the NF&#x003ba;B signalling pathway</article-title>. <source>Comput. Biol. Med</source>
<volume>107</volume>, <fpage>257</fpage>&#x02013;<lpage>264</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.compbiomed.2019.03.003</pub-id><pub-id pub-id-type="pmid">30870702</pub-id>
</mixed-citation></ref><ref id="R127"><mixed-citation publication-type="journal"><name><surname>Jorg</surname><given-names>DJ</given-names></name>, <name><surname>Fuertinger</surname><given-names>DH</given-names></name>, <name><surname>Cherif</surname><given-names>A</given-names></name>, <name><surname>Bushinsky</surname><given-names>DA</given-names></name>, <name><surname>Mermelstein</surname><given-names>A</given-names></name>, <name><surname>Raimann</surname><given-names>JG</given-names></name>, <etal/> (<year>2022</year>). <article-title>Modeling osteoporosis to design and optimize pharmacologica therapies comprising multiple drug types</article-title>. <source>eLife</source>
<volume>11</volume>, <fpage>e76228</fpage>. doi:<pub-id pub-id-type="doi">10.7554/elife.76228</pub-id><pub-id pub-id-type="pmid">35942681</pub-id>
</mixed-citation></ref><ref id="R128"><mixed-citation publication-type="journal"><name><surname>Kameo</surname><given-names>Y</given-names></name>, <name><surname>Miya</surname><given-names>Y</given-names></name>, <name><surname>Hayashi</surname><given-names>M</given-names></name>, <name><surname>Nakashima</surname><given-names>T</given-names></name>, and <name><surname>Adachi</surname><given-names>T</given-names></name> (<year>2020</year>). <article-title><italic toggle="yes">In silico</italic> experiments of bone remodeling explore metabolic diseases and their drug treatment</article-title>. <source>Sci. Adv</source>
<volume>6</volume>, <fpage>eaax0938</fpage>. doi:<pub-id pub-id-type="doi">10.1126/sciadv.aax0938</pub-id><pub-id pub-id-type="pmid">32181336</pub-id>
</mixed-citation></ref><ref id="R129"><mixed-citation publication-type="journal"><name><surname>Keirns</surname><given-names>BH</given-names></name>, <name><surname>Lucas</surname><given-names>EA</given-names></name>, and <name><surname>Smith</surname><given-names>BJ</given-names></name> (<year>2020</year>). <article-title>Phytochemicals affect T helper 17 and T regulatory cells and gut integrity: implications on the gut-bone axis</article-title>. <source>Nutr. Res</source>
<volume>83</volume>, <fpage>30</fpage>&#x02013;<lpage>48</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.nutres.2020.08.006</pub-id><pub-id pub-id-type="pmid">33010588</pub-id>
</mixed-citation></ref><ref id="R130"><mixed-citation publication-type="journal"><name><surname>Kenkre</surname><given-names>JS</given-names></name>, and <name><surname>Bassett</surname><given-names>JHD</given-names></name> (<year>2018</year>). <article-title>The bone remodelling cycle</article-title>. <source>Ann. Clin. Biochem</source>
<volume>55</volume>, <fpage>308</fpage>&#x02013;<lpage>327</lpage>. doi:<pub-id pub-id-type="doi">10.1177/0004563218759371</pub-id><pub-id pub-id-type="pmid">29368538</pub-id>
</mixed-citation></ref><ref id="R131"><mixed-citation publication-type="journal"><name><surname>Khosla</surname><given-names>S</given-names></name>, <name><surname>Oursler</surname><given-names>MJ</given-names></name>, and <name><surname>Monroe</surname><given-names>DG</given-names></name> (<year>2012</year>). <article-title>Estrogen and the skeleton</article-title>. <source>Trends Endocrinol. Metab</source>
<volume>23</volume>, <fpage>576</fpage>&#x02013;<lpage>581</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.tem.2012.03.008</pub-id><pub-id pub-id-type="pmid">22595550</pub-id>
</mixed-citation></ref><ref id="R132"><mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>J-M</given-names></name>, <name><surname>Lin</surname><given-names>C</given-names></name>, <name><surname>Stavre</surname><given-names>Z</given-names></name>, <name><surname>Greenblatt</surname><given-names>MB</given-names></name>, and <name><surname>Shim</surname><given-names>J-H</given-names></name> (<year>2020</year>). <article-title>Osteoblast-osteoclast communication and bone homeostasis</article-title>. <source>Cells</source>
<volume>9</volume>, <fpage>2073</fpage>. doi:<pub-id pub-id-type="doi">10.3390/cells9092073</pub-id><pub-id pub-id-type="pmid">32927921</pub-id>
</mixed-citation></ref><ref id="R133"><mixed-citation publication-type="journal"><name><surname>Kitaura</surname><given-names>H</given-names></name>, <name><surname>Marahleh</surname><given-names>A</given-names></name>, <name><surname>Ohori</surname><given-names>F</given-names></name>, <name><surname>Noguchi</surname><given-names>T</given-names></name>, <name><surname>Shen</surname><given-names>W-R</given-names></name>, <name><surname>Qi</surname><given-names>J</given-names></name>, <etal/> (<year>2020</year>). <article-title>Osteocyte-related cytokines regulate osteoclast formation and bone resorption</article-title>. <source>Int. J. Mol. Sci</source>
<volume>21</volume>, <fpage>5169</fpage>. doi:<pub-id pub-id-type="doi">10.3390/ijms21145169</pub-id><pub-id pub-id-type="pmid">32708317</pub-id>
</mixed-citation></ref><ref id="R134"><mixed-citation publication-type="journal"><name><surname>Komarova</surname><given-names>SV</given-names></name> (<year>2005</year>). <article-title>Mathematical model of paracrine interactions between osteoclasts and osteoblasts predicts anabolic action of parathyroid hormone on bone</article-title>. <source>Endocrinology</source>
<volume>146</volume>, <fpage>3589</fpage>&#x02013;<lpage>3595</lpage>. doi:<pub-id pub-id-type="doi">10.1210/en.2004-1642</pub-id><pub-id pub-id-type="pmid">15860557</pub-id>
</mixed-citation></ref><ref id="R135"><mixed-citation publication-type="journal"><name><surname>Komarova</surname><given-names>SV</given-names></name>, <name><surname>Smith</surname><given-names>RJ</given-names></name>, <name><surname>Dixon</surname><given-names>SJ</given-names></name>, <name><surname>Sims</surname><given-names>SM</given-names></name>, and <name><surname>Wahl</surname><given-names>LM</given-names></name> (<year>2003</year>). <article-title>Mathematical model predicts a critical role for osteoclast autocrine regulation in the control of bone remodeling</article-title>. <source>Bone</source>
<volume>33</volume>, <fpage>206</fpage>&#x02013;<lpage>215</lpage>. doi:<pub-id pub-id-type="doi">10.1016/s8756-3282(03)00157-1</pub-id><pub-id pub-id-type="pmid">14499354</pub-id>
</mixed-citation></ref><ref id="R136"><mixed-citation publication-type="journal"><name><surname>Kotake</surname><given-names>S</given-names></name>, <name><surname>Udagawa</surname><given-names>N</given-names></name>, <name><surname>Takahashi</surname><given-names>N</given-names></name>, <name><surname>Matsuzaki</surname><given-names>K</given-names></name>, <name><surname>Itoh</surname><given-names>K</given-names></name>, <name><surname>Ishiyama</surname><given-names>S</given-names></name>, <etal/> (<year>1999</year>). <article-title>IL-17 in synovial fluids from patients with rheumatoid arthritis is a poten stimulator of osteoclastogenesis</article-title>. <source>J. Clin. Investig</source>
<volume>103</volume>, <fpage>1345</fpage>&#x02013;<lpage>1352</lpage>. doi:<pub-id pub-id-type="doi">10.1172/jci5703</pub-id><pub-id pub-id-type="pmid">10225978</pub-id>
</mixed-citation></ref><ref id="R137"><mixed-citation publication-type="journal"><name><surname>Kovats</surname><given-names>S</given-names></name> (<year>2015</year>). <article-title>Estrogen receptors regulate innate immune cells and signaling pathways</article-title>. <source>Cell. Immunol</source>
<volume>294</volume>, <fpage>63</fpage>&#x02013;<lpage>69</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cellimm.2015.01.018</pub-id><pub-id pub-id-type="pmid">25682174</pub-id>
</mixed-citation></ref><ref id="R138"><mixed-citation publication-type="journal"><name><surname>Kramer</surname><given-names>I</given-names></name>, <name><surname>Halleux</surname><given-names>C</given-names></name>, <name><surname>Keller</surname><given-names>H</given-names></name>, <name><surname>Pegurri</surname><given-names>M</given-names></name>, <name><surname>Gooi</surname><given-names>JH</given-names></name>, <name><surname>Weber</surname><given-names>PB</given-names></name>, <etal/> (<year>2010</year>). <article-title>Osteocyte wnt/beta-catenin signaling is required for normal bone homeostasis</article-title>. <source>Molec Cell. Biol</source>
<volume>30</volume>, <fpage>3071</fpage>&#x02013;<lpage>3085</lpage>. doi:<pub-id pub-id-type="doi">10.1128/MCB.01428-09</pub-id><pub-id pub-id-type="pmid">20404086</pub-id>
</mixed-citation></ref><ref id="R139"><mixed-citation publication-type="journal"><name><surname>Kroll</surname><given-names>M</given-names></name> (<year>2000</year>). <article-title>Parathyroid hormone temporal effects on bone formation and resorption</article-title>. <source>Bull. Math. Biol</source>
<volume>62</volume>, <fpage>163</fpage>&#x02013;<lpage>188</lpage>. doi:<pub-id pub-id-type="doi">10.1006/bulm.1999.0146</pub-id><pub-id pub-id-type="pmid">10824426</pub-id>
</mixed-citation></ref><ref id="R140"><mixed-citation publication-type="journal"><name><surname>Larcher</surname><given-names>I</given-names></name>, and <name><surname>Scheiner</surname><given-names>S</given-names></name> (<year>2021</year>). <article-title>Parameter reduction, sensitivity studies, and correlation analyses applied to a mechanobiologically regulated bone cell population model of the bone metabolism</article-title>. <source>Comput. Biol. Med</source>
<volume>136</volume>, <fpage>104717</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.compbiomed.2021.104717</pub-id><pub-id pub-id-type="pmid">34426166</pub-id>
</mixed-citation></ref><ref id="R141"><mixed-citation publication-type="journal"><name><surname>Lavaill</surname><given-names>M</given-names></name>, <name><surname>Trichilo</surname><given-names>S</given-names></name>, <name><surname>Scheiner</surname><given-names>S</given-names></name>, <name><surname>Forwood</surname><given-names>MR</given-names></name>, <name><surname>Cooper</surname><given-names>DML</given-names></name>, and <name><surname>Pivonka</surname><given-names>P</given-names></name> (<year>2020</year>). <article-title>Study of the combined effects of PTH treatment and mechanical loading in postmenopausal osteoporosis using a new mechanistic PK-PD model</article-title>. <source>Biomech. Model. Mechanobiol</source>
<volume>19</volume>, <fpage>1765</fpage>&#x02013;<lpage>1780</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s10237-020-01307-6</pub-id><pub-id pub-id-type="pmid">32100180</pub-id>
</mixed-citation></ref><ref id="R142"><mixed-citation publication-type="journal"><name><surname>Ledoux</surname><given-names>C</given-names></name>, <name><surname>Boaretti</surname><given-names>D</given-names></name>, <name><surname>Sachan</surname><given-names>A</given-names></name>, <name><surname>M&#x000fc;ller</surname><given-names>R</given-names></name>, and <name><surname>Collins</surname><given-names>CJ</given-names></name> (<year>2022</year>). <article-title>Clinical data for parametrization of in silico bone models incorporating cell-cytokine dynamics: a systematic review of literature</article-title>. <source>Front. Bioeng. Biotechnol</source>
<volume>10</volume>, <fpage>901720</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fbioe.2022.901720</pub-id><pub-id pub-id-type="pmid">35910035</pub-id>
</mixed-citation></ref><ref id="R143"><mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>W-H</given-names></name>, and <name><surname>Okos</surname><given-names>MR</given-names></name> (<year>2016</year>). <article-title>Model-based analysis of IGF-1 effect on osteoblast and osteoclast regulation in bone turnover</article-title>. <source>J. Biol. Syst</source>
<volume>24</volume>, <fpage>63</fpage>&#x02013;<lpage>89</lpage>. doi:<pub-id pub-id-type="doi">10.1142/s0218339016500042</pub-id></mixed-citation></ref><ref id="R144"><mixed-citation publication-type="journal"><name><surname>Legette</surname><given-names>LL</given-names></name>, <name><surname>Lee</surname><given-names>W</given-names></name>, <name><surname>Martin</surname><given-names>BR</given-names></name>, <name><surname>Story</surname><given-names>JA</given-names></name>, <name><surname>Campbell</surname><given-names>JK</given-names></name>, and <name><surname>Weaver</surname><given-names>CM</given-names></name> (<year>2012</year>). <article-title>Prebiotics enhance magnesium absorption and inulin-based fibers exert chronic effects on calcium utilization in a postmenopausal rodent model</article-title>. <source>J. Food Sci</source>
<volume>77</volume>, <fpage>H88</fpage>&#x02013;<lpage>H94</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1750-3841.2011.02612.x</pub-id><pub-id pub-id-type="pmid">22394255</pub-id>
</mixed-citation></ref><ref id="R145"><mixed-citation publication-type="journal"><name><surname>Lehmann</surname><given-names>J</given-names></name>, <name><surname>Thiele</surname><given-names>S</given-names></name>, <name><surname>Baschant</surname><given-names>U</given-names></name>, <name><surname>Rachner</surname><given-names>TD</given-names></name>, <name><surname>Niehrs</surname><given-names>C</given-names></name>, <name><surname>Hofbauer</surname><given-names>LC</given-names></name>, <etal/> (<year>2021</year>). <article-title>Mice lacking DKK1 in T cells exhibit high bone mass and are protected from estrogen-deficiency-induced bone loss</article-title>. <source>iScience</source>
<volume>24</volume>, <fpage>102224</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.isci.2021.102224</pub-id><pub-id pub-id-type="pmid">33748710</pub-id>
</mixed-citation></ref><ref id="R146"><mixed-citation publication-type="journal"><name><surname>Lemaire</surname><given-names>V</given-names></name>, and <name><surname>Cox</surname><given-names>DR</given-names></name> (<year>2019</year>). <article-title>Dynamics of bone cell interactions and differential responses to PTH and antibody-based therapies</article-title>. <source>Bull. Math. Biol</source>
<volume>81</volume>, <fpage>3575</fpage>&#x02013;<lpage>3622</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11538-018-0533-0</pub-id><pub-id pub-id-type="pmid">30460589</pub-id>
</mixed-citation></ref><ref id="R147"><mixed-citation publication-type="journal"><name><surname>Lemaire</surname><given-names>V</given-names></name>, <name><surname>Tobin</surname><given-names>FL</given-names></name>, <name><surname>Greller</surname><given-names>LD</given-names></name>, <name><surname>Cho</surname><given-names>CR</given-names></name>, and <name><surname>Suva</surname><given-names>LJ</given-names></name> (<year>2004</year>). <article-title>Modeling the interactions between osteoblast and osteoclast activities in bone remodeling</article-title>. <source>J. Theor Biol</source>
<volume>229</volume>, <fpage>293</fpage>&#x02013;<lpage>309</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jtbi.2004.03.023</pub-id><pub-id pub-id-type="pmid">15234198</pub-id>
</mixed-citation></ref><ref id="R148"><mixed-citation publication-type="journal"><name><surname>Lerebours</surname><given-names>C</given-names></name>, <name><surname>Buenzli</surname><given-names>PR</given-names></name>, <name><surname>Scheiner</surname><given-names>S</given-names></name>, and <name><surname>Pivonka</surname><given-names>P</given-names></name> (<year>2016</year>). <article-title>A multiscale mechanobiological model of bone remodelling predicts site-specific bone loss in the femur during osteoporosis and mechanical disuse</article-title>. <source>Biomech. Model. Mechanobiol</source>
<volume>15</volume>, <fpage>43</fpage>&#x02013;<lpage>67</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s10237-015-0705-x</pub-id><pub-id pub-id-type="pmid">26239380</pub-id>
</mixed-citation></ref><ref id="R149"><mixed-citation publication-type="journal"><name><surname>Lerner</surname><given-names>UH</given-names></name> (<year>2006</year>). <article-title>Bone remodeling in post-menopausal osteoporosis</article-title>. <source>J. Dent. Res</source>
<volume>85</volume>, <fpage>584</fpage>&#x02013;<lpage>595</lpage>. doi:<pub-id pub-id-type="doi">10.1177/154405910608500703</pub-id><pub-id pub-id-type="pmid">16798857</pub-id>
</mixed-citation></ref><ref id="R150"><mixed-citation publication-type="journal"><name><surname>Lerner</surname><given-names>UH</given-names></name>, and <name><surname>Ohlsson</surname><given-names>C</given-names></name> (<year>2015</year>). <article-title>The WNT system: background and its role in bone</article-title>. <source>J. Intern. Med</source>
<volume>277</volume>, <fpage>630</fpage>&#x02013;<lpage>649</lpage>. doi:<pub-id pub-id-type="doi">10.1111/joim.12368</pub-id><pub-id pub-id-type="pmid">25845559</pub-id>
</mixed-citation></ref><ref id="R151"><mixed-citation publication-type="journal"><name><surname>Levin</surname><given-names>VA</given-names></name>, <name><surname>Jiang</surname><given-names>X</given-names></name>, and <name><surname>Kagan</surname><given-names>R</given-names></name> (<year>2018</year>). <article-title>Estrogen therapy for osteoporosis in the modern era</article-title>. <source>Osteoporos. Int</source>
<volume>29</volume>, <fpage>1049</fpage>&#x02013;<lpage>1055</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00198-018-4414-z</pub-id><pub-id pub-id-type="pmid">29520604</pub-id>
</mixed-citation></ref><ref id="R152"><mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>J-Y</given-names></name>, <name><surname>Chassaing</surname><given-names>B</given-names></name>, <name><surname>Tyagi</surname><given-names>AM</given-names></name>, <name><surname>Vaccaro</surname><given-names>C</given-names></name>, <name><surname>Luo</surname><given-names>T</given-names></name>, <name><surname>Adams</surname><given-names>J</given-names></name>, <etal/> (<year>2016</year>). <article-title>Sex steroid deficiency-associated bone loss is microbiota dependent and prevented b probiotics</article-title>. <source>J. Clin. Invest</source>
<volume>126</volume>, <fpage>2049</fpage>&#x02013;<lpage>2063</lpage>. doi:<pub-id pub-id-type="doi">10.1172/jci86062</pub-id><pub-id pub-id-type="pmid">27111232</pub-id>
</mixed-citation></ref><ref id="R153"><mixed-citation publication-type="journal"><name><surname>Li&#x000f2;</surname><given-names>P</given-names></name>, <name><surname>Paoletti</surname><given-names>N</given-names></name>, <name><surname>Moni</surname><given-names>MA</given-names></name>, <name><surname>Atwell</surname><given-names>K</given-names></name>, <name><surname>Merelli</surname><given-names>E</given-names></name>, and <name><surname>Viceconti</surname><given-names>M</given-names></name> (<year>2012</year>). <article-title>Modelling osteomyelitis</article-title>. <source>BMC Bioinf</source>
<volume>13</volume>, <fpage>S12</fpage>. doi:<pub-id pub-id-type="doi">10.1186/1471-2105-13-s14-s12</pub-id></mixed-citation></ref><ref id="R154"><mixed-citation publication-type="journal"><name><surname>Llorente</surname><given-names>I</given-names></name>, <name><surname>Garc&#x000ed;a-Casta&#x000f1;eda</surname><given-names>N</given-names></name>, <name><surname>Valero</surname><given-names>C</given-names></name>, <name><surname>Gonz&#x000e1;lez-&#x000c1;lvaro</surname><given-names>I</given-names></name>, and <name><surname>Casta&#x000f1;eda</surname><given-names>S</given-names></name> (<year>2020</year>). <article-title>Osteoporosis in rheumatoid arthritis: dangerous liaisons</article-title>. <source>Front. Med</source>
<volume>7</volume>, <fpage>601618</fpage> doi:<pub-id pub-id-type="doi">10.3389/fmed.2020.601618</pub-id></mixed-citation></ref><ref id="R155"><mixed-citation publication-type="journal"><name><surname>Lu</surname><given-names>L</given-names></name>, <name><surname>Chen</surname><given-names>X</given-names></name>, <name><surname>Liu</surname><given-names>Y</given-names></name>, and <name><surname>Yu</surname><given-names>X</given-names></name> (<year>2021</year>). <article-title>Gut microbiota and bone metabolism</article-title>. <source>FASEB J</source>. <volume>35</volume>, <fpage>e21740</fpage>. doi:<pub-id pub-id-type="doi">10.1096/fj.202100451r</pub-id><pub-id pub-id-type="pmid">34143911</pub-id>
</mixed-citation></ref><ref id="R156"><mixed-citation publication-type="journal"><name><surname>Maeda</surname><given-names>K</given-names></name>, <name><surname>Kobayashi</surname><given-names>Y</given-names></name>, <name><surname>Koide</surname><given-names>M</given-names></name>, <name><surname>Uehara</surname><given-names>S</given-names></name>, <name><surname>Okamoto</surname><given-names>M</given-names></name>, <name><surname>Ishihara</surname><given-names>A</given-names></name>, <etal/> (<year>2019</year>). <article-title>The regulation of bone metabolism and disorders by Wnt signaling</article-title>. <source>Int. J. Mol. Sci</source>
<volume>20</volume>, <fpage>5525</fpage>. doi:<pub-id pub-id-type="doi">10.3390/ijms20225525</pub-id><pub-id pub-id-type="pmid">31698687</pub-id>
</mixed-citation></ref><ref id="R157"><mixed-citation publication-type="journal"><name><surname>Manson</surname><given-names>JE</given-names></name>, <name><surname>Chlebowski</surname><given-names>RT</given-names></name>, <name><surname>Stefanick</surname><given-names>ML</given-names></name>, <name><surname>Aragaki</surname><given-names>AK</given-names></name>, <name><surname>Rossouw</surname><given-names>JE</given-names></name>, <name><surname>Prentice</surname><given-names>RL</given-names></name>, <etal/> (<year>2013</year>). <article-title>Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women&#x02019;s Health Initiative randomized trials</article-title>. <source>JAMA</source>
<volume>310</volume>, <fpage>1353</fpage>&#x02013;<lpage>1368</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jama.2013.278040</pub-id><pub-id pub-id-type="pmid">24084921</pub-id>
</mixed-citation></ref><ref id="R158"><mixed-citation publication-type="journal"><name><surname>Marathe</surname><given-names>A</given-names></name>, <name><surname>Peterson</surname><given-names>MC</given-names></name>, and <name><surname>Mager</surname><given-names>DE</given-names></name> (<year>2008</year>). <article-title>Integrated cellular bone homeostasis model for denosumab pharmacodynamics in multiple myeloma patients</article-title>. <source>J. Pharmacol. Exp. Ther</source>
<volume>326</volume>, <fpage>555</fpage>&#x02013;<lpage>562</lpage>. doi:<pub-id pub-id-type="doi">10.1124/jpet.108.137703</pub-id><pub-id pub-id-type="pmid">18460643</pub-id>
</mixed-citation></ref><ref id="R159"><mixed-citation publication-type="journal"><name><surname>Marathe</surname><given-names>DD</given-names></name>, <name><surname>Marathe</surname><given-names>A</given-names></name>, and <name><surname>Mager</surname><given-names>DE</given-names></name> (<year>2011</year>). <article-title>Integrated model for denosumab and ibandronate pharmacodynamics in postmenopausal women</article-title>. <source>Biopharm. Drug Dispos</source>
<volume>32</volume>, <fpage>471</fpage>&#x02013;<lpage>481</lpage>. doi:<pub-id pub-id-type="doi">10.1002/bdd.770</pub-id><pub-id pub-id-type="pmid">21953540</pub-id>
</mixed-citation></ref><ref id="R160"><mixed-citation publication-type="journal"><name><surname>Martin</surname><given-names>M</given-names></name>, <name><surname>Sansalone</surname><given-names>V</given-names></name>, <name><surname>Cooper</surname><given-names>DML</given-names></name>, <name><surname>Forwood</surname><given-names>MR</given-names></name>, and <name><surname>Pivonka</surname><given-names>P</given-names></name> (<year>2019</year>). <article-title>Mechanobiological osteocyte feedback drives mechanostat regulation of bone in multiscale computational model</article-title>. <source>Biomech. Model. Mechanobiol</source>
<volume>18</volume>, <fpage>1475</fpage>&#x02013;<lpage>1496</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s10237-019-01158-w</pub-id><pub-id pub-id-type="pmid">31087221</pub-id>
</mixed-citation></ref><ref id="R161"><mixed-citation publication-type="journal"><name><surname>Martin</surname><given-names>M</given-names></name>, <name><surname>Sansalone</surname><given-names>V</given-names></name>, <name><surname>Cooper</surname><given-names>DML</given-names></name>, <name><surname>Forwood</surname><given-names>MR</given-names></name>, and <name><surname>Pivonka</surname><given-names>P</given-names></name> (<year>2020</year>) <article-title>Assessment of romosozumab efficacy in the treatment of postmenopausal osteoporosis: results from a mechanistic PK-PD mechanostat model of bone remodeling</article-title>. <source>Bone</source>
<volume>133</volume>
<fpage>115223</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bone.2020.115223</pub-id><pub-id pub-id-type="pmid">31935526</pub-id>
</mixed-citation></ref><ref id="R162"><mixed-citation publication-type="journal"><name><surname>Martin</surname><given-names>MJ</given-names></name>, and <name><surname>Buckland-Wright</surname><given-names>JC</given-names></name> (<year>2004</year>). <article-title>Sensitivity analysis of a novel mathematical model identifies factors determining bone resorption rates</article-title>. <source>Bone</source>
<volume>35</volume>
<fpage>918</fpage>&#x02013;<lpage>928</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bone.2004.06.010</pub-id><pub-id pub-id-type="pmid">15454099</pub-id>
</mixed-citation></ref><ref id="R163"><mixed-citation publication-type="book"><name><surname>Martin</surname><given-names>TJ</given-names></name>, and <name><surname>Rodan</surname><given-names>GA</given-names></name> (<year>2009</year>). &#x0201c;<part-title>Intercellular communication during bone remodeling</part-title>,&#x0201d; in <source>Fundamentals of osteoporosis</source>. Editors <name><surname>Feldman</surname><given-names>D</given-names></name>, <name><surname>Nelson</surname><given-names>D</given-names></name>, and <name><surname>Rosen</surname><given-names>CJ</given-names></name>
<edition>1st edn</edition> (<publisher-loc>Burlington</publisher-loc>: <publisher-name>Elsevier</publisher-name>), <fpage>509</fpage>&#x02013;<lpage>522</lpage>. doi:<pub-id pub-id-type="doi">10.1016/b978-0-12-375098-3.50021-4</pub-id></mixed-citation></ref><ref id="R164"><mixed-citation publication-type="journal"><name><surname>Mart&#x000ed;nez-Reina</surname><given-names>J</given-names></name>, and <name><surname>Pivonka</surname><given-names>P</given-names></name> (<year>2019</year>). <article-title>Effects of long-term treatment of denosumab on bone mineral density: insights from an in-silico model of bone mineralization</article-title>. <source>Bone</source>
<volume>125</volume>, <fpage>87</fpage>&#x02013;<lpage>95</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bone.2019.04.022</pub-id><pub-id pub-id-type="pmid">31055117</pub-id>
</mixed-citation></ref><ref id="R165"><mixed-citation publication-type="journal"><name><surname>Matatall</surname><given-names>KA</given-names></name>, <name><surname>Jeong</surname><given-names>M</given-names></name>, <name><surname>Chen</surname><given-names>S</given-names></name>, <name><surname>Sun</surname><given-names>D</given-names></name>, <name><surname>Chen</surname><given-names>F</given-names></name>, <name><surname>Mo</surname><given-names>Q</given-names></name>, <etal/> (<year>2016</year>). <article-title>Chronic infection depletes hematopoietic stem cells through stress-induced termina differentiation</article-title>. <source>Cell Rep</source>. <volume>17</volume>, <fpage>2584</fpage>&#x02013;<lpage>2595</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.celrep.2016.11.031</pub-id><pub-id pub-id-type="pmid">27926863</pub-id>
</mixed-citation></ref><ref id="R166"><mixed-citation publication-type="journal"><name><surname>Matsumoto</surname><given-names>T</given-names></name>, and <name><surname>Abe</surname><given-names>M</given-names></name> (<year>2011</year>). <article-title>TGF-&#x003b2;-related mechanisms of bone destruction in multiple myeloma</article-title>. <source>Bone</source>
<volume>48</volume>, <fpage>129</fpage>&#x02013;<lpage>134</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bone.2010.05.036</pub-id><pub-id pub-id-type="pmid">20570621</pub-id>
</mixed-citation></ref><ref id="R167"><mixed-citation publication-type="journal"><name><surname>Messora</surname><given-names>MR</given-names></name>, <name><surname>Oliveira</surname><given-names>LF</given-names></name>, <name><surname>Foureaux</surname><given-names>RC</given-names></name>, <name><surname>Taba</surname><given-names>JM</given-names></name>, <name><surname>Zanger&#x000f4;nimo</surname><given-names>MG</given-names></name>, <name><surname>Furlaneto</surname><given-names>FA</given-names></name>, <etal/> (<year>2013</year>). <article-title>Probiotic therapy reduces periodontal tissue destruction and improves the intestinal morphology in rats with ligature-induced periodontitis</article-title>. <source>J. Periodontol</source>
<volume>84</volume>, <fpage>1818</fpage>&#x02013;<lpage>1826</lpage>. doi:<pub-id pub-id-type="doi">10.1902/jop.2013.120644</pub-id><pub-id pub-id-type="pmid">23327675</pub-id>
</mixed-citation></ref><ref id="R168"><mixed-citation publication-type="journal"><name><surname>Miranda</surname><given-names>R</given-names></name>, <name><surname>Vinga</surname><given-names>S</given-names></name>, and <name><surname>Val&#x000e9;rio</surname><given-names>D</given-names></name> (<year>2020</year>). <article-title>Studying bone remodelling and tumour growth for therapy predictive control</article-title>. <source>Mathematics</source>
<volume>8</volume>, <fpage>679</fpage>. doi:<pub-id pub-id-type="doi">10.3390/math8050679</pub-id></mixed-citation></ref><ref id="R169"><mixed-citation publication-type="journal"><name><surname>Moroz</surname><given-names>A</given-names></name>, <name><surname>Crane</surname><given-names>MC</given-names></name>, <name><surname>Smith</surname><given-names>G</given-names></name>, and <name><surname>Wimpenny</surname><given-names>DI</given-names></name> (<year>2006</year>). <article-title>Phenomenological model of bone remodeling cycle containing osteocyte regulation loop</article-title>. <source>Biosystems</source>
<volume>84</volume>
<fpage>183</fpage>&#x02013;<lpage>190</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.biosystems.2005.11.002</pub-id><pub-id pub-id-type="pmid">16387419</pub-id>
</mixed-citation></ref><ref id="R170"><mixed-citation publication-type="journal"><name><surname>Moroz</surname><given-names>A</given-names></name>, and <name><surname>Wimpenny</surname><given-names>DI</given-names></name> (<year>2007</year>). <article-title>Allosteric control model of bone remodelling containing periodical modes</article-title>. <source>Biophys. Chem</source>
<volume>127</volume>, <fpage>194</fpage>&#x02013;<lpage>212</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bpc.200702.001</pub-id><pub-id pub-id-type="pmid">17321664</pub-id>
</mixed-citation></ref><ref id="R171"><mixed-citation publication-type="journal"><name><surname>Naito</surname><given-names>A</given-names></name>, <name><surname>Azuma</surname><given-names>S</given-names></name>, <name><surname>Tanaka</surname><given-names>S</given-names></name>, <name><surname>Miyazaki</surname><given-names>T</given-names></name>, <name><surname>Takaki</surname><given-names>S</given-names></name>, <name><surname>Takatsu</surname><given-names>K</given-names></name>, <etal/> (<year>1999</year>). <article-title>Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice</article-title>. <source>Genes cells</source>. <volume>4</volume>, <fpage>353</fpage>&#x02013;<lpage>362</lpage>. doi:<pub-id pub-id-type="doi">10.1046/j.1365-2443.1999.00265.x</pub-id><pub-id pub-id-type="pmid">10421844</pub-id>
</mixed-citation></ref><ref id="R172"><mixed-citation publication-type="journal"><name><surname>Noirrit-Esclassan</surname><given-names>E</given-names></name>, <name><surname>Valera</surname><given-names>M-C</given-names></name>, <name><surname>Tremollieres</surname><given-names>F</given-names></name>, <name><surname>Arnal</surname><given-names>J-F</given-names></name>, <name><surname>Lenfant</surname><given-names>F</given-names></name>, <name><surname>Fontaine</surname><given-names>C</given-names></name>, <etal/> (<year>2021</year>). <article-title>Critical role of estrogens on bone homeostasis in both male and female: from physiology to medical implications</article-title>. <source>Int. J. Mol. Sci</source>
<volume>22</volume>, <fpage>1568</fpage> doi:<pub-id pub-id-type="doi">10.3390/ijms22041568</pub-id><pub-id pub-id-type="pmid">33557249</pub-id>
</mixed-citation></ref><ref id="R173"><mixed-citation publication-type="journal"><name><surname>Nudy</surname><given-names>M</given-names></name>, <name><surname>Buerger</surname><given-names>J</given-names></name>, <name><surname>Dreibelbis</surname><given-names>S</given-names></name>, <name><surname>Jiang</surname><given-names>X</given-names></name>, <name><surname>Hodis</surname><given-names>HN</given-names></name>, and <name><surname>Schnatz</surname><given-names>PF</given-names></name> (<year>2023</year>) <article-title>Menopausal hormone therapy and coronary heart disease: the roller-coaster history</article-title>. <source>Climacteric</source>
<volume>27</volume>, <fpage>81</fpage>&#x02013;<lpage>88</lpage>. doi:<pub-id pub-id-type="doi">10.1080/13697137.2023.2282690</pub-id></mixed-citation></ref><ref id="R174"><mixed-citation publication-type="journal"><name><surname>Nutini</surname><given-names>A</given-names></name>, <name><surname>Sohail</surname><given-names>A</given-names></name>, and <name><surname>Farwa</surname><given-names>S</given-names></name> (<year>2021</year>). <article-title>Biomedical engineering of sclerostin action in the bone remodeling</article-title>. <source>Biomed. Eng. Appl. Basis Commun</source>
<volume>33</volume>, <fpage>2150016</fpage>. doi:<pub-id pub-id-type="doi">10.4015/s1016237221500162</pub-id></mixed-citation></ref><ref id="R175"><mixed-citation publication-type="journal"><name><surname>Ohlsson</surname><given-names>C</given-names></name>, <name><surname>Engdahl</surname><given-names>C</given-names></name>, <name><surname>F&#x000e5;k</surname><given-names>F</given-names></name>, <name><surname>Andersson</surname><given-names>A</given-names></name>, <name><surname>Windahl</surname><given-names>SH</given-names></name>, <name><surname>Farman</surname><given-names>HH</given-names></name>, <etal/> (<year>2014</year>). <article-title>Probiotics protect mice from ovariectomy-induced cortical bone loss</article-title>. <source>PLoS One</source>
<volume>9</volume>, <fpage>e92368</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0092368</pub-id><pub-id pub-id-type="pmid">24637895</pub-id>
</mixed-citation></ref><ref id="R176"><mixed-citation publication-type="journal"><name><surname>Ojo</surname><given-names>B</given-names></name>, <name><surname>El-Rassi</surname><given-names>GD</given-names></name>, <name><surname>Payton</surname><given-names>ME</given-names></name>, <name><surname>Perkins-Veazie</surname><given-names>P</given-names></name>, <name><surname>Clarke</surname><given-names>S</given-names></name>, <name><surname>Smith</surname><given-names>BJ</given-names></name>, <etal/> (<year>2016</year>). <article-title>Mango supplementation modulates gut microbial dysbiosis and short-chain fatty acid production independent of body weight reduction in C57BL/6 mice fed a high-fat diet</article-title>. <source>J. Nutr</source>
<volume>146</volume>, <fpage>1483</fpage>&#x02013;<lpage>1491</lpage>. doi:<pub-id pub-id-type="doi">10.3945/jn.115.226688</pub-id><pub-id pub-id-type="pmid">27358411</pub-id>
</mixed-citation></ref><ref id="R177"><mixed-citation publication-type="journal"><name><surname>Ojo</surname><given-names>BA</given-names></name>, <name><surname>Lu</surname><given-names>P</given-names></name>, <name><surname>Alake</surname><given-names>SE</given-names></name>, <name><surname>Keirns</surname><given-names>B</given-names></name>, <name><surname>Anderson</surname><given-names>K</given-names></name>, <name><surname>Gallucci</surname><given-names>G</given-names></name>, <etal/> (<year>2021</year>). <article-title>Pinto beans modulate the gut microbiome, augment MHC II protein, and antimicrobial peptide gene expression in mice fed a normal or western-style diet</article-title>. <source>J. Nutr. Biochem</source>
<volume>88</volume>, <fpage>108543</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jnutbio.2020.108543</pub-id><pub-id pub-id-type="pmid">33144228</pub-id>
</mixed-citation></ref><ref id="R178"><mixed-citation publication-type="journal"><name><surname>Ojo</surname><given-names>BA</given-names></name>, <name><surname>O&#x02019;Hara</surname><given-names>C</given-names></name>, <name><surname>Wu</surname><given-names>L</given-names></name>, <name><surname>El-Rassi</surname><given-names>GD</given-names></name>, <name><surname>Ritchey</surname><given-names>JW</given-names></name>, <name><surname>Chowanadisai</surname><given-names>W</given-names></name>, <etal/> (<year>2019</year>). <article-title>Wheat germ supplementation increases lactobacillaceae and promotes an anti-inflammatory gut milieu in C57bl/6 mice fed a high-fat, high-sucrose diet</article-title>. <source>J. Nutr</source>
<volume>149</volume>, <fpage>1107</fpage>&#x02013;<lpage>1115</lpage>. doi:<pub-id pub-id-type="doi">10.1093/jn/nxz061</pub-id><pub-id pub-id-type="pmid">31162575</pub-id>
</mixed-citation></ref><ref id="R179"><mixed-citation publication-type="journal"><name><surname>Okamoto</surname><given-names>K</given-names></name>, <name><surname>Nakashima</surname><given-names>T</given-names></name>, <name><surname>Shinohara</surname><given-names>M</given-names></name>, <name><surname>Negishi-Koga</surname><given-names>T</given-names></name>, <name><surname>Komatsu</surname><given-names>N</given-names></name>, <name><surname>Terashima</surname><given-names>A</given-names></name>, <etal/> (<year>2017</year>). <article-title>Osteoimmunology: the conceptual framework unifying the immune and skeletal systems</article-title>. <source>Physiol. Rev</source>
<volume>97</volume>, <fpage>1295</fpage>&#x02013;<lpage>1349</lpage>. doi:<pub-id pub-id-type="doi">10.1152/physrev.00036.2016</pub-id><pub-id pub-id-type="pmid">28814613</pub-id>
</mixed-citation></ref><ref id="R180"><mixed-citation publication-type="journal"><name><surname>Onwude</surname><given-names>JL</given-names></name> (<year>2022</year>). <article-title>Risks and benefits of HRT versus ERT in order to separate HRT from ERT</article-title>. <source>Pregn. Womens Health Care Int. J</source>
<volume>2</volume>, <fpage>1</fpage>&#x02013;<lpage>4</lpage>. doi:<pub-id pub-id-type="doi">10.53902/PWHCIJ.2022.02.000511</pub-id></mixed-citation></ref><ref id="R181"><mixed-citation publication-type="journal"><name><surname>Pacifici</surname><given-names>R</given-names></name> (<year>2012</year>). <article-title>Role of T cells in ovariectomy induced bone loss-revisited</article-title>. <source>J. Bone Min. Res</source>
<volume>27</volume>, <fpage>231</fpage>&#x02013;<lpage>239</lpage>. doi:<pub-id pub-id-type="doi">10.1002/jbmr.1500</pub-id></mixed-citation></ref><ref id="R182"><mixed-citation publication-type="journal"><name><surname>Pant</surname><given-names>A</given-names></name>, <name><surname>Paul</surname><given-names>E</given-names></name>, <name><surname>Niebur</surname><given-names>GL</given-names></name>, and <name><surname>Vahdati</surname><given-names>A</given-names></name> (<year>2021</year>). <article-title>Integration of mechanics and biology in computer simulation of bone remodeling</article-title>. <source>Prog. Biophys. Mol. Biol</source>
<volume>164</volume>, <fpage>33</fpage>&#x02013;<lpage>45</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.pbiomolbio.2021.05.001</pub-id><pub-id pub-id-type="pmid">33965425</pub-id>
</mixed-citation></ref><ref id="R183"><mixed-citation publication-type="journal"><name><surname>Paone</surname><given-names>P</given-names></name>, and <name><surname>Cani</surname><given-names>PD</given-names></name> (<year>2020</year>). <article-title>Mucus barrier, mucins and gut microbiota: the expected slimy partners?</article-title>
<source>Gut</source>
<volume>69</volume>, <fpage>2232</fpage>&#x02013;<lpage>2243</lpage>. doi:<pub-id pub-id-type="doi">10.1136/gutjnl-2020-322260</pub-id><pub-id pub-id-type="pmid">32917747</pub-id>
</mixed-citation></ref><ref id="R184"><mixed-citation publication-type="journal"><name><surname>Parfitt</surname><given-names>AM</given-names></name> (<year>1994</year>). <article-title>Osteonal and hemi-osteonal remodeling: the spatial and temporal framework for signal traffic in adult human bone</article-title>. <source>J. Cell. Biochem</source>
<volume>55</volume>, <fpage>273</fpage>&#x02013;<lpage>286</lpage>. doi:<pub-id pub-id-type="doi">10.1002/jcb.240550303</pub-id><pub-id pub-id-type="pmid">7962158</pub-id>
</mixed-citation></ref><ref id="R185"><mixed-citation publication-type="journal"><name><surname>Pastrama</surname><given-names>M-I</given-names></name>, <name><surname>Scheiner</surname><given-names>S</given-names></name>, <name><surname>Pivonka</surname><given-names>P</given-names></name>, and <name><surname>Hellmich</surname><given-names>C</given-names></name> (<year>2018</year>). <article-title>A mathematical multiscale model of bone remodeling, accounting for pore space-specific mechanosensation</article-title>. <source>Bone</source>
<volume>107</volume>, <fpage>208</fpage>&#x02013;<lpage>221</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bone.2017.11.009</pub-id><pub-id pub-id-type="pmid">29170108</pub-id>
</mixed-citation></ref><ref id="R186"><mixed-citation publication-type="journal"><name><surname>Perkins</surname><given-names>RS</given-names></name>, <name><surname>Singh</surname><given-names>R</given-names></name>, <name><surname>Abell</surname><given-names>AN</given-names></name>, <name><surname>Krum</surname><given-names>SA</given-names></name>, and <name><surname>Miranda-Carboni</surname><given-names>GA</given-names></name> (<year>2023</year>). <article-title>The role of WNT10B in physiology and disease: a 10-year update</article-title>. <source>Front. Cell Dev. Biol</source>
<volume>11</volume>, <fpage>1120365</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fcell.2023.1120365</pub-id><pub-id pub-id-type="pmid">36814601</pub-id>
</mixed-citation></ref><ref id="R187"><mixed-citation publication-type="journal"><name><surname>Peterson</surname><given-names>MC</given-names></name>, and <name><surname>Riggs</surname><given-names>MM</given-names></name> (<year>2010</year>). <article-title>A physiologically based mathematical model of integrated calcium homeostasis and bone remodeling</article-title>. <source>Bone</source>
<volume>46</volume>, <fpage>49</fpage>&#x02013;<lpage>63</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bone.2009.08.053</pub-id><pub-id pub-id-type="pmid">19732857</pub-id>
</mixed-citation></ref><ref id="R188"><mixed-citation publication-type="journal"><name><surname>Peterson</surname><given-names>MC</given-names></name>, and <name><surname>Riggs</surname><given-names>MM</given-names></name> (<year>2012</year>). <article-title>Predicting nonlinear changes in bone mineral density over time using a multiscale systems pharmacology model</article-title>. <source>CPT Pharmacometrics Syst. Pharmacol</source>
<volume>1</volume>, <fpage>e14</fpage>. doi:<pub-id pub-id-type="doi">10.1038/psp.2012.15</pub-id><pub-id pub-id-type="pmid">23835796</pub-id>
</mixed-citation></ref><ref id="R189"><mixed-citation publication-type="journal"><name><surname>Peyroteo</surname><given-names>MMA</given-names></name>, <name><surname>Belinha</surname><given-names>J</given-names></name>, <name><surname>Dinis</surname><given-names>LMJS</given-names></name>, and <name><surname>Natal Jorge</surname><given-names>RM</given-names></name> (<year>2019</year>). <article-title>A new biological bone remodeling <italic toggle="yes">in silico</italic> model combined with advanced discretization methods</article-title>. <source>Int. J. Numer. Methods Biomed. Eng</source>
<volume>35</volume>, <fpage>e3196</fpage>. doi:<pub-id pub-id-type="doi">10.1002/cnm.3196</pub-id></mixed-citation></ref><ref id="R190"><mixed-citation publication-type="journal"><name><surname>Pivonka</surname><given-names>P</given-names></name>, <name><surname>Buenzli</surname><given-names>PR</given-names></name>, <name><surname>Scheiner</surname><given-names>S</given-names></name>, <name><surname>Hellmich</surname><given-names>C</given-names></name>, and <name><surname>Dunstan</surname><given-names>CR</given-names></name> (<year>2013</year>). <article-title>The influence of bone surface availability in bone remodelling-a mathematical model including coupled geometrical and biomechanical regulations of bone cells</article-title>. <source>Eng. Struct</source>
<volume>47</volume>, <fpage>134</fpage>&#x02013;<lpage>147</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.engstruct.2012.09.006</pub-id></mixed-citation></ref><ref id="R191"><mixed-citation publication-type="journal"><name><surname>Pivonka</surname><given-names>P</given-names></name>, and <name><surname>Komarova</surname><given-names>SV</given-names></name> (<year>2010</year>). <article-title>Mathematical modeling in bone biology: from intracellular signaling to tissue mechanics</article-title>. <source>Bone</source>
<volume>47</volume>, <fpage>181</fpage>&#x02013;<lpage>189</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bone.2010.04.601</pub-id><pub-id pub-id-type="pmid">20417739</pub-id>
</mixed-citation></ref><ref id="R192"><mixed-citation publication-type="journal"><name><surname>Pivonka</surname><given-names>P</given-names></name>, <name><surname>Zimak</surname><given-names>J</given-names></name>, <name><surname>Smith</surname><given-names>DW</given-names></name>, <name><surname>Gardiner</surname><given-names>BS</given-names></name>, <name><surname>Dunstan</surname><given-names>CR</given-names></name>, <name><surname>Sims</surname><given-names>NA</given-names></name>, <etal/> (<year>2008</year>). <article-title>Model structure and control of bone remodeling: a theoretical study</article-title>. <source>Bone</source>
<volume>43</volume>
<fpage>249</fpage>&#x02013;<lpage>263</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bone.2008.03.025</pub-id><pub-id pub-id-type="pmid">18514606</pub-id>
</mixed-citation></ref><ref id="R193"><mixed-citation publication-type="journal"><name><surname>Pivonka</surname><given-names>P</given-names></name>, <name><surname>Zimak</surname><given-names>J</given-names></name>, <name><surname>Smith</surname><given-names>DW</given-names></name>, <name><surname>Gardiner</surname><given-names>BS</given-names></name>, <name><surname>Dunstan</surname><given-names>CR</given-names></name>, <name><surname>Sims</surname><given-names>NA</given-names></name>, <etal/> (<year>2010</year>). <article-title>Theoretical investigation of the role of the RANK-RANKL-OPG system in bone remodeling</article-title>. <source>J. Theor. Biol</source>
<volume>262</volume>, <fpage>306</fpage>&#x02013;<lpage>316</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jtbi.2009.09.021</pub-id><pub-id pub-id-type="pmid">19782692</pub-id>
</mixed-citation></ref><ref id="R194"><mixed-citation publication-type="book"><name><surname>Plotkin</surname><given-names>LI</given-names></name>, and <name><surname>Bivi</surname><given-names>N</given-names></name> (<year>2014</year>). &#x0201c;<part-title>Local regulation of bone cell function</part-title>,&#x0201d; in <source>Basic and applied bone biology</source>. Editors <name><surname>Burr</surname><given-names>DB</given-names></name> and <name><surname>Allen</surname><given-names>MR</given-names></name> (<publisher-loc>New York</publisher-loc>: <publisher-name>Academic Press</publisher-name>), <fpage>47</fpage>&#x02013;<lpage>73</lpage>. doi:<pub-id pub-id-type="doi">10.1016/B978-0-12-416015-6.00003-4</pub-id></mixed-citation></ref><ref id="R195"><mixed-citation publication-type="journal"><name><surname>Ponzetti</surname><given-names>M</given-names></name>, and <name><surname>Rucci</surname><given-names>N</given-names></name> (<year>2019</year>). <article-title>Updates on osteoimmunology: what&#x02019;s new on the cross-talk between bone and immune system</article-title>. <source>Front. Endocrinol</source>
<volume>10</volume>, <fpage>236</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fendo.2019.00236</pub-id></mixed-citation></ref><ref id="R196"><mixed-citation publication-type="journal"><name><surname>Post</surname><given-names>TM</given-names></name>, <name><surname>Schmidt</surname><given-names>S</given-names></name>, <name><surname>Peletier</surname><given-names>LA</given-names></name>, <name><surname>de Greef</surname><given-names>R</given-names></name>, <name><surname>Kerbusch</surname><given-names>T</given-names></name>, and <name><surname>Danhof</surname><given-names>M</given-names></name> (<year>2013</year>). <article-title>Application of a mechanism-based disease systems model for osteoporosis to clinical data</article-title>. <source>J. Pharmacokinet. Pharmacodyn</source>
<volume>40</volume>, <fpage>143</fpage>&#x02013;<lpage>156</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s10928-012-9294-9</pub-id><pub-id pub-id-type="pmid">23315144</pub-id>
</mixed-citation></ref><ref id="R197"><mixed-citation publication-type="journal"><name><surname>Proctor</surname><given-names>CJ</given-names></name>, and <name><surname>Gartland</surname><given-names>A</given-names></name> (<year>2016</year>). <article-title>Simulated interventions to ameliorate agerelated bone loss indicate the importance of timing</article-title>. <source>Front. Endocrinol</source>
<volume>7</volume>, <fpage>61</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fendo.2016.00061</pub-id></mixed-citation></ref><ref id="R198"><mixed-citation publication-type="journal"><name><surname>Raje</surname><given-names>N</given-names></name>, <name><surname>Terpos</surname><given-names>E</given-names></name>, <name><surname>Willenbacher</surname><given-names>W</given-names></name>, <name><surname>Shimizu</surname><given-names>K</given-names></name>, <name><surname>Garc&#x000ed;a-Sanz</surname><given-names>R</given-names></name>, <name><surname>Durie</surname><given-names>B</given-names></name>, <etal/> (<year>2018</year>). <article-title>Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy randomised, controlled, phase 3 study</article-title>. <source>Lancet Oncol</source>. <volume>19</volume>, <fpage>370</fpage>&#x02013;<lpage>381</lpage>. doi:<pub-id pub-id-type="doi">10.1016/s1470-2045(18)30072-x</pub-id><pub-id pub-id-type="pmid">29429912</pub-id>
</mixed-citation></ref><ref id="R199"><mixed-citation publication-type="journal"><name><surname>Rao</surname><given-names>SR</given-names></name>, <name><surname>Edwards</surname><given-names>CM</given-names></name>, and <name><surname>Edwards</surname><given-names>JR</given-names></name> (<year>2020</year>). <article-title>Modeling the human bone-tumor niche: reducing and replacing the need for animal data</article-title>. <source>JBMR Plus</source>
<volume>4</volume>, <fpage>e10356</fpage> doi:<pub-id pub-id-type="doi">10.1002/jbm4.10356</pub-id><pub-id pub-id-type="pmid">32258970</pub-id>
</mixed-citation></ref><ref id="R200"><mixed-citation publication-type="journal"><name><surname>Rattanakul</surname><given-names>C</given-names></name>, <name><surname>Lenbury</surname><given-names>Y</given-names></name>, <name><surname>Krishnamara</surname><given-names>N</given-names></name>, and <name><surname>Wollkind</surname><given-names>DJ</given-names></name> (<year>2003</year>). <article-title>Modeling of bone formation and resorption mediated by parathyroid hormone: response to estrogen/PTH therapy</article-title>. <source>Biosystems</source>
<volume>70</volume>, <fpage>55</fpage>&#x02013;<lpage>72</lpage>. doi:<pub-id pub-id-type="doi">10.1016/s0303-2647(03)00040-6</pub-id><pub-id pub-id-type="pmid">12753937</pub-id>
</mixed-citation></ref><ref id="R201"><mixed-citation publication-type="journal"><name><surname>Rendina</surname><given-names>E</given-names></name>, <name><surname>Lim</surname><given-names>YF</given-names></name>, <name><surname>Marlow</surname><given-names>D</given-names></name>, <name><surname>Wang</surname><given-names>Y</given-names></name>, <name><surname>Clarke</surname><given-names>SL</given-names></name>, <name><surname>Kuvibidila</surname><given-names>S</given-names></name>, <etal/> (<year>2012</year>). <article-title>Dietary supplementation with dried plum prevents ovariectomy-induced bone loss while modulating the immune response in C57BL/6J mice</article-title>. <source>J. Nutr. Biochem</source>
<volume>23</volume>, <fpage>60</fpage>&#x02013;<lpage>68</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jnutbio.2010.10.010</pub-id><pub-id pub-id-type="pmid">21414765</pub-id>
</mixed-citation></ref><ref id="R202"><mixed-citation publication-type="journal"><name><surname>Riggs</surname><given-names>MM</given-names></name>, and <name><surname>Cremers</surname><given-names>S</given-names></name> (<year>2019</year>). <article-title>Pharmacometrics and systems pharmacology for metabolic bone diseases</article-title>. <source>Br. J. Clin. Pharmacol</source>
<volume>85</volume>, <fpage>1136</fpage>&#x02013;<lpage>1146</lpage>. doi:<pub-id pub-id-type="doi">10.1111/bcp13881</pub-id><pub-id pub-id-type="pmid">30690761</pub-id>
</mixed-citation></ref><ref id="R203"><mixed-citation publication-type="journal"><name><surname>Rios-Arce</surname><given-names>ND</given-names></name>, <name><surname>Collins</surname><given-names>FL</given-names></name>, <name><surname>Schepper</surname><given-names>JD</given-names></name>, <name><surname>Steury</surname><given-names>MD</given-names></name>, <name><surname>Raehtz</surname><given-names>S</given-names></name>, <name><surname>Mallin</surname><given-names>H</given-names></name>, <etal/> (<year>2017</year>). <article-title>Epithelial barrier function in gut-bone signaling</article-title>. <source>Adv. Exp. Med. Biol</source>
<volume>1033</volume>
<fpage>151</fpage>&#x02013;<lpage>183</lpage>. doi:<pub-id pub-id-type="doi">10.1007/978-3-319-66653-2_8</pub-id><pub-id pub-id-type="pmid">29101655</pub-id>
</mixed-citation></ref><ref id="R204"><mixed-citation publication-type="journal"><name><surname>Roberfroid</surname><given-names>MB</given-names></name>, <name><surname>Cumps</surname><given-names>J</given-names></name>, and <name><surname>Devogelaer</surname><given-names>JP</given-names></name> (<year>2002</year>). <article-title>Dietary chicory inulin increases whole-body bone mineral density in growing male rats</article-title>. <source>J. Nutr</source>
<volume>132</volume>, <fpage>3599</fpage>&#x02013;<lpage>3602</lpage>. doi:<pub-id pub-id-type="doi">10.1093/jn/132.12.3599</pub-id><pub-id pub-id-type="pmid">12468594</pub-id>
</mixed-citation></ref><ref id="R205"><mixed-citation publication-type="journal"><name><surname>Ross</surname><given-names>DS</given-names></name>, <name><surname>Battista</surname><given-names>C</given-names></name>, <name><surname>Cabal</surname><given-names>A</given-names></name>, and <name><surname>Mehta</surname><given-names>K</given-names></name> (<year>2012</year>). <article-title>Dynamics of bone cell signaling and PTH treatments of osteoporosis</article-title>. <source>Discrete Contin. Dyn. Syst. - B</source>
<volume>17</volume>, <fpage>2185</fpage>&#x02013;<lpage>2200</lpage>. doi:<pub-id pub-id-type="doi">10.3934/dcdsb.2012.17.2185</pub-id></mixed-citation></ref><ref id="R206"><mixed-citation publication-type="journal"><name><surname>Ross</surname><given-names>DS</given-names></name>, <name><surname>Mehta</surname><given-names>K</given-names></name>, and <name><surname>Cabal</surname><given-names>A</given-names></name> (<year>2017</year>). <article-title>Mathematical model of bone remodeling captures the antiresorptive and anabolic actions of various therapies</article-title>. <source>Bull. Math. Biol</source>
<volume>79</volume>, <fpage>117</fpage>&#x02013;<lpage>142</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11538-016-0229-2</pub-id><pub-id pub-id-type="pmid">27905067</pub-id>
</mixed-citation></ref><ref id="R207"><mixed-citation publication-type="journal"><name><surname>Rutkovskiy</surname><given-names>A</given-names></name>, <name><surname>Stensl&#x000f8;kken</surname><given-names>KO</given-names></name>, and <name><surname>Vaage</surname><given-names>IJ</given-names></name> (<year>2016</year>). <article-title>Osteoblast differentiation at a glance</article-title>. <source>Med. Sci. Monit. Basic Res</source>
<volume>22</volume>, <fpage>95</fpage>&#x02013;<lpage>106</lpage>. doi:<pub-id pub-id-type="doi">10.12659/msmbr.901142</pub-id><pub-id pub-id-type="pmid">27667570</pub-id>
</mixed-citation></ref><ref id="R208"><mixed-citation publication-type="journal"><name><surname>Ryser</surname><given-names>MD</given-names></name>, <name><surname>Komarova</surname><given-names>SV</given-names></name>, and <name><surname>Nigam</surname><given-names>N</given-names></name> (<year>2010</year>). <article-title>The cellular dynamics of bone remodeling: a mathematical model</article-title>. <source>SIAM J. Appl. Math</source>
<volume>70</volume>, <fpage>1899</fpage>&#x02013;<lpage>1921</lpage>. doi:<pub-id pub-id-type="doi">10.1137/090746094</pub-id></mixed-citation></ref><ref id="R209"><mixed-citation publication-type="journal"><name><surname>Ryser</surname><given-names>MD</given-names></name>, and <name><surname>Murgas</surname><given-names>KA</given-names></name> (<year>2017</year>). <article-title>Bone remodeling as a spatial evolutionary game</article-title>. <source>J. Theor. Biol</source>
<volume>418</volume>, <fpage>16</fpage>&#x02013;<lpage>26</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jtbi.2017.01.021</pub-id><pub-id pub-id-type="pmid">28108306</pub-id>
</mixed-citation></ref><ref id="R210"><mixed-citation publication-type="journal"><name><surname>Ryser</surname><given-names>MD</given-names></name>, <name><surname>Nigam</surname><given-names>N</given-names></name>, and <name><surname>Komarova</surname><given-names>SV</given-names></name> (<year>2009</year>). <article-title>Mathematical modeling of spatio-temporal dynamics of a single bone multicellular unit</article-title>. <source>J. Bone Min. Res</source>
<volume>24</volume>
<fpage>860</fpage>&#x02013;<lpage>870</lpage>. doi:<pub-id pub-id-type="doi">10.1359/jbmr.081229</pub-id></mixed-citation></ref><ref id="R211"><mixed-citation publication-type="journal"><name><surname>Ryser</surname><given-names>MD</given-names></name>, <name><surname>Qu</surname><given-names>Y</given-names></name>, and <name><surname>Komarova</surname><given-names>SV</given-names></name> (<year>2012</year>). <article-title>Osteoprotegerin in bone metastases: mathematical solution to the puzzle</article-title>. <source>PLoS Comput. Biol</source>
<volume>8</volume>, <fpage>el002703</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pcbi.1002703</pub-id></mixed-citation></ref><ref id="R212"><mixed-citation publication-type="journal"><name><surname>Savageau</surname><given-names>M</given-names></name> (<year>1970</year>). <article-title>Biochemical systems analysis. III. dynamic solutions using a power-law approximation</article-title>. <source>J. Theor. Biol</source>
<volume>26</volume>, <fpage>215</fpage>&#x02013;<lpage>266</lpage>. doi:<pub-id pub-id-type="doi">10.1016/s0022-5193(70)80013-3</pub-id><pub-id pub-id-type="pmid">5434343</pub-id>
</mixed-citation></ref><ref id="R213"><mixed-citation publication-type="journal"><name><surname>Saxena</surname><given-names>Y</given-names></name>, <name><surname>Routh</surname><given-names>S</given-names></name>, and <name><surname>Mukhopadhaya</surname><given-names>A</given-names></name> (<year>2021</year>). <article-title>Immunoporosis: role of innate immune cells in osteoporosis</article-title>. <source>Front. Immunol</source>
<volume>12</volume>, <fpage>687037</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fimmu.2021.687037</pub-id><pub-id pub-id-type="pmid">34421899</pub-id>
</mixed-citation></ref><ref id="R214"><mixed-citation publication-type="journal"><name><surname>Scheiner</surname><given-names>S</given-names></name>, <name><surname>Pivonka</surname><given-names>P</given-names></name>, and <name><surname>Hellmich</surname><given-names>C</given-names></name> (<year>2013</year>). <article-title>Coupling systems biology with multiscale mechanics, for computer simulations of bone remodeling</article-title>. <source>Comput. Method Appl. Mech. Eng</source>
<volume>254</volume>, <fpage>181</fpage>&#x02013;<lpage>196</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cma.2012.10.015</pub-id></mixed-citation></ref><ref id="R215"><mixed-citation publication-type="journal"><name><surname>Scheiner</surname><given-names>S</given-names></name>, <name><surname>Pivonka</surname><given-names>P</given-names></name>, <name><surname>Smith</surname><given-names>DW</given-names></name>, <name><surname>Dunstan</surname><given-names>CR</given-names></name>, and <name><surname>Hellmich</surname><given-names>C</given-names></name> (<year>2014</year>) <article-title>Mathematical modeling of postmenopausal osteoporosis and its treatment by the anti-catabolic drug denosumab</article-title>. <source>Int. J. Numer. Methods Biomed. Eng</source>
<volume>30</volume>, <fpage>1</fpage>&#x02013;<lpage>27</lpage>. doi:<pub-id pub-id-type="doi">10.1002/cnm.2584</pub-id></mixed-citation></ref><ref id="R216"><mixed-citation publication-type="journal"><name><surname>Schepper</surname><given-names>JD</given-names></name>, <name><surname>Collins</surname><given-names>FL</given-names></name>, <name><surname>Rios-Arce</surname><given-names>ND</given-names></name>, <name><surname>Raehtz</surname><given-names>S</given-names></name>, <name><surname>Schaefer</surname><given-names>L</given-names></name>, <name><surname>Gardinier</surname><given-names>JD</given-names></name>, <etal/> (<year>2019</year>). <article-title>Probiotic Lactobacillus reuteri prevents postantibiotic bone loss by reducing intestinal dysbiosis and preventing barrier disruption</article-title>. <source>J. Bone Min. Res</source>
<volume>34</volume>
<fpage>681</fpage>&#x02013;<lpage>698</lpage>. doi:<pub-id pub-id-type="doi">10.1002/jbmr.3635</pub-id></mixed-citation></ref><ref id="R217"><mixed-citation publication-type="journal"><name><surname>Schmidt</surname><given-names>S</given-names></name>, <name><surname>Post</surname><given-names>TM</given-names></name>, <name><surname>Peletier</surname><given-names>LA</given-names></name>, <name><surname>Boroujerdi</surname><given-names>MA</given-names></name>, and <name><surname>Danhof</surname><given-names>M</given-names></name> (<year>2011</year>). <article-title>Coping with time scales in disease systems analysis: application to bone remodeling</article-title>. <source>J. Pharmacokinet. Pharmacodyn</source>
<volume>38</volume>, <fpage>873</fpage>&#x02013;<lpage>900</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s10928-011-9224-2</pub-id><pub-id pub-id-type="pmid">22028207</pub-id>
</mixed-citation></ref><ref id="R218"><mixed-citation publication-type="journal"><name><surname>Scholz-Ahrens</surname><given-names>KE</given-names></name>, <name><surname>Ade</surname><given-names>P</given-names></name>, <name><surname>Marten</surname><given-names>B</given-names></name>, <name><surname>Weber</surname><given-names>P</given-names></name>, <name><surname>Timm</surname><given-names>W</given-names></name>, <name><surname>A&#x000e7;il</surname><given-names>Y</given-names></name>, <etal/> (<year>2007</year>). <article-title>Prebiotics, probiotics, and synbiotics affect mineral absorption, bone mineral content, and bone structure</article-title>. <source>J. Nutr</source>
<volume>137</volume>, <fpage>838S</fpage>&#x02013;<lpage>46s</lpage>. doi:<pub-id pub-id-type="doi">10.1093/jn/137.3.838S</pub-id><pub-id pub-id-type="pmid">17311984</pub-id>
</mixed-citation></ref><ref id="R219"><mixed-citation publication-type="journal"><name><surname>Sharma</surname><given-names>A</given-names></name>, <name><surname>Sharma</surname><given-names>L</given-names></name>, and <name><surname>Goyal</surname><given-names>R</given-names></name> (<year>2020</year>). <article-title>Molecular signaling pathways and essential metabolic elements in bone remodeling: an implication of therapeutic target for bone diseases</article-title>. <source>Curr. Drug Targets</source>
<volume>22</volume>, <fpage>77</fpage>&#x02013;<lpage>104</lpage>. doi:<pub-id pub-id-type="doi">10.2174/1389450121666200910160404</pub-id></mixed-citation></ref><ref id="R220"><mixed-citation publication-type="journal"><name><surname>Shen</surname><given-names>C-L</given-names></name>, <name><surname>Smith</surname><given-names>BJ</given-names></name>, <name><surname>Li</surname><given-names>J</given-names></name>, <name><surname>Cao</surname><given-names>JJ</given-names></name>, <name><surname>Song</surname><given-names>X</given-names></name>, <name><surname>Newhardt</surname><given-names>MF</given-names></name>, <etal/> (<year>2019</year>). <article-title>Effect of long-term green tea polyphenol supplementation on bone architecture, turnover, and mechanical properties in middle-aged ovariectomized rats</article-title>. <source>Calcif. Tissue Int</source>
<volume>104</volume>, <fpage>285</fpage>&#x02013;<lpage>300</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00223-018-0489-y</pub-id><pub-id pub-id-type="pmid">30413854</pub-id>
</mixed-citation></ref><ref id="R221"><mixed-citation publication-type="journal"><name><surname>Siddiqui</surname><given-names>JA</given-names></name>, and <name><surname>Partridge</surname><given-names>NC</given-names></name> (<year>2016</year>). <article-title>Physiological bone remodeling: systemic regulation and growth factor involvement</article-title>. <source>Physiology</source>
<volume>31</volume>, <fpage>233</fpage>&#x02013;<lpage>245</lpage>. doi:<pub-id pub-id-type="doi">10.1152/physiol.00061.2014</pub-id><pub-id pub-id-type="pmid">27053737</pub-id>
</mixed-citation></ref><ref id="R222"><mixed-citation publication-type="journal"><name><surname>Silva</surname><given-names>BC</given-names></name>, and <name><surname>Bilezikian</surname><given-names>JP</given-names></name> (<year>2015</year>). <article-title>Parathyroid hormone: anabolic and catabolic actions on the skeleton</article-title>. <source>Curr. Opin. Pharmacol</source>
<volume>22</volume>, <fpage>41</fpage>&#x02013;<lpage>50</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.coph.2015.03.005</pub-id><pub-id pub-id-type="pmid">25854704</pub-id>
</mixed-citation></ref><ref id="R223"><mixed-citation publication-type="journal"><name><surname>Sims</surname><given-names>NA</given-names></name>, and <name><surname>Martin</surname><given-names>TJ</given-names></name> (<year>2020</year>). <article-title>Osteoclasts provide coupling signals to osteoblast lineage cells through multiple mechanisms</article-title>. <source>Annu. Rev. Physiol</source>
<volume>82</volume>
<fpage>507</fpage>&#x02013;<lpage>529</lpage>. doi:<pub-id pub-id-type="doi">10.1146/annurev-physiol-021119-034425</pub-id><pub-id pub-id-type="pmid">31553686</pub-id>
</mixed-citation></ref><ref id="R224"><mixed-citation publication-type="journal"><name><surname>Singh</surname><given-names>N</given-names></name>, <name><surname>Gurav</surname><given-names>A</given-names></name>, <name><surname>Sivaprakasam</surname><given-names>S</given-names></name>, <name><surname>Brady</surname><given-names>E</given-names></name>, <name><surname>Padia</surname><given-names>R</given-names></name>, <name><surname>Shi</surname><given-names>H</given-names></name>, <etal/> (<year>2014</year>). <article-title>Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate suppresses colonic inflammation and carcinogenesis</article-title>. <source>Immunity</source>
<volume>40</volume>, <fpage>128</fpage>&#x02013;<lpage>139</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.immuni.2013.12.007</pub-id><pub-id pub-id-type="pmid">24412617</pub-id>
</mixed-citation></ref><ref id="R225"><mixed-citation publication-type="journal"><name><surname>Sj&#x000f6;gren</surname><given-names>K</given-names></name>, <name><surname>Engdahl</surname><given-names>C</given-names></name>, <name><surname>Henning</surname><given-names>P</given-names></name>, <name><surname>Lerner</surname><given-names>UH</given-names></name>, <name><surname>Tremaroli</surname><given-names>V</given-names></name>, <name><surname>Lagerquist</surname><given-names>MK</given-names></name>, <etal/> (<year>2012</year>). <article-title>The gut microbiota regulates bone mass in mice</article-title>. <source>J. Bone Min. Res</source>
<volume>27</volume>
<fpage>1357</fpage>&#x02013;<lpage>1367</lpage>. doi:<pub-id pub-id-type="doi">10.1002/jbmr.1588</pub-id></mixed-citation></ref><ref id="R226"><mixed-citation publication-type="journal"><name><surname>Smith</surname><given-names>BJ</given-names></name>, <name><surname>Bu</surname><given-names>SY</given-names></name>, <name><surname>Wang</surname><given-names>Y</given-names></name>, <name><surname>Rendina</surname><given-names>E</given-names></name>, <name><surname>Lim</surname><given-names>YF</given-names></name>, <name><surname>Marlow</surname><given-names>D</given-names></name>, <etal/> (<year>2014</year>). <article-title>A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat</article-title>. <source>Bone</source>
<volume>58</volume>, <fpage>151</fpage>&#x02013;<lpage>159</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bone.2013.10.005</pub-id><pub-id pub-id-type="pmid">24125756</pub-id>
</mixed-citation></ref><ref id="R227"><mixed-citation publication-type="journal"><name><surname>Smith</surname><given-names>BJ</given-names></name>, <name><surname>Crockett</surname><given-names>EK</given-names></name>, <name><surname>Chongwatpol</surname><given-names>P</given-names></name>, <name><surname>Graef</surname><given-names>JL</given-names></name>, <name><surname>Clarke</surname><given-names>SL</given-names></name>, <name><surname>Rendina-Ruedy</surname><given-names>E</given-names></name>, <etal/> (<year>2019</year>). <article-title>Montmorency tart cherry protects against age-related bone loss in female C57BL/6 mice and demonstrates some anabolic effects</article-title>. <source>Eur. J. Nutr</source>
<volume>58</volume>
<fpage>3035</fpage>&#x02013;<lpage>3046</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00394-018-1848-1</pub-id><pub-id pub-id-type="pmid">30377814</pub-id>
</mixed-citation></ref><ref id="R228"><mixed-citation publication-type="journal"><name><surname>Smith</surname><given-names>BJ</given-names></name>, <name><surname>Hatter</surname><given-names>B</given-names></name>, <name><surname>Washburn</surname><given-names>K</given-names></name>, <name><surname>Graef-Downard</surname><given-names>J</given-names></name>, <name><surname>Ojo</surname><given-names>BA</given-names></name>, <name><surname>El-Rassi</surname><given-names>GD</given-names></name>, <etal/> (<year>2022</year>). <article-title>Dried plum&#x02019;s polyphenolic compounds and carbohydrates contribute to its osteoprotective effects and exhibit prebiotic activity in estrogen deficient C57BL/6 mice</article-title>. <source>Nutrients</source>
<volume>14</volume>, <fpage>1685</fpage>. doi:<pub-id pub-id-type="doi">10.3390/nu14091685</pub-id><pub-id pub-id-type="pmid">35565653</pub-id>
</mixed-citation></ref><ref id="R229"><mixed-citation publication-type="journal"><name><surname>Smith</surname><given-names>PM</given-names></name>, <name><surname>Howitt</surname><given-names>MR</given-names></name>, <name><surname>Panikov</surname><given-names>N</given-names></name>, <name><surname>Michaud</surname><given-names>M</given-names></name>, <name><surname>Gallini</surname><given-names>CA</given-names></name>, <name><surname>Bohlooly-Y</surname><given-names>M</given-names></name>, <etal/> (<year>2013</year>). <article-title>The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis</article-title>. <source>Science</source>
<volume>341</volume>, <fpage>569</fpage>&#x02013;<lpage>573</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1241165</pub-id><pub-id pub-id-type="pmid">23828891</pub-id>
</mixed-citation></ref><ref id="R230"><mixed-citation publication-type="journal"><name><surname>Srinath</surname><given-names>S</given-names></name>, and <name><surname>Gunawan</surname><given-names>R</given-names></name> (<year>2010</year>). <article-title>Parameter identifiability of power-law biochemical system models</article-title>. <source>J. Biotechnol</source>
<volume>149</volume>, <fpage>132</fpage>&#x02013;<lpage>140</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jbiotec.2010.02.019</pub-id><pub-id pub-id-type="pmid">20197073</pub-id>
</mixed-citation></ref><ref id="R231"><mixed-citation publication-type="journal"><name><surname>Srivastava</surname><given-names>RK</given-names></name>, <name><surname>Dar</surname><given-names>HY</given-names></name>, and <name><surname>Mishra</surname><given-names>PK</given-names></name> (<year>2018</year>). <article-title>Immunoporosis: immunology of osteoporosis-role of T cells</article-title>. <source>Front. Immunol</source>
<volume>9</volume>, <fpage>657</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fimmu.2018.00657</pub-id><pub-id pub-id-type="pmid">29675022</pub-id>
</mixed-citation></ref><ref id="R232"><mixed-citation publication-type="journal"><name><surname>Srivastava</surname><given-names>RK</given-names></name>, and <name><surname>Sapra</surname><given-names>L</given-names></name> (<year>2022</year>). <article-title>The rising era of &#x0201c;immunoporosis&#x0201d;: role of immune system in the pathophysiology of osteoporosis</article-title>. <source>J. Inflamm. Res</source>
<volume>15</volume>, <fpage>1667</fpage>&#x02013;<lpage>1698</lpage>. doi:<pub-id pub-id-type="doi">10.2147/jir.s351918</pub-id><pub-id pub-id-type="pmid">35282271</pub-id>
</mixed-citation></ref><ref id="R233"><mixed-citation publication-type="journal"><name><surname>Stopeck</surname><given-names>AT</given-names></name>, <name><surname>Lipton</surname><given-names>A</given-names></name>, <name><surname>Body</surname><given-names>JJ</given-names></name>, <name><surname>Steger</surname><given-names>GG</given-names></name>, <name><surname>Tonkin</surname><given-names>K</given-names></name>, <name><surname>de Boer</surname><given-names>RH</given-names></name>, <etal/> (<year>2010</year>). <article-title>Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study</article-title>. <source>J. Clin. Oncol</source>
<volume>28</volume>, <fpage>5132</fpage>&#x02013;<lpage>5139</lpage>. doi:<pub-id pub-id-type="doi">10.1200/jco.2010.29.7101</pub-id><pub-id pub-id-type="pmid">21060033</pub-id>
</mixed-citation></ref><ref id="R234"><mixed-citation publication-type="journal"><name><surname>Suda</surname><given-names>T</given-names></name>, <name><surname>Takahashi</surname><given-names>N</given-names></name>, <name><surname>Udagawa</surname><given-names>N</given-names></name>, <name><surname>Jimi</surname><given-names>E</given-names></name>, <name><surname>Gillespie</surname><given-names>MT</given-names></name>, and <name><surname>Martin</surname><given-names>TJ</given-names></name> (<year>1999</year>). <article-title>Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families</article-title>. <source>Endocr. Rev</source>
<volume>20</volume>, <fpage>345</fpage>&#x02013;<lpage>357</lpage>. doi:<pub-id pub-id-type="doi">10.1210/edrv.20.3.0367</pub-id><pub-id pub-id-type="pmid">10368775</pub-id>
</mixed-citation></ref><ref id="R235"><mixed-citation publication-type="journal"><name><surname>Takayanagi</surname><given-names>H</given-names></name> (<year>2007</year>). <article-title>Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems</article-title>. <source>Nat. Rev. Immunol</source>
<volume>7</volume>, <fpage>292</fpage>&#x02013;<lpage>304</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nri2062</pub-id><pub-id pub-id-type="pmid">17380158</pub-id>
</mixed-citation></ref><ref id="R236"><mixed-citation publication-type="journal"><name><surname>Takimoto</surname><given-names>T</given-names></name>, <name><surname>Hatanaka</surname><given-names>M</given-names></name>, <name><surname>Hoshino</surname><given-names>T</given-names></name>, <name><surname>Takara</surname><given-names>T</given-names></name>, <name><surname>Tanaka</surname><given-names>K</given-names></name>, <name><surname>Shimizu</surname><given-names>A</given-names></name>, <etal/> (<year>2018</year>). <article-title>Effect of Bacillus subtilis C-3102 on bone mineral density in healthy postmenopausal Japanese women: a randomized, placebo-controlled, double-blin clinical trial</article-title>. <source>Biosci. Microbiota Food Health</source>
<volume>37</volume>, <fpage>87</fpage>&#x02013;<lpage>96</lpage>. doi:<pub-id pub-id-type="doi">10.12938/bmfh.18-006</pub-id><pub-id pub-id-type="pmid">30370192</pub-id>
</mixed-citation></ref><ref id="R237"><mixed-citation publication-type="journal"><name><surname>Tan</surname><given-names>J</given-names></name>, <name><surname>McKenzie</surname><given-names>C</given-names></name>, <name><surname>Vuillermin</surname><given-names>PJ</given-names></name>, <name><surname>Goverse</surname><given-names>G</given-names></name>, <name><surname>Vinuesa</surname><given-names>CG</given-names></name>, <name><surname>Mebius</surname><given-names>RE</given-names></name>, <etal/> (<year>2016</year>). <article-title>Dietary fiber and bacterial SCFA enhance oral tolerance and protect against food allergy through diverse cellular pathways</article-title>. <source>Cell Rep</source>. <volume>15</volume>, <fpage>2809</fpage>&#x02013;<lpage>2824</lpage>. doi:<pub-id pub-id-type="doi">10.1016/jcelrep.2016.05.047</pub-id><pub-id pub-id-type="pmid">27332875</pub-id>
</mixed-citation></ref><ref id="R238"><mixed-citation publication-type="journal"><name><surname>Taylor-King</surname><given-names>JP</given-names></name>, <name><surname>Buenzli</surname><given-names>PR</given-names></name>, <name><surname>Chapman</surname><given-names>SJ</given-names></name>, <name><surname>Lynch</surname><given-names>CC</given-names></name>, and <name><surname>Basanta</surname><given-names>D</given-names></name> (<year>2020</year>) <article-title>Modeling osteocyte network formation: healthy and cancerous environments</article-title>. <source>Front. Bioeng. Biotechnol</source>
<volume>8</volume>, <fpage>757</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fbioe.2020.00757</pub-id><pub-id pub-id-type="pmid">32793566</pub-id>
</mixed-citation></ref><ref id="R239"><mixed-citation publication-type="journal"><name><surname>Tilg</surname><given-names>H</given-names></name>, <name><surname>Moschen</surname><given-names>AR</given-names></name>, <name><surname>Kaser</surname><given-names>A</given-names></name>, <name><surname>Pines</surname><given-names>A</given-names></name>, and <name><surname>Dotan</surname><given-names>I</given-names></name> (<year>2008</year>). <article-title>Gut, inflammation and osteoporosis: basic and clinical concepts</article-title>. <source>Gut</source>
<volume>57</volume>, <fpage>684</fpage>&#x02013;<lpage>694</lpage>. doi:<pub-id pub-id-type="doi">10.1136/gut.2006.117382</pub-id><pub-id pub-id-type="pmid">18408105</pub-id>
</mixed-citation></ref><ref id="R240"><mixed-citation publication-type="journal"><name><surname>Tomkinson</surname><given-names>A</given-names></name>, <name><surname>Gevers</surname><given-names>EF</given-names></name>, <name><surname>Wit</surname><given-names>JM</given-names></name>, <name><surname>Reeve</surname><given-names>J</given-names></name>, and <name><surname>Noble</surname><given-names>BS</given-names></name> (<year>1998</year>). <article-title>The role of estrogen in the control of rat osteocyte apoptosis</article-title>. <source>J. Bone Min. Res</source>
<volume>13</volume>, <fpage>1243</fpage>&#x02013;<lpage>1250</lpage>. doi:<pub-id pub-id-type="doi">10.1359/jbmr.1998.13.8.1243</pub-id></mixed-citation></ref><ref id="R241"><mixed-citation publication-type="journal"><name><surname>Tomkinson</surname><given-names>A</given-names></name>, <name><surname>Reeve</surname><given-names>J</given-names></name>, <name><surname>Shaw</surname><given-names>RW</given-names></name>, and <name><surname>Noble</surname><given-names>BS</given-names></name> (<year>1997</year>). <article-title>The death of osteocyte via apoptosis accompanies estrogen withdrawal in human bone</article-title>. <source>J. Clin. Endocrinol. Metab</source>
<volume>82</volume>, <fpage>3128</fpage>&#x02013;<lpage>3135</lpage>. doi:<pub-id pub-id-type="doi">10.1210/jcem.82.9.4200</pub-id><pub-id pub-id-type="pmid">9284757</pub-id>
</mixed-citation></ref><ref id="R242"><mixed-citation publication-type="journal"><name><surname>Tourolle</surname><given-names>DC</given-names></name>, <name><surname>Dempster</surname><given-names>DW</given-names></name>, <name><surname>Ledoux</surname><given-names>C</given-names></name>, <name><surname>Boaretti</surname><given-names>D</given-names></name>, <name><surname>Aguilera</surname><given-names>M</given-names></name>, <name><surname>Saleem</surname><given-names>N</given-names></name>, <etal/> (<year>2021</year>). <article-title>Ten-year simulation of the effects of denosumab on bone remodeling in human biopsies</article-title>. <source>JBMR Plus</source>
<volume>5</volume>, <fpage>e10494</fpage>. doi:<pub-id pub-id-type="doi">10.1002/jbm4.10494</pub-id><pub-id pub-id-type="pmid">34189383</pub-id>
</mixed-citation></ref><ref id="R243"><mixed-citation publication-type="journal"><name><surname>Tovazzi</surname><given-names>V</given-names></name>, <name><surname>Dalla Volta</surname><given-names>A</given-names></name>, <name><surname>Pedersini</surname><given-names>R</given-names></name>, <name><surname>Amoroso</surname><given-names>V</given-names></name>, and <name><surname>Berruti</surname><given-names>A</given-names></name> (<year>2019</year>). <article-title>Excess of second tumors in denosumab-treated patients: a metabolic hypothesis</article-title>. <source>Future Oncol</source>. <volume>15</volume>, <fpage>2319</fpage>&#x02013;<lpage>2321</lpage>. doi:<pub-id pub-id-type="doi">10.2217/fon-2019-0170</pub-id><pub-id pub-id-type="pmid">31237145</pub-id>
</mixed-citation></ref><ref id="R244"><mixed-citation publication-type="journal"><name><surname>Trejo</surname><given-names>I</given-names></name>, <name><surname>Kojouharov</surname><given-names>H</given-names></name>, and <name><surname>Chen-Charpentier</surname><given-names>B</given-names></name> (<year>2019</year>). <article-title>Modeling the macrophage-mediated inflammation involved in the bone fracture healing process</article-title>. <source>Math. Comput. Appl</source>
<volume>24</volume>, <fpage>12</fpage>. doi:<pub-id pub-id-type="doi">10.3390/mca24010012</pub-id></mixed-citation></ref><ref id="R245"><mixed-citation publication-type="journal"><name><surname>Trichilo</surname><given-names>S</given-names></name>, <name><surname>Scheiner</surname><given-names>S</given-names></name>, <name><surname>Forwood</surname><given-names>M</given-names></name>, <name><surname>Cooper</surname><given-names>DML</given-names></name>, and <name><surname>Pivonka</surname><given-names>P</given-names></name> (<year>2019</year>). <article-title>Computational model of the dual action of PTH - application to a rat model of osteoporosis</article-title>. <source>J. Theor. Biol</source>
<volume>473</volume>, <fpage>67</fpage>&#x02013;<lpage>79</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jtbi.2019.04.020</pub-id><pub-id pub-id-type="pmid">31009612</pub-id>
</mixed-citation></ref><ref id="R246"><mixed-citation publication-type="journal"><name><surname>Tyagi</surname><given-names>AM</given-names></name>, <name><surname>Yu</surname><given-names>M</given-names></name>, <name><surname>Darby</surname><given-names>TM</given-names></name>, <name><surname>Vaccaro</surname><given-names>C</given-names></name>, <name><surname>Li</surname><given-names>J-Y</given-names></name>, <name><surname>Owens</surname><given-names>JA</given-names></name>, <etal/> (<year>2018</year>) <article-title>The microbial metabolite butyrate stimulates bone formation via T regulatory cell-mediated regulation of WNT10B expression</article-title>. <source>Immunity</source>
<volume>49</volume>, <fpage>1116</fpage>&#x02013;<lpage>1131</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.immuni.2018.10.013</pub-id><pub-id pub-id-type="pmid">30446387</pub-id>
</mixed-citation></ref><ref id="R247"><mixed-citation publication-type="journal"><name><surname>van Oers</surname><given-names>RFM</given-names></name>, <name><surname>Ruimerman</surname><given-names>R</given-names></name>, <name><surname>Tanck</surname><given-names>E</given-names></name>, <name><surname>Hilbers</surname><given-names>PAJ</given-names></name>, and <name><surname>Huiskes</surname><given-names>R</given-names></name> (<year>2008</year>). <article-title>A unified theory for osteonal and hemi-osteonal remodeling</article-title>. <source>Bone</source>
<volume>42</volume>, <fpage>250</fpage>&#x02013;<lpage>259</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bone.2007.10.009</pub-id><pub-id pub-id-type="pmid">18063436</pub-id>
</mixed-citation></ref><ref id="R248"><mixed-citation publication-type="journal"><name><surname>Vera</surname><given-names>J</given-names></name>, <name><surname>Balsa-Canto</surname><given-names>E</given-names></name>, <name><surname>Wellstead</surname><given-names>P</given-names></name>, <name><surname>Banga</surname><given-names>JR</given-names></name>, and <name><surname>Wolkenhauer</surname><given-names>O</given-names></name> (<year>2007</year>). <article-title>Power-law models of signal transduction pathways</article-title>. <source>Cell. Signal</source>
<volume>19</volume>, <fpage>1531</fpage>&#x02013;<lpage>1541</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cellsig.2007.01.029</pub-id><pub-id pub-id-type="pmid">17399948</pub-id>
</mixed-citation></ref><ref id="R249"><mixed-citation publication-type="journal"><name><surname>Voit</surname><given-names>EO</given-names></name>, <name><surname>Martens</surname><given-names>HA</given-names></name>, and <name><surname>Omholt</surname><given-names>SW</given-names></name> (<year>2015</year>). <article-title>150 years of the mass action law</article-title>. <source>PLoS Comput. Biol</source>
<volume>11</volume>, <fpage>e1004012</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pcbi.1004012</pub-id><pub-id pub-id-type="pmid">25569257</pub-id>
</mixed-citation></ref><ref id="R250"><mixed-citation publication-type="journal"><name><surname>Vulevic</surname><given-names>J</given-names></name>, <name><surname>Drakoularakou</surname><given-names>A</given-names></name>, <name><surname>Yaqoob</surname><given-names>P</given-names></name>, <name><surname>Tzortzis</surname><given-names>G</given-names></name>, and <name><surname>Gibson</surname><given-names>GR</given-names></name> (<year>2008</year>). <article-title>Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers</article-title>. <source>Am. J. Clin. Nutr</source>
<volume>88</volume>, <fpage>1438</fpage>&#x02013;<lpage>1446</lpage>. doi:<pub-id pub-id-type="doi">10.3945/ajcn.2008.26242</pub-id><pub-id pub-id-type="pmid">18996881</pub-id>
</mixed-citation></ref><ref id="R251"><mixed-citation publication-type="journal"><name><surname>Vulevic</surname><given-names>J</given-names></name>, <name><surname>Juric</surname><given-names>A</given-names></name>, <name><surname>Walton</surname><given-names>GE</given-names></name>, <name><surname>Claus</surname><given-names>SP</given-names></name>, <name><surname>Tzortzis</surname><given-names>G</given-names></name>, <name><surname>Toward</surname><given-names>RE</given-names></name>, <etal/> (<year>2015</year>). <article-title>Influence of galacto-oligosaccharide mixture (B-GOS) on gut microbiota immune parameters and metabonomics in elderly persons</article-title>. <source>Br. J. Nutr</source>
<volume>114</volume>, <fpage>586</fpage>&#x02013;<lpage>595</lpage>. doi:<pub-id pub-id-type="doi">10.1017/s0007114515001889</pub-id><pub-id pub-id-type="pmid">26218845</pub-id>
</mixed-citation></ref><ref id="R252"><mixed-citation publication-type="journal"><name><surname>Walsh</surname><given-names>MC</given-names></name>, and <name><surname>Choi</surname><given-names>Y</given-names></name> (<year>2014</year>). <article-title>Biology of the RANKL-RANK-OPG system in immunity, bone, and beyond</article-title>. <source>Front. Immunol</source>
<volume>5</volume>, <fpage>511</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fimmu.2014.00511</pub-id><pub-id pub-id-type="pmid">25368616</pub-id>
</mixed-citation></ref><ref id="R253"><mixed-citation publication-type="journal"><name><surname>Walsh</surname><given-names>MC</given-names></name>, <name><surname>Kim</surname><given-names>N</given-names></name>, <name><surname>Kadono</surname><given-names>Y</given-names></name>, <name><surname>Rho</surname><given-names>J</given-names></name>, <name><surname>Lee</surname><given-names>SY</given-names></name>, <name><surname>Lorenzo</surname><given-names>J</given-names></name>, <etal/> (<year>2006</year>). <article-title>Osteoimmunology: interplay between the immune system and bone metabolism</article-title>. <source>Annu. Rev. Im&#x00442;&#x00438;nol</source>
<volume>24</volume>, <fpage>33</fpage>&#x02013;<lpage>63</lpage>. doi:<pub-id pub-id-type="doi">10.1146/annurev.immunol.24.021605.090646</pub-id></mixed-citation></ref><ref id="R254"><mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>Y</given-names></name>, <name><surname>Pivonka</surname><given-names>P</given-names></name>, <name><surname>Buenzli</surname><given-names>PR</given-names></name>, <name><surname>Smith</surname><given-names>DW</given-names></name>, and <name><surname>Dunstan</surname><given-names>CR</given-names></name> (<year>2011</year>). <article-title>Computational modeling of interactions between multiple myeloma and the bone microenvironment</article-title>. <source>PLoS ONE</source>
<volume>6</volume>, <fpage>e27494</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0027494</pub-id><pub-id pub-id-type="pmid">22110661</pub-id>
</mixed-citation></ref><ref id="R255"><mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>Y</given-names></name>, and <name><surname>Qin</surname><given-names>Q-H</given-names></name> (<year>2012</year>). <article-title>A theoretical study of bone remodelling under PEMF at cellular level</article-title>. <source>Comput. Methods Biomech. Biomed. Engin</source>
<volume>15</volume>, <fpage>885</fpage>&#x02013;<lpage>897</lpage>. doi:<pub-id pub-id-type="doi">10.1080/10255842.2011.565752</pub-id><pub-id pub-id-type="pmid">21604221</pub-id>
</mixed-citation></ref><ref id="R256"><mixed-citation publication-type="journal"><name><surname>Weaver</surname><given-names>CM</given-names></name>, <name><surname>Martin</surname><given-names>BR</given-names></name>, <name><surname>Nakatsu</surname><given-names>CH</given-names></name>, <name><surname>Armstrong</surname><given-names>AP</given-names></name>, <name><surname>Clavijo</surname><given-names>A</given-names></name>, <name><surname>McCabe</surname><given-names>LD</given-names></name>, <etal/> (<year>2011</year>). <article-title>Galactooligosaccharides improve mineral absorption and bone properties in growing rats through gut fermentation</article-title>. <source>J. Agric. Food Chem</source>
<volume>59</volume>, <fpage>6501</fpage>&#x02013;<lpage>6510</lpage>. doi:<pub-id pub-id-type="doi">10.1021/jf2009777</pub-id><pub-id pub-id-type="pmid">21553845</pub-id>
</mixed-citation></ref><ref id="R257"><mixed-citation publication-type="journal"><name><surname>Webster</surname><given-names>D</given-names></name>, and <name><surname>M&#x000fc;ller</surname><given-names>R</given-names></name> (<year>2011</year>). <article-title>In silico models of bone remodeling from macro to nano-from organ to cell</article-title>. <source>WIREs Syst. Biol. Med</source>
<volume>3</volume>, <fpage>241</fpage>&#x02013;<lpage>251</lpage>. doi:<pub-id pub-id-type="doi">10.1002/wsbm.115</pub-id></mixed-citation></ref><ref id="R258"><mixed-citation publication-type="journal"><name><surname>Weilbaecher</surname><given-names>KN</given-names></name> (<year>2000</year>). <article-title>Mechanisms of osteoporosis after hematopoietic cell transplantation</article-title>. <source>Biol. Blood Marrow Tr</source>
<volume>6</volume>, <fpage>165</fpage>&#x02013;<lpage>174</lpage>. doi:<pub-id pub-id-type="doi">10.1016/s1083-8791(00)70039-5</pub-id></mixed-citation></ref><ref id="R259"><mixed-citation publication-type="journal"><name><surname>Wein</surname><given-names>MN</given-names></name>, and <name><surname>Kronenberg</surname><given-names>HM</given-names></name> (<year>2018</year>). <article-title>Regulation of bone remodeling by parathyroid hormone</article-title>. <source>Cold Spring Harb. Perspect. Med</source>
<volume>8</volume>, <fpage>a031237</fpage>. doi:<pub-id pub-id-type="doi">10.1101/cshperspect.a031237</pub-id><pub-id pub-id-type="pmid">29358318</pub-id>
</mixed-citation></ref><ref id="R260"><mixed-citation publication-type="journal"><name><surname>Weitzmann</surname><given-names>MN</given-names></name> (<year>2017</year>). <article-title>Bone and the immune system</article-title>. <source>Toxicol. Pathol</source>
<volume>45</volume>, <fpage>911</fpage>&#x02013;<lpage>924</lpage>. doi:<pub-id pub-id-type="doi">10.1177/0192623317735316</pub-id><pub-id pub-id-type="pmid">29046115</pub-id>
</mixed-citation></ref><ref id="R261"><mixed-citation publication-type="journal"><name><surname>Weitzmann</surname><given-names>MN</given-names></name>, and <name><surname>Ofotokun</surname><given-names>I</given-names></name> (<year>2016</year>). <article-title>Physiological and pathophysiologica bone turnover - role of the immune system</article-title>. <source>Nat. Rev. Endocrinol</source>
<volume>12</volume>, <fpage>518</fpage>&#x02013;<lpage>532</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrendo.2016.9</pub-id><pub-id pub-id-type="pmid">27312863</pub-id>
</mixed-citation></ref><ref id="R262"><mixed-citation publication-type="journal"><name><surname>Wong</surname><given-names>BR</given-names></name>, <name><surname>Rho</surname><given-names>J</given-names></name>, <name><surname>Arron</surname><given-names>J</given-names></name>, <name><surname>Robinson</surname><given-names>E</given-names></name>, <name><surname>Orlinick</surname><given-names>J</given-names></name>, <name><surname>Chao</surname><given-names>M</given-names></name>, <etal/> (<year>1997</year>). <article-title>TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells</article-title>. <source>J. Biol. Chem</source>
<volume>272</volume>, <fpage>25190</fpage>&#x02013;<lpage>25194</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.272.40.25190</pub-id><pub-id pub-id-type="pmid">9312132</pub-id>
</mixed-citation></ref><ref id="R263"><mixed-citation publication-type="journal"><name><surname>Wu</surname><given-names>M</given-names></name>, <name><surname>Chen</surname><given-names>G</given-names></name>, and <name><surname>Li</surname><given-names>Y-P</given-names></name> (<year>2016</year>). <article-title>TGF-&#x003b2; and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease</article-title>. <source>Bone Res</source>. <volume>4</volume>, <fpage>16009</fpage>. doi:<pub-id pub-id-type="doi">10.1038/boneres.2016.9</pub-id><pub-id pub-id-type="pmid">27563484</pub-id>
</mixed-citation></ref><ref id="R264"><mixed-citation publication-type="journal"><name><surname>Zaiss</surname><given-names>MM</given-names></name>, <name><surname>Jones</surname><given-names>RM</given-names></name>, <name><surname>Schett</surname><given-names>G</given-names></name>, and <name><surname>Pacifici</surname><given-names>R</given-names></name> (<year>2019</year>). <article-title>The gut-bone axis: how bacteria metabolites bridge the distance</article-title>. <source>J. Clin. Invest</source>
<volume>129</volume>, <fpage>3018</fpage>&#x02013;<lpage>3028</lpage>. doi:<pub-id pub-id-type="doi">10.1172/jci128521</pub-id><pub-id pub-id-type="pmid">31305265</pub-id>
</mixed-citation></ref><ref id="R265"><mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>J</given-names></name>, <name><surname>Motyl</surname><given-names>KJ</given-names></name>, <name><surname>Irwin</surname><given-names>R</given-names></name>, <name><surname>MacDougald</surname><given-names>OA</given-names></name>, <name><surname>Britton</surname><given-names>RA</given-names></name>, and <name><surname>McCabe</surname><given-names>LR</given-names></name> (<year>2015</year>). <article-title>Loss of bone and Wnt10b expression in male type 1 diabetic mice is blocked by the probiotic Lactobacillus reuteri</article-title>. <source>Endocrinology</source>
<volume>156</volume>, <fpage>3169</fpage>&#x02013;<lpage>3182</lpage>. doi:<pub-id pub-id-type="doi">10.1210/en.2015-1308</pub-id><pub-id pub-id-type="pmid">26135835</pub-id>
</mixed-citation></ref><ref id="R266"><mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>L</given-names></name>, and <name><surname>Mager</surname><given-names>DE</given-names></name> (<year>2019</year>). <article-title>Systems modeling of bortezomib and dexamethasone combinatorial effects on bone homeostasis in multiple myeloma patients</article-title>. <source>J. Pharm. Sci</source>
<volume>108</volume>, <fpage>732</fpage>&#x02013;<lpage>740</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.xphs.2018.11.024</pub-id><pub-id pub-id-type="pmid">30472266</pub-id>
</mixed-citation></ref><ref id="R267"><mixed-citation publication-type="journal"><name><surname>Zhao</surname><given-names>Y</given-names></name>, and <name><surname>Zhang</surname><given-names>G</given-names></name> (<year>2019</year>). <article-title>A computational study of the dual effect of intermittent and continuous administration of parathyroid hormone on bone remodeling</article-title>. <source>Acta Biomater</source>. <volume>93</volume>, <fpage>200</fpage>&#x02013;<lpage>209</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.actbio.2019.04.007</pub-id><pub-id pub-id-type="pmid">30954625</pub-id>
</mixed-citation></ref><ref id="R268"><mixed-citation publication-type="journal"><name><surname>Zumsande</surname><given-names>M</given-names></name>, <name><surname>Stiefs</surname><given-names>D</given-names></name>, <name><surname>Siegmund</surname><given-names>S</given-names></name>, and <name><surname>Gross</surname><given-names>T</given-names></name> (<year>2011</year>). <article-title>General analysis of mathematical models for bone remodeling</article-title>. <source>Bone</source>
<volume>48</volume>, <fpage>910</fpage>&#x02013;<lpage>917</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bone.2010.12.010</pub-id><pub-id pub-id-type="pmid">21185412</pub-id>
</mixed-citation></ref></ref-list></back><floats-group><fig position="float" id="F1"><label>FIGURE 1</label><caption><p id="P102">Bone remodeling cycle. Resting bone is covered in bone lining cells with healthy osteocytes embedded in the bone. Step 1, Activation: Bone remodeling starts when the osteocytes are activated or damaged. Step 2, Resorption: During the resorption phase, osteoclasts are formed from preosteoclasts and break down bone in a cavity. Step 3, Reversal: Mononuclear cells that are known as reversal cells prepare the surface as preosteoblasts arrive at the cavity during the reversal phase. These preosteoblasts proliferate and convert into osteoblasts. Step 4, Formation: Osteoblasts reform the bone matrix by depositing osteoid, which later mineralizes. While the matrix is being deposited, some osteoblasts embed in the bone, becoming osteocytes. Step 5, Resting: The bone remains resting until another cycle of bone remodeling is initiated. Created with <ext-link xlink:href="http://BioRender.com" ext-link-type="uri">BioRender.com</ext-link>.</p></caption><graphic xlink:href="nihms-2015369-f0001" position="float"/></fig><fig position="float" id="F2"><label>FIGURE 2</label><caption><p id="P103">Osteoclasts and osteoblasts form via osteoclastogenesis and osteoblastogenesis, respectively. In osteoclastogenesis, osteoclasts are derived from monocyte progenitor cells that differentiate into mononuclear preosteoclasts, which fuse into active multinucleated osteoclasts. Preosteoclast proliferation and fusion is stimulated by osteoblastic lineage-derived receptor activator of nuclear factor kappa B ligand (RANKL) binding to RANK on osteoclastic cells. Osteoblast-produced osteoprotegerin (OPG), a decoy receptor, inhibits osteoclastogenesis by binding to RANKL. In osteoblastogenesis, osteoblasts originate from mesenchymal stem cells that differentiate into preosteoblasts. Osteoblastogenesis is typically stimulated by canonical wingless-related integration site (Wnt) signaling, which occurs when osteoclast-derived Wnt-10b ligands bind to lipoprotein receptor-related protein 5 or 6 (LRP5/6) and Frizzled coreceptors on osteoblastic cells. Canonical Wnt signaling also stimulates OPG expression and inhibits osteoblast apoptosis. Osteoblastogenesis is inhibited by osteoblast-derived dickkopf-related protein 1 (DKK1) and osteocyte-derived sclerostin, which bind to canonical Wnt LRP5/6 receptors. Receptors and ligands expressed from osteoclastic or osteoblastic sources are not explicitly shown with arrows to simplify this diagram; instead, they are indicated by color. Ligands from osteoclastic sources include Wnt-10b (white). Receptors from osteoclastic sources include RANK (orange). Ligands from osteoblastic sources include RANKL, sclerostin, and DKK1 (purple). Receptors from osteoblastic sources include OPG, LRP5/6, and Frizzled (blue). Created with <ext-link xlink:href="http://BioRender.com" ext-link-type="uri">BioRender.com</ext-link>.</p></caption><graphic xlink:href="nihms-2015369-f0002" position="float"/></fig><fig position="float" id="F3"><label>FIGURE 3</label><caption><p id="P104">Several local and systemic cells and chemicals influence bone health, and their complex interactions can be explored via mathematical models of the bone remodeling process. Created with <ext-link xlink:href="http://BioRender.com" ext-link-type="uri">BioRender.com</ext-link>. Adapted from &#x0201c;Pie Chart 7X&#x0201d; by <ext-link xlink:href="http://BioRender.com" ext-link-type="uri">BioRender.com</ext-link> (2022). Retrieved from <ext-link xlink:href="https://app.biorender.com/biorender-templates" ext-link-type="uri">https://app.biorender.com/biorender-templates</ext-link>.</p></caption><graphic xlink:href="nihms-2015369-f0003" position="float"/></fig><fig position="float" id="F4"><label>FIGURE 4</label><caption><p id="P105">Endocrine and pharmaceutical modulators of bone health. Intermittent dosing of parathyroid hormone (PTH) stimulates preosteoblast formation and inhibits preosteoblasts&#x02019; differentiation to osteoblasts. Estrogen inhibits the development of osteoclasts while also protecting osteoblasts and osteocytes from apoptosis. Glucocorticoids inhibit osteoblast development and survival, increase osteocyte apoptosis, and decrease osteoclast apoptosis. Antiresorptives such as bisphosphonates and monoclonal antibodies promote osteoclast apoptosis. Created with <ext-link xlink:href="http://BioRender.com" ext-link-type="uri">BioRender.com</ext-link>.</p></caption><graphic xlink:href="nihms-2015369-f0004" position="float"/></fig><fig position="float" id="F5"><label>FIGURE 5</label><caption><p id="P106">A network graph shows the citation relationship between mathematical models of bone remodeling that use the power law approach popularized by <xref rid="R135" ref-type="bibr">Komarova et al. (2003)</xref> and the mass action kinetics approach popularized by <xref rid="R147" ref-type="bibr">Lemaire et al. (2004)</xref> and <xref rid="R192" ref-type="bibr">Pivonka et al. (2008)</xref>, which are detailed in <xref rid="T1" ref-type="table">Tables 1</xref>&#x02013;<xref rid="T3" ref-type="table">3</xref> and <xref rid="SD1" ref-type="supplementary-material">Supplementary Tables S1</xref>&#x02013;<xref rid="SD1" ref-type="supplementary-material">S2</xref>. Each dot indicates a model publication, and curves represent a citation from one article to another. Yellow dots indicate temporal models, and dark blue dots indicate spatiotemporal models. Larger dots correspond to models with more publications (cited by). Models most connected to other articles are higher in the diagram (map relevance), while the left-to-right organization aids in clarity and label visibility (cluster). Note that not all labels are shown because of space constraints. The naming convention is the first author&#x02019;s last name followed by the year of publication. This literature map was created using the online tool <ext-link xlink:href="http://app.litmaps.com" ext-link-type="uri">app.litmaps.com</ext-link>.</p></caption><graphic xlink:href="nihms-2015369-f0005" position="float"/></fig><fig position="float" id="F6"><label>FIGURE 6</label><caption><p id="P107">Quantitative comparison of cells (top row) and chemical signals (bottom row) commonly included in the 88 mathematical models of bone remodeling detailed in <xref rid="T1" ref-type="table">Tables 1</xref>&#x02013;<xref rid="T4" ref-type="table">4</xref>. Abbreviations: pOCL, preosteoclasts; OCL, osteoclasts; pOBL, preosteoblasts; OBL, osteoblasts; OCY, osteocytes; Immune, immune cells; A&#x00026;P, general autocrine and paracrine signaling; RANK, receptor activator of nuclear factor kappa-B; RANKL, receptor activator of nuclear factor kappa-B ligand; OPG, osteoprotegerin; TGF-<inline-formula><mml:math id="M1" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula>, transforming growth factor beta; SCL, sclerostin; Wnt, wingless-related integration site; PTH, parathyroid hormone; Cyt, cytokines other than RANK, RANKL, OPG, and TGF-<inline-formula><mml:math id="M2" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula>; E, estrogen.</p></caption><graphic xlink:href="nihms-2015369-f0006" position="float"/></fig><table-wrap position="float" id="T1" orientation="landscape"><label>TABLE 1</label><caption><p id="P108">Overview of cells and signaling molecules commonly included in spatiotemporal biochemical models of bone remodeling.</p></caption><table frame="box" rules="all"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1">References</th><th align="center" valign="middle" rowspan="1" colspan="1">pOCL</th><th align="center" valign="middle" rowspan="1" colspan="1">OCL</th><th align="center" valign="middle" rowspan="1" colspan="1">pOBL</th><th align="center" valign="middle" rowspan="1" colspan="1">OBL</th><th align="center" valign="middle" rowspan="1" colspan="1">OCY</th><th align="center" valign="middle" rowspan="1" colspan="1">RANK</th><th align="center" valign="middle" rowspan="1" colspan="1">RANKL</th><th align="center" valign="middle" rowspan="1" colspan="1">OPG</th><th align="center" valign="middle" rowspan="1" colspan="1">A&#x00026;P</th><th align="center" valign="middle" rowspan="1" colspan="1">TGF&#x003b2;</th><th align="center" valign="middle" rowspan="1" colspan="1">PTH</th><th align="center" valign="middle" rowspan="1" colspan="1">Other</th></tr></thead><tbody><tr><td colspan="13" align="left" valign="middle" rowspan="1">ABMs</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R247" ref-type="bibr">van Oers et al. (2008)</xref>
<xref rid="TFN1" ref-type="table-fn">*</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R35" ref-type="bibr">Buenzli et al. (2012a)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R9" ref-type="bibr">Arias et al. (2018)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R238" ref-type="bibr">Taylor-King et al. (2020)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td colspan="13" align="left" valign="middle" rowspan="1">ABMs &#x00026; PDEs</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R8" ref-type="bibr">Araujo et al. (2014)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td colspan="13" align="left" valign="middle" rowspan="1">PDEs</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R210" ref-type="bibr">Ryser et al. (2009)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R16" ref-type="bibr">Ayati et al. (2010)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R208" ref-type="bibr">Ryser et al. (2010)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R37" ref-type="bibr">Buenzli et al. (2011)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R96" ref-type="bibr">Graham and Ayati (2012)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R211" ref-type="bibr">Ryser et al. (2012)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R38" ref-type="bibr">Buenzli et al. (2014)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R34" ref-type="bibr">Buenzli (2015)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R148" ref-type="bibr">Lerebours et al. (2016)</xref>
<xref rid="TFN1" ref-type="table-fn">*</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R209" ref-type="bibr">Ryser and Murgas (2017)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R189" ref-type="bibr">Peyroteo et al. (2019)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R128" ref-type="bibr">Kameo et al. (2020)</xref>
<xref rid="TFN1" ref-type="table-fn">*</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">SCL</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R18" ref-type="bibr">Baldonedo et al. (2021)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">SCL</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R40" ref-type="bibr">Calvo-Gallego et al. (2023)</xref>
<xref rid="TFN1" ref-type="table-fn">*</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R111" ref-type="bibr">Idrees and Sohail (2023)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p id="P109">The * symbol indicates models that include biomechanical features. The modeling approaches and additional details are available in <xref rid="SD1" ref-type="supplementary-material">Supplementary Tables S1</xref>&#x02013;<xref rid="SD1" ref-type="supplementary-material">S3</xref>.</p></fn><fn id="TFN2"><p id="P110">Abbreviations: ABMs, agent-based models; PDEs, partial differential equations; pOCL, preosteoclasts; OCL, osteoclasts; pOBL, preosteoblasts; OBL, osteoblasts; OCY, osteocytes; RANK, receptor activator of nuclear factor kappa-B; RANKL, receptor activator of nuclear factor kappa-B ligand; OPG, osteoprotegerin; A&#x00026;P, general autocrine and paracrine signaling; TGF-<inline-formula><mml:math id="M3" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula>, transforming growth factor beta; PTH, parathyroid hormone; SCL, sclerostin.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T2" orientation="landscape"><label>TABLE 2</label><caption><p id="P111">Overview of cells and signaling molecules commonly included in ODEs-based temporal biochemical models of bone remodeling that follow the power law approach.</p></caption><table frame="box" rules="all"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">References</td><td align="center" valign="middle" rowspan="1" colspan="1">pOCL</td><td align="center" valign="middle" rowspan="1" colspan="1">OCL</td><td align="center" valign="middle" rowspan="1" colspan="1">pOBL</td><td align="center" valign="middle" rowspan="1" colspan="1">OBL</td><td align="center" valign="middle" rowspan="1" colspan="1">OCY</td><td align="center" valign="middle" rowspan="1" colspan="1">RANKL</td><td align="center" valign="middle" rowspan="1" colspan="1">TGF&#x003b2;</td><td align="center" valign="middle" rowspan="1" colspan="1">SCL</td><td align="center" valign="middle" rowspan="1" colspan="1">Wnt</td><td align="center" valign="middle" rowspan="1" colspan="1">PTH</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R135" ref-type="bibr">Komarova et al. (2003)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R134" ref-type="bibr">Komarova (2005)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R87" ref-type="bibr">Garz&#x000f3;n-Alvarado (2012)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R153" ref-type="bibr">Li&#x000f2; et al. (2012)</xref>
<sup>
<xref rid="TFN4" ref-type="table-fn">&#x02020;</xref>
</sup>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R95" ref-type="bibr">Graham et al. (2013)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R121" ref-type="bibr">Jerez and Chen (2015)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R47" ref-type="bibr">Chen-Charpentier and Diakite (2016)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R49" ref-type="bibr">Coelho et al. (2016)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R122" ref-type="bibr">Jerez et al. (2018)</xref>
<sup>
<xref rid="TFN4" ref-type="table-fn">&#x02020;</xref>
</sup>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R41" ref-type="bibr">Camacho and Jerez (2019)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R112" ref-type="bibr">Idrees et al. (2019)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R119" ref-type="bibr">Javed et al. (2019)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R110" ref-type="bibr">Idrees and Sohail (2020)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R168" ref-type="bibr">Miranda et al. (2020)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R42" ref-type="bibr">Camacho and Jerez (2021)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R114" ref-type="bibr">Islam et al. (2021)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R52" ref-type="bibr">Cook et al. (2022)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="TFN3"><p id="P112">All models include general autocrine and paracrine (A&#x00026;P) signaling.</p></fn><fn id="TFN4"><p id="P113">The <sup>&#x02020;</sup> symbol indicates models that include stochasticity. Additional details are available in <xref rid="SD1" ref-type="supplementary-material">Supplementary Table S1</xref>.</p></fn><fn id="TFN5"><p id="P114">Abbreviations: ODEs, ordinary differential equations; pOCL, preosteoclasts; OCL, osteoclasts; pOBL, preosteoblasts; OBL, osteoblasts; OCY, osteocytes; RANKL, receptor activator of nuclear factor kappa-B ligand; TGF-<inline-formula><mml:math id="M4" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula>, transforming growth factor beta; SCL, sclerostin; Wnt, wingless-related integration site; PTH, parathyroid hormone.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T3" orientation="landscape"><label>TABLE 3</label><caption><p id="P115">Overview of cells and signaling molecules commonly included in ODEs-based temporal biochemical models of bone remodeling that follow the mass action kinetics approach.</p></caption><table frame="box" rules="all"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1">References</th><th align="center" valign="middle" rowspan="1" colspan="1">pOCL</th><th align="center" valign="middle" rowspan="1" colspan="1">OCL</th><th align="center" valign="middle" rowspan="1" colspan="1">pOBL</th><th align="center" valign="middle" rowspan="1" colspan="1">OBL</th><th align="center" valign="middle" rowspan="1" colspan="1">OCY</th><th align="center" valign="middle" rowspan="1" colspan="1">SCL</th><th align="center" valign="middle" rowspan="1" colspan="1">Wnt</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R147" ref-type="bibr">Lemaire et al. (2004)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R158" ref-type="bibr">Marathe et al. (2008)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R192" ref-type="bibr">Pivonka et al. (2008)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R187" ref-type="bibr">Peterson and Riggs (2010)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R193" ref-type="bibr">Pivonka et al. (2010)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R159" ref-type="bibr">Marathe et al. (2011)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R217" ref-type="bibr">Schmidt et al. (2011)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R254" ref-type="bibr">Wang et al. (2011)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R36" ref-type="bibr">Buenzli et al. (2012b)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R188" ref-type="bibr">Peterson and Riggs (2012)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R205" ref-type="bibr">Ross et al. (2012)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R255" ref-type="bibr">Wang and Qin (2012)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R190" ref-type="bibr">Pivonka et al. (2013)</xref>
<xref rid="TFN7" ref-type="table-fn">*</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R196" ref-type="bibr">Post et al. (2013)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R214" ref-type="bibr">Scheiner et al. (2013)</xref>
<xref rid="TFN7" ref-type="table-fn">*</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R124" ref-type="bibr">Ji et al. (2014)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R215" ref-type="bibr">Scheiner et al. (2014)</xref>
<xref rid="TFN7" ref-type="table-fn">*</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R25" ref-type="bibr">Berkhout et al. (2015)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R70" ref-type="bibr">Eudy et al. (2015)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R24" ref-type="bibr">Berkhout et al. (2016)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R143" ref-type="bibr">Lee and Okos (2016)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R72" ref-type="bibr">Farhat et al. (2017)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R206" ref-type="bibr">Ross et al. (2017)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R100" ref-type="bibr">Hasegawa and Duffull (2018)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R185" ref-type="bibr">Pastrama et al. (2018)</xref>
<xref rid="TFN7" ref-type="table-fn">*</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R126" ref-type="bibr">Ji et al. (2019)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R146" ref-type="bibr">Lemaire and Cox (2019)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R160" ref-type="bibr">Martin et al. (2019)</xref>
<xref rid="TFN7" ref-type="table-fn">*</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">X</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R164" ref-type="bibr">Mart&#x000ed;nez-Reina and Pivonka (2019)</xref>
<xref rid="TFN7" ref-type="table-fn">*</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R245" ref-type="bibr">Trichilo et al. (2019)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R266" ref-type="bibr">Zhang and Mager (2019)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R15" ref-type="bibr">Ashrafi et al. (2020)</xref>
<xref rid="TFN7" ref-type="table-fn">*</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R17" ref-type="bibr">Bahia et al. (2020)</xref>
<xref rid="TFN7" ref-type="table-fn">*</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R123" ref-type="bibr">Ji et al. (2020)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R141" ref-type="bibr">Lavaill et al. (2020)</xref>
<xref rid="TFN7" ref-type="table-fn">*</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R161" ref-type="bibr">Martin et al. (2020)</xref>
<xref rid="TFN7" ref-type="table-fn">*</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">X</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R140" ref-type="bibr">Larcher and Scheiner (2021)</xref>
<xref rid="TFN7" ref-type="table-fn">*</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="TFN6"><p id="P116">All models include RANK, RANKL, OPG, TGF-<inline-formula><mml:math id="M5" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula>, and PTH.</p></fn><fn id="TFN7"><p id="P117">The * symbol indicates models that include biomechanical features. Additional details are available in <xref rid="SD1" ref-type="supplementary-material">Supplementary Table S2</xref>.</p></fn><fn id="TFN8"><p id="P118">Abbreviations: ODEs, ordinary differential equations; pOCL, preosteoclasts; OCL, osteoclasts; pOBL, preosteoblasts; OBL, osteoblasts; OCY, osteocytes; RANK, receptor activator of nuclear factor kappa-B; RANKL, receptor activator of nuclear factor kappa-B ligand; OPG, osteoprotegerin; TGF-<inline-formula><mml:math id="M6" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula>, transforming growth factor beta; PTH, parathyroid hormone; SCL, sclerostin; Wnt, wingless-related integration site.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T4" orientation="landscape"><label>TABLE 4</label><caption><p id="P119">Overview of cells and signaling molecules commonly included in ODEs-based temporal biochemical models of bone remodeling that do not follow the power law or mass action kinetics approaches.</p></caption><table frame="box" rules="all"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1">References</th><th align="center" valign="middle" rowspan="1" colspan="1">pOCL</th><th align="center" valign="middle" rowspan="1" colspan="1">pOBL</th><th align="center" valign="middle" rowspan="1" colspan="1">OCY</th><th align="center" valign="middle" rowspan="1" colspan="1">A&#x00026;P</th><th align="center" valign="middle" rowspan="1" colspan="1">RANK</th><th align="center" valign="middle" rowspan="1" colspan="1">RANKL</th><th align="center" valign="middle" rowspan="1" colspan="1">OPG</th><th align="center" valign="middle" rowspan="1" colspan="1">TGF&#x003b2;</th><th align="center" valign="middle" rowspan="1" colspan="1">SCL</th><th align="center" valign="middle" rowspan="1" colspan="1">Wnt</th><th align="center" valign="middle" rowspan="1" colspan="1">PTH</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R139" ref-type="bibr">Kroll (2000)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R200" ref-type="bibr">Rattanakul et al. (2003)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R162" ref-type="bibr">Martin and Buckland-Wright (2004)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R169" ref-type="bibr">Moroz et al. (2006)</xref>
<xref rid="TFN10" ref-type="table-fn">*</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R170" ref-type="bibr">Moroz and Wimpenny (2007)</xref>
<xref rid="TFN10" ref-type="table-fn">*</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R4" ref-type="bibr">Akchurin et al. (2008)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R125" ref-type="bibr">Ji et al. (2012)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R197" ref-type="bibr">Proctor and Gartland (2016)</xref>
<xref rid="TFN10" ref-type="table-fn">*</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R43" ref-type="bibr">Chaiya and Rattanakul (2017)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R118" ref-type="bibr">Javed et al. (2018)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R267" ref-type="bibr">Zhao and Zhang (2019)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R117" ref-type="bibr">Javed et al. (2020)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R174" ref-type="bibr">Nutini et al. (2021)</xref>
<xref rid="TFN10" ref-type="table-fn">*</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R127" ref-type="bibr">Jorg et al. (2022)</xref>
</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">x</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="TFN9"><p id="P120">All models include OCL and OBL except <xref rid="R162" ref-type="bibr">Martin and Buckland-Wright (2004)</xref> and <xref rid="R4" ref-type="bibr">Akchurin et al. (2008)</xref>, which only include OCL, and <xref rid="R174" ref-type="bibr">Nutini et al. (2021)</xref>, which only includes OBL.</p></fn><fn id="TFN10"><p id="P121">The * symbol indicates models that include biomechanical features. Additional details are available in <xref rid="SD1" ref-type="supplementary-material">Supplementary Table S3</xref>.</p></fn><fn id="TFN11"><p id="P122">Abbreviations: ODEs, ordinary differential equations; OCL, osteoclasts; OBL, osteoblasts; pOCL, preosteoclasts; pOBL, preosteoblasts; OCY, osteocytes; A&#x00026;P, general autocrine and paracrine signaling; RANK, receptor activator of nuclear factor kappa-B; RANKL, receptor activator of nuclear factor kappa-B ligand; OPG, osteoprotegerin; TGF-<inline-formula><mml:math id="M7" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula>, transforming growth factor beta; SCL, sclerostin; Wnt, wingless-related integration site; PTH, parathyroid hormone.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T5" orientation="landscape"><label>TABLE 5</label><caption><p id="P123">Representation of cytokines in mathematical models of bone remodeling.</p></caption><table frame="box" rules="all"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">References</th><th align="left" valign="top" rowspan="1" colspan="1">Cytokine</th><th align="left" valign="top" rowspan="1" colspan="1">Variable type</th><th align="left" valign="top" rowspan="1" colspan="1">Cytokine interactions</th></tr></thead><tbody><tr><td rowspan="3" align="left" valign="top" colspan="1"><xref rid="R139" ref-type="bibr">Kroll (2000)</xref><sup><xref rid="TFN12" ref-type="table-fn">3</xref></sup>, <xref rid="R112" ref-type="bibr">Idrees et al. (2019)</xref><sup><xref rid="TFN12" ref-type="table-fn">1</xref></sup></td><td rowspan="3" align="left" valign="top" colspan="1">IL-6</td><td rowspan="3" align="left" valign="top" colspan="1">Dynamic</td><td align="left" valign="top" rowspan="1" colspan="1">Stimulates OCL formation (time-delayed)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Production rate by OBL</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Elimination rate of IL-6</td></tr><tr><td rowspan="4" align="left" valign="top" colspan="1"><xref rid="R254" ref-type="bibr">Wang et al. (2011)</xref><sup><xref rid="TFN12" ref-type="table-fn">2</xref></sup>, <xref rid="R124" ref-type="bibr">Ji et al. (2014)</xref><sup><xref rid="TFN12" ref-type="table-fn">2</xref></sup>, <xref rid="R123" ref-type="bibr">Ji et al. (2020)</xref><sup><xref rid="TFN12" ref-type="table-fn">2</xref></sup></td><td rowspan="4" align="left" valign="top" colspan="1">IL-6</td><td rowspan="4" align="left" valign="top" colspan="1">Dynamic</td><td align="left" valign="top" rowspan="1" colspan="1">Production rate by BMSC via TGF-&#x003b2;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Stimulates RANKL expression by pOBL</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Production by tumor-BMSC adhesion via VLA4</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Stimulates tumor cell proliferation</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="R162" ref-type="bibr">Martin and Buckland-Wright (2004)</xref>
<sup><xref rid="TFN12" ref-type="table-fn">3</xref>,<xref rid="TFN13" ref-type="table-fn">&#x02021;</xref></sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">MCSF</td><td align="left" valign="top" rowspan="1" colspan="1">Constant</td><td align="left" valign="top" rowspan="1" colspan="1">Presence in healthy bone tissue</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><xref rid="R190" ref-type="bibr">Pivonka et al. (2013)</xref><sup><xref rid="TFN12" ref-type="table-fn">2</xref></sup>, <xref rid="R148" ref-type="bibr">Lerebours et al. (2016)</xref><sup><xref rid="TFN12" ref-type="table-fn">2</xref>,<xref rid="TFN14" ref-type="table-fn">&#x000a7;</xref></sup></td><td align="left" valign="top" rowspan="1" colspan="1">MCSF</td><td align="left" valign="top" rowspan="1" colspan="1">Constant</td><td align="left" valign="top" rowspan="1" colspan="1">Binding on uncommitted OCL</td></tr><tr><td rowspan="5" align="left" valign="top" colspan="1">
<xref rid="R197" ref-type="bibr">Proctor and Gartland (2016)</xref>
<sup><xref rid="TFN12" ref-type="table-fn">3</xref>,<xref rid="TFN13" ref-type="table-fn">&#x02021;</xref></sup>
</td><td rowspan="5" align="left" valign="top" colspan="1">MCSF</td><td rowspan="5" align="left" valign="top" colspan="1">Dynamic</td><td align="left" valign="top" rowspan="1" colspan="1">Stimulates HSC differentiation to pOCL</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Production by OBL progenitor</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Production by pOBL and OBL</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Production by PTH-stimulated pOBL and OBL</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Degradation rate of MCSF</td></tr><tr><td rowspan="2" align="left" valign="top" colspan="1">
<xref rid="R87" ref-type="bibr">Garz&#x000f3;n-Alvarado (2012)</xref>
<sup><xref rid="TFN12" ref-type="table-fn">1</xref>,<xref rid="TFN13" ref-type="table-fn">&#x02021;</xref></sup>
</td><td rowspan="2" align="left" valign="top" colspan="1">IGF</td><td rowspan="2" align="left" valign="top" colspan="1">Dynamic</td><td align="left" valign="top" rowspan="1" colspan="1">Inhibits OBL differentiation</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Production by tumor cells</td></tr><tr><td rowspan="3" align="left" valign="top" colspan="1">
<xref rid="R143" ref-type="bibr">Lee and Okos (2016)</xref>
<sup>
<xref rid="TFN12" ref-type="table-fn">2</xref>
</sup>
</td><td rowspan="3" align="left" valign="top" colspan="1">IGF-1</td><td rowspan="3" align="left" valign="top" colspan="1">Dynamic</td><td align="left" valign="top" rowspan="1" colspan="1">Binding kinetics to IGFBP3 receptor</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Stimulates pOBL formation</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Stimulates pOBL differentiation to OBL</td></tr></tbody></table><table-wrap-foot><fn id="TFN12"><p id="P124">The modeling approach is denoted by superscripts as follows: (1) power law, (2) mass action kinetics, or (3) neither. All models that follow the mass action kinetics approach include RANK, RANKL, OPG, and TGF-<inline-formula><mml:math id="M8" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula>.</p></fn><fn id="TFN13"><p id="P125">Models that do not follow this approach but include any of the signals above are indicated by the <sup>&#x02021;</sup> symbol.</p></fn><fn id="TFN14"><p id="P126">Spatiotemporal models are indicated by the <sup>&#x000a7;</sup> symbol.</p></fn><fn id="TFN15"><p id="P127">Abbreviations: RANK, receptor activator of nuclear factor kappa-B; RANKL, receptor activator of nuclear factor kappa-B ligand; OPG, osteoprotegerin; TGF-<inline-formula><mml:math id="M9" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula>, IL-6, transforming growth factor beta; interleukin-6; OCL, osteoclasts; OBL, osteoblasts; BMSC, bone marrow stromal cells also known as mesenchymal stem cells; pOBL, preosteoblasts; VLA4, very late antigen-4; MCSF, macrophage colony-stimulating factor; HSC, hematopoietic stem cells; pOCL, preosteoclasts; PTH, parathyroid hormone; IGF, insulin-like growth factor; IGFBP3, insulin-like growth factor binding protein 3.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T6" orientation="landscape"><label>TABLE 6</label><caption><p id="P128">Representation of immune cells in mathematical models of bone remodeling.</p></caption><table frame="box" rules="all"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">References</th><th align="left" valign="top" rowspan="1" colspan="1">Immune Cell(s)</th><th align="left" valign="top" rowspan="1" colspan="1">Variable type</th><th align="left" valign="top" rowspan="1" colspan="1">Cell interactions</th></tr></thead><tbody><tr><td rowspan="2" align="left" valign="top" colspan="1">
<xref rid="R4" ref-type="bibr">Akchurin et al. (2008)</xref>
<sup><xref rid="TFN16" ref-type="table-fn">3</xref>,<xref rid="TFN17" ref-type="table-fn">&#x02021;</xref></sup>
</td><td rowspan="2" align="left" valign="top" colspan="1">Monocytes</td><td rowspan="2" align="left" valign="top" colspan="1">Dynamic</td><td align="left" valign="top" rowspan="1" colspan="1">Proliferation and fusion of monocytes</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Differentiation to OCL</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="R197" ref-type="bibr">Proctor and Gartland (2016)</xref>
<sup><xref rid="TFN16" ref-type="table-fn">3</xref>,<xref rid="TFN17" ref-type="table-fn">&#x02021;</xref></sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">HSC</td><td align="left" valign="top" rowspan="1" colspan="1">Constant</td><td align="left" valign="top" rowspan="1" colspan="1">Differentiation to pOCL by MCSF</td></tr><tr><td rowspan="4" align="left" valign="top" colspan="1">
<xref rid="R114" ref-type="bibr">Islam et al. (2021)</xref>
<sup>
<xref rid="TFN16" ref-type="table-fn">1</xref>
</sup>
</td><td rowspan="4" align="left" valign="top" colspan="1">Na&#x000ef;ve CD4<sup>+</sup> T cells, Tregs</td><td rowspan="4" align="left" valign="top" colspan="1">Dynamic</td><td align="left" valign="top" rowspan="1" colspan="1">Differentiation of Na&#x000ef;ve T to Tregs</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Effects of butyrate on T cell differentiation</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Migration of Tregs between compartments</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Effects of Tregs on TGF-&#x003b2; fold change</td></tr></tbody></table><table-wrap-foot><fn id="TFN16"><p id="P129">The modeling approach is denoted by superscripts as follows: (1) power law, (2) mass action kinetics, or (3) neither. All models that follow the mass action kinetics approach include RANK, RANKL, OPG, and TGF-<inline-formula><mml:math id="M10" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula>.</p></fn><fn id="TFN17"><p id="P130">Models that do not follow this approach but include any of the signals above are indicated by the <sup>&#x02021;</sup> symbol.</p></fn><fn id="TFN18"><p id="P131">Abbreviations: RANK, receptor activator of nuclear factor kappa-B; RANKL, receptor activator of nuclear factor kappa-B ligand; OPG, osteoprotegerin; TGF-<inline-formula><mml:math id="M11" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula>, transforming growth factor beta; OCL, osteoclasts; HSC, hematopoietic stem cells; pOCL, preosteoclasts; MCSF, macrophage colony-stimulating factor; Tregs, regulatory T cells.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T7" orientation="landscape"><label>TABLE 7</label><caption><p id="P132">Estrogen representation in mathematical models of bone remodeling</p></caption><table frame="box" rules="all"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">References</th><th align="left" valign="top" rowspan="1" colspan="1">PMO treatment</th><th align="left" valign="top" rowspan="1" colspan="1">Estrogen effects in the models</th></tr></thead><tbody><tr><td colspan="3" align="left" valign="top" rowspan="1">Explicit estrogen effects</td></tr><tr><td rowspan="2" align="left" valign="top" colspan="1">
<xref rid="R200" ref-type="bibr">Rattanakul et al. (2003)</xref>
<sup><xref rid="TFN19" ref-type="table-fn">3</xref>,<xref rid="TFN20" ref-type="table-fn">&#x02021;</xref></sup>
</td><td rowspan="2" align="left" valign="top" colspan="1">Estrogen</td><td align="left" valign="top" rowspan="1" colspan="1">Estrogen amplitude</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Increasing OCL removal rate</td></tr><tr><td rowspan="3" align="left" valign="top" colspan="1"><xref rid="R217" ref-type="bibr">Schmidt et al. (2011)</xref><sup><xref rid="TFN19" ref-type="table-fn">2</xref></sup>, <xref rid="R196" ref-type="bibr">Post et al. (2013)</xref><sup><xref rid="TFN19" ref-type="table-fn">2</xref></sup></td><td rowspan="3" align="left" valign="top" colspan="1">Estrogen, tibolone, Ca placebo</td><td align="left" valign="top" rowspan="1" colspan="1">Inhibiting OPG production rate</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Estrogen decay</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Estrogen production rates (endo and exogenous)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><xref rid="R25" ref-type="bibr">Berkhout et al. (2015)</xref><sup><xref rid="TFN19" ref-type="table-fn">2</xref></sup>, <xref rid="R24" ref-type="bibr">Berkhout et al. (2016)</xref><sup><xref rid="TFN19" ref-type="table-fn">2</xref></sup></td><td align="left" valign="top" rowspan="1" colspan="1">Ca placebo, bisphosphonates</td><td align="left" valign="top" rowspan="1" colspan="1">Estrogen elimination rate</td></tr><tr><td rowspan="3" align="left" valign="top" colspan="1">
<xref rid="R43" ref-type="bibr">Chaiya and Rattanakul (2017)</xref>
<sup>
<xref rid="TFN19" ref-type="table-fn">3</xref>
</sup>
</td><td rowspan="3" align="left" valign="top" colspan="1">Estrogen</td><td align="left" valign="top" rowspan="1" colspan="1">Intermittent dosing</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">First-order OCL degradation</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Zero-order OBL production</td></tr><tr><td rowspan="2" align="left" valign="top" colspan="1">
<xref rid="R118" ref-type="bibr">Javed et al. (2018)</xref>
<sup><xref rid="TFN19" ref-type="table-fn">3</xref>,<xref rid="TFN20" ref-type="table-fn">&#x02021;</xref></sup>
</td><td rowspan="2" align="left" valign="top" colspan="1">Denosumab</td><td align="left" valign="top" rowspan="1" colspan="1">Inhibiting RANKL production</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Relative estrogen concentration</td></tr><tr><td rowspan="4" align="left" valign="top" colspan="1">
<xref rid="R127" ref-type="bibr">Jorg et al. (2022)</xref>
<sup>
<xref rid="TFN19" ref-type="table-fn">3</xref>
</sup>
</td><td rowspan="4" align="left" valign="top" colspan="1">Bisphosphonates, RANKL antibodies, SCL antibodies, PTH analogs</td><td align="left" valign="top" rowspan="1" colspan="1">Inhibiting OCL differentiation</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Inhibiting SCL secretion</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Stimulating OCL apoptosis</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Age-dependent estrogen concentration</td></tr><tr><td colspan="3" align="left" valign="top" rowspan="1">Implicit estrogen effects</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="R147" ref-type="bibr">Lemaire et al. (2004)</xref>
<sup>
<xref rid="TFN19" ref-type="table-fn">2</xref>
</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">Parameter variations</td><td align="left" valign="top" rowspan="1" colspan="1">Decreasing OPG production rate</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><xref rid="R214" ref-type="bibr">Scheiner et al. (2013)</xref><sup><xref rid="TFN19" ref-type="table-fn">2</xref></sup>, <xref rid="R140" ref-type="bibr">Larcher and Scheiner (2021)</xref><sup><xref rid="TFN19" ref-type="table-fn">2</xref></sup></td><td align="left" valign="top" rowspan="1" colspan="1">-</td><td align="left" valign="top" rowspan="1" colspan="1">Disease-modifying PTH production (dosage)</td></tr><tr><td rowspan="2" align="left" valign="top" colspan="1">
<xref rid="R215" ref-type="bibr">Scheiner et al. (2014)</xref>
<sup>
<xref rid="TFN19" ref-type="table-fn">2</xref>
</sup>
</td><td rowspan="2" align="left" valign="top" colspan="1">Denosumab</td><td align="left" valign="top" rowspan="1" colspan="1">Disease-modifying RANKL production</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Disease-modifying mechanical sensitivity</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><xref rid="R245" ref-type="bibr">Trichilo et al. (2019)</xref><sup><xref rid="TFN19" ref-type="table-fn">2</xref></sup>, <xref rid="R160" ref-type="bibr">Martin et al. (2019)</xref><sup><xref rid="TFN19" ref-type="table-fn">2</xref></sup></td><td align="left" valign="top" rowspan="1" colspan="1">PTH</td><td align="left" valign="top" rowspan="1" colspan="1">Disease-modifying RANKL production (dosage)</td></tr><tr><td rowspan="2" align="left" valign="top" colspan="1">
<xref rid="R146" ref-type="bibr">Lemaire and Cox (2019)</xref>
<sup>
<xref rid="TFN19" ref-type="table-fn">2</xref>
</sup>
</td><td rowspan="2" align="left" valign="top" colspan="1">Denosumab, romosozumab</td><td align="left" valign="top" rowspan="1" colspan="1">Decreasing OPG production rate</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Decreasing TGF-&#x003b2; production rate</td></tr></tbody></table><table-wrap-foot><fn id="TFN19"><p id="P133">The modeling approach is denoted by superscripts as follows: (1) power law, (2) mass action kinetics, or (3) neither. All models that follow the mass action kinetics approach include RANK, RANKL, OPG, and TGF-<inline-formula><mml:math id="M12" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula>.</p></fn><fn id="TFN20"><p id="P134">Models that do not follow this approach but include any of the signals above are indicated by the <sup>&#x02021;</sup> symbol.</p></fn><fn id="TFN21"><p id="P135">Abbreviations: RANK, receptor activator of nuclear factor kappa-B; RANKL, receptor activator of nuclear factor kappa-B ligand; OPG, osteoprotegerin; TGF-<inline-formula><mml:math id="M13" display="inline"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula>, transforming growth factor beta; PMO, post-menopausal osteoporosis; OCL, osteoclasts; Ca, calcium; OBL, osteoblasts; SCL, sclerostin; PTH, parathyroid hormone.</p></fn></table-wrap-foot></table-wrap></floats-group></article>